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Summary 
        In a first part of the PhD research we established the degree of correspondence 
between the vaginal and the rectal microflora. The composition of the human vaginal 
microflora is affected by several host factors, including, among others, age, menarche, 
hormonal changes, sexual activity, pregnancy and the use of contraceptives or 
spermicides, as well as individual habits such as douching (405). Studies of vaginal 
lactobacilli have demonstrated that Lactobacillus crispatus, L. jensenii, L. gasseri and L. 
vaginalis are the most commonly recovered species of H2O2-producing lactobacilli (5, 
172, 287, 380) and the absence of H2O2-producing lactobacilli from the vagina has been 
associated with an increased risk for bacterial vaginosis (BV) (161, 241). BV is a 
condition whereby the lactobacilli are overgrown by anaerobic bacteria, such as 
Gardnerella vaginalis, Atopobium vaginae, Mobiluncus spp., Mycoplasma spp., 
Peptostreptococcus spp. and Prevotella spp. BV has been linked to increased shedding of 
HIV in the female genital tract (63), increased acquisition of HIV (161) and herpes 
simplex virus type 2 (63, 161) and with preterm birth (174). Several bacterial species 
are known to colonize both the gastrointestinal and the reproductive tract, and the 
rectum may play an important role as a source or reservoir for organisms that colonize 
the vagina (6, 238). The question remains whether these vaginal organisms are 
endogeneous or originate from the gastrointestinal tract.  
To establish whether the rectum can serve as a possible bacterial reservoir for 
colonisation of the vaginal econiche, we cultured vaginal and rectal specimen from 
pregnant women at 35-37 weeks of gestation as part of the group B streptococci (GBS) 
screening program to prevent GBS neonatal disease, we identified the isolates to the 
species level with tRNA intergenic length polymorphism analysis (tDNA-PCR) and 
genotyped the isolates for those subjects from which the same species was isolated 
simultaneously vaginally and rectally, by RAPD-analysis (100). Also we compared the 
genotype of GBS isolates between the vagina and rectum (99). To further establish the 
potential role of the rectum as a reservoir for the vaginal microflora, we quantified the 
bacterial loads of six of the vaginally most important species by quantitative real-time 
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PCR (qPCR), for those women where these species were present simultaneously in both 
niches (96). 
In summary, the species composition and the genotype similarity for those species 
simultaneously present in both niches, were unexpectedly high, indicating that indeed 
the rectum is probably the most important source of the vaginal microflora, or that 
strong dynamic exchange between both niches exist. This was further confirmed by the 
finding that for five of the six species tested (except for G. vaginalis), the vaginal and 
rectal bacterial load were in strong correspondence. 
A second part of this PhD research regarded improving the prepartum detection of 
group B streptococci. Group B streptococci (GBS) are an important cause of neonatal 
sepsis and meningitis, and maternal infection. Early neonatal GBS infection can be 
prevented by identifying high-risk pregnancies and administering intrapartum 
antibiotics. Two different strategies, the screening-based and the risk-based approach, 
are used today in order to decrease the incidence of early-onset neonatal infection. To 
detect GBS colonization in pregnant women, the CDC recommends isolation of the 
bacterium from vaginal and anorectal swab samples by growth in a selective enrichment 
medium, such as Lim Broth (Todd–Hewitt broth supplemented with selective 
antibiotics), followed by subculture on sheep blood agar (57). However, this procedure 
may require 48 h to complete and its sensitivity might be improved.  
We compared different sampling and culture techniques for the detection of group B 
streptococci (98) and found that rectovaginal sampling was the most sensitive method 
for sampling and that Granada agar and Chromagar were the most sensitive culture 
techniques, only slightly improved by Lim broth enrichment.  Also we compared two 
different targets (sip and cfb genes), using two different real-time PCR (qPCR) 
approaches, i.e. the hydrolysis probe (Taqman, Roche) and hybridisation probe 
(Hybprobe, Roche) techniques, directly on the clinical sample and after Lim broth 
enrichment, with the previously optimized culture approach (97), i.e. Lim broth 
enrichment, followed by subculture on Chromagar (97).  
We could establish that the sensitivity of these molecular techniques is significantly 
higher than that of the CDC recommended culture approach and also than that of our 
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improved culture approach. Rather surprisingly, the sensitivity of these molecular 
techniques is further significantly improved by Lim broth enrichment compared to 
direct application on the clinical sample. The consequences of this observation for the 
application of the rapid combined DNA extraction/qPCR techniques, as they are now 
available for intrapartum screening, are still unclear, and will be the basis for future 
research in the rapidly evolving GBS diagnostics. 
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Samenvatting 
        In het eerste deel van dit doctoraatsonderzoek, bepaalden we de overeenstemming 
tussen de vaginale en de rectale microflora. De samenstelling van de menselijke vaginale 
microflora wordt door verschillende gastheerfactoren bepaald, o.a. door leeftijd, 
menarche, hormonale veranderingen tijdens de menstruele cyclus, sexuele activiteit, 
zwangerschap en het gebruik van contraceptiva, maar ook door individuele 
gedragsverschillen (405). Studies van vaginale lactobacillen hebben aangetoond dat 
Lactobacillus crispatus, L. jensenii, L. gasseri en L. vaginalis de meest algemeen aanwezige 
H2O2-producerende lactobacillen zijn (5, 172, 287, 380) en de afwezighied van H2O2-
producerende lactobacillen in de vagina is geassocieerd geworden met een toegenomen 
risico op bacteriële vaginose (BV) (161, 241). BV is een toestand waarbij de lactobacillen 
zijn overgroeid door anaërobe bacteriën, zoals Gardnerella vaginalis, Atopobium vaginae, 
Mobiluncus spp., Mycoplasma spp., Peptostreptococcus spp. en Prevotella spp. BV is 
daarenboven in verband gebracht met toegenomen excretie van HIV in de vrouwelijke 
genitale tractus (63), toegenomen besmettingsrisico door HIV (161) en herpes simplex 
virus type 2 (63, 161) en met vroegtijdige geboorte (174). De vraag blijft of deze 
bacteriën van endogene oorsprong zijn, dan wel bvb. vanuit de gastro-intestinale tractus 
opstijgen. 
Verschillende bacteriële species zijn gekend om zowel de gastro-intestinale als de 
urogenitale tractus te koloniseren, en het rectum kan daarom een belangrijke rol spelen 
als reservoir voor de genitale microflora (6, 238). Om vast te stellen of het rectum 
inderdaad dergelijke rol kan spelen, kweekten we vaginale en rectale monsters bij 
vrouwen die 35-37 weken zwanger waren. Deze monstername gebeurt als onderdeel 
van de routine screening naar group B streptococcen (GBS). We identificeerden de 
gekweekte isolaten met tRNA intergenische lengte polymorfisme analyse (tDNA-PCR) en 
genotypeerden ook de isolaten voor die vrouwen waarbij we hetzelfde species zowel 
rectaal als vaginaal aantroffen, door middel van RAPD-analyse (100). We vergeleken ook 
de GBS-isolaten voor beide niches (99). Om de potentiële rol van het rectum als 
rerservoir voor vaginale microflora verder te documenteren, bepaalden we ook 
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kwantitatief het bacteriële inoculum van zes van de belangrijkste vaginale soorten, 
rectaal en vaginaal, d.m.v. real-time PCR (qPCR), voor die vrouwen waarbij deze soorten 
in beide niches waren aangetroffen (96).  
Samengevat, konden we aantonen dat zowel de soortsamenstelling als de genotypische 
identiteit van de isolaten van die soorten die terzelfdertijd in beide niches werden 
aangetroffen, onverwachts hoog waren. Dit is een sterke aanduiding voor de rol van het 
rectum als reservoir voor de vaginale microflora, of voor een sterke uitwisseling tussen 
beide niches. Dit werd verder bevestigd door de vaststelling dat voor vijf van de zes 
gesteste soorten (uitgezonderd voor G. vaginalis) het vaginale en het rectale bacteriële 
inoculum sterk correspondeerden. 
Een tweede deel van dit doctoraatsonderzoek betrof het verbeteren van de 
methodologie voor prepartum screening naar kolonisatie met GBS. GBS zijn een 
belangrijke oorzaak van neonatale sepsis en meningitis, en van maternale infectie. 
Vroege neonatale GBS-infectie kan voorkomen worden door hoog risico 
zwangerschappen op te sporen, zodat gepaste intrapartum antibiotica-therapie kan 
gestart worden. Twee verschillende strategieën, met name de screening-gebaseerde en 
de risico-gebaseerde benadering, worden momenteel toegepast om de incidentie van 
‘early-onset’ GBS-infectie te doen afnemen. Om GBS-kolonisatie van zwangere vrouwen 
te detecteren, beveelt het CDC aan de bacterie uit vaginale en anorectale monsters te 
isoleren door middel van aanrijkingscultuur, bvb. met Lim Broth (Todd-Hewitt broth 
met selectieve antibiotica), gevolgd door subcultuur op schapenbloedagar (57). Het 
nadeel is dat deze procedure in totaal 48 uur in beslag neemt en de gevoeligheid ervan 
voor verbetering vatbaar is.  
Wij vergeleken verschillende monstername- en kweektechnieken voor de detectie van 
GBS (98) en vonden dat rectovaginale staalname , zoals aanbevolen door het CDC, de 
meest gevoelige monsternamemethode was, en dat Granada agar en Chromagar de 
meest gevoelige kweektechnieken waren, slechts weinig verbeterd door voorafgaande 
Lim broth aanrijking.  
Ook vergeleken we twee verschillende genetische targets (de sip en cfb genen), gebruik 
makend van twee verschillende real-time PCR (qPCR) technieken, met name de 
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hydrolyse-probe (Taqman, Roche) en de hybridizatie-probe (Hybprobe, Roche) 
technieken, onmiddellijk op rectovaginaal monster en na Lim broth-aanrijking (97), met 
de eerder ge-optimaliseerde kweekmethode (93) (aanrijking op Lim broth, gevolgd door 
subcultuur op Chromagar). We konden aantonen dat de gevoeligheid van deze 
moleculaire technieken significant hoger lag dan die van de door het CDC aanbevolen 
kweek en ook dan die van de door ons ge-optimaliseerde kweek. Een verrassende 
bevinding was dat de gevoeligheid van deze moleculaire technieken nogmaals 
beduidend hoger lag na Lim broth aanrijking, in vergelijking met toepassing direct op 
het monster. De gevolgen van deze bevinding voor de toepasbaarheid van de snelle 
DNA-extractie/qPCR technieken, zoals ze sinds kort beschikbaar zijn voor intrapartum 
screening van GBS, zijn onduidelijk en zullen de basis vormen voor verder onderzoek in 
het snel evoluerende domein van GBS diagnostiek. 
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Research objectives 
      The main objectives of this doctoral thesis were to study vaginal and rectal 
colonization and to obtain a more complete knowledge of the composition of the vaginal 
microflora in pregnant women and to compare conventional culture methods and 
advanced molecular techniques in the prenatal screening programme of goup B 
streptococci.  
Specific objectives: 
1. To characterize the vaginal microflora using culture-dependent and culture-
independent analysis. 
2. To establish the potential role of the rectum as a reservoir for the vaginal microflora, 
using tDNA-PCR, RAPD analysis and qPCR. 
3. To improve prenatal screening of group B streptococci by comparing different 
selective media and different DNA detection chemistries. 
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Chapter I: General introduction 
I.1. Female genital tract 
       The female genital tract is composed of a sequence of cavities. The external genital 
tract (vulva) leads into the vagina that connects in succession to the endocervix, the 
uterus and then to the Fallopian (or uterine) tubes (Figure 1). The exposure of the 
female genital tract to the external environment carries with it the risk, caused by 
infections, of potentially compromising reproductive functions (406). Among the 
defense mechanisms that are operational in preventing infections in this area, 
undoubtedly one of the most important is the composition of the microflora that 
colonizes the vagina (406). 
 
 
Figure 1: The female genital tract. 
(from http://www.daviddarling.info/encyclopedia/F/female_genital_tract.html) 
 
At birth, the vagina of the female infant is sterile. Because of the elevated glycogen 
content of the neonatal vaginal epithelial cells, with the glycogen derived from the 
mother at birth, the infant’s vagina is colonized by lactobacilli migrating from the 
mother. This is in line with the generally recognized fact that the normal bacterial flora 
in humans originates from the mother (125). The vaginal microflora of the infant girl 
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becomes interspersed with contributions of coagulase negative staphylococci, 
streptococci, Escherichia coli and other intestinal bacteria. Small quantities of lactobacilli 
remain, however, and the oestrogen produced at menarche will cause a thickening of the 
vaginal mucosa (Figure 2), increased glycogen production (402). and possibly 
estrogenization and the expression of new receptors (Verstraelen, pers. comm.), a 
prerequisite for the propagation of lactobacilli, the dominant vaginal microflora of the 
adult female (291). The bacteria isolated from the vaginal secretions of women of 
childbearing age number around 107 or 108 CFU/g fluid (291). This microflora 
composition continues until the menopause, when it is replaced by a mixed flora not 
unlike that of the infant female, but with a considerable portion of Mycoplasma species 
and small quantities of anaerobic bacteria (including G. vaginalis). Hormone 
replacement therapy, when used, will cause lactobacilli to continue as the dominant 
microflora (125). 
 
 
Figure 2: The vaginal epithelium (Adapted from (355)). 
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I.2. Vaginal ecosystem 
A healthy vaginal ecosystem is characterized by an intact vaginal epithelium and a 
microflora dominated by lactobacilli. Lactobacillus spp. account for more than 95% of all 
bacteria present (105, 347). Also, these organisms are believed to provide defense 
against infection by maintaining an acidic pH in the vagina (31). The lactobacilli of 
healthy women tend to contain more hydrogen peroxide-producing species, which 
damage organisms lacking free radical scavengers (105, 107). Some lactic acid bacteria 
produce hydrogen peroxide (oxidizing agent) and bacteriocins, which are antimicrobial 
substances. Bacteriocin production is often proposed as a beneficial characteristic of 
probiotic bacteria (122, 201). It may contribute to the colonisation resistance of the 
host, i.e.  its protection against pathogens (35, 294). 
The composition of the vaginal ecosystem is not static but changes over time and in 
response to endogenous and exogenous influences (109, 110, 284, 331). Variables 
include stage of the menstrual cycle, pregnancy, use of contraceptive agents, frequency 
of sexual intercourse, specific sexual partners, vaginal douching, use of panty liners or 
vaginal deodorants, and utilization of antibiotics or other medications with immune or 
endocrine activities. Exposure to an altered milieu will cause a fluctuation in the local 
environment and heighten or diminish the selective advantage of specific vaginal 
microbes. For example, the loss of lactobacilli from the vagina has been associated with 
sexual intercourse or with the use of antibiotics for non-vaginal illnesses (110).  
 
I.3. The normal vaginal microflora 
The vaginal microflora of healthy asymptomatic women consists of a wide variety of 
anaerobic and aerobic bacterial genera and species dominated by the facultative, 
microaerophilic, anaerobic genus Lactobacillus.  
The first extensive study of the human vaginal microflora was published in 1892 by 
Döderlein (84). Döderlein and his contemporaries considered the vaginal flora to be 
homogeneous, consisting only of gram-positive bacilli. Döderlein's bacilli are now 
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known to be members of the genus Lactobacillus. A wide variety of microorganisms, 
including coliforms, diphtheroids, aerobic gram-positive cocci are recognized as a 
normal flora of the vagina. Anaerobic bacteria were recognized in the normal vagina as 
early as 1928 (159). In 1938, Weinstein reported that anaerobic organisms were 
present in the vaginal secretions of more than 90% of pregnant and nonpregnant 
women (391). Similarly, in 1947, Hite et al. reported the frequent observation of 
anaerobic organisms in the normal vagina (175). 
 
I.3.1. Vaginal lactobacilli 
Lactobacilli are Gram-positive, non-spore-forming microorganisms. Considering cellular 
shape, they can occur as rods or as coccobacilli. They are strictly fermentative, 
aerotolerant or anaerobic, requiring rich media to grow. They are catalase negative, 
even though pseudocatalase activity can be present in some species (116, 157). Since the 
first description of lactobacilli by Döderlein (84), it has been widely assumed that 
lactobacilli normally present in the vagina protect against the overgrowth of potentially 
pathogenic indigenous microflora and exogenous pathogens. The pathogenesis of 
bacterial vaginosis is thought to include the elimination or reduction of antibacterial 
activity expressed by indigenous vaginal lactobacilli (291, 337). Lactobacilli inhibit the 
in vitro growth of bacterial vaginosis-associated organisms, including species of 
Gardnerella, Mobiluncus, Peptostreptococcus, and Bacteroides (291, 337). Similarly, 
Candida vaginitis following systemic antibiotic therapy has been attributed to loss of the 
protective vaginal population of lactobacilli. Lactobacillus deficient conditions are 
associated with the development of numerous infections and promote the transmission 
of sexually transmitted diseases such as gonorrhoeae, chlamydiosis, syphilis, 
trichomoniasis, HIV, and HPV, whereby the latter may lead to cervical cancer (86). There 
are many different strains of lactobacilli present in the vagina, the most frequent being L. 
crispatus, L. jensenii, L. gasseri, L. iners and, and there is a wide variation in species and 
relative numbers of species according to the population studied (275). 
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1.3.2. Taxonomy of vaginal lactobacilli 
The genus Lactobacillus belongs to the lactic acid bacteria (LAB), to which also belong 
the genera Enterococcus, Leuconostoc , Oenococcus, Pediococcus, Sporolactobacillus and 
Streptococcus. LAB are representative of a group of bacteria, which are functionally 
related through their ability to produce lactic acid, either as a single product 
(homofermentative metabolism) or together with other products such as organic acids 
and ethanols (heterofermentative metabolism) (207). In 1928, Thomas identified the 
dominant vaginal species as being L. acidophilus. Determination of the species to which 
Döderleins bacillus belongs has been a long and complicated process (366). In early 
studies by Rogosa and Sharpe (301) and by Wylie and Henderson (412), the 
predominant species isolated from the vagina were identified as L. acidophilus and L. 
fermentum, with L. brevis, L. casei, L. delbrueckii, L. jensenii, L. plantarum, and L. salivarius 
isolated less frequently.  
Considering DNA base composition of the genome, lactobacilli usually show a GC content 
ranging from 33 to 55 mol% (352). In 1975, Carlsson reported with the help of 
phenotypic methods, that species in the L. acidophilus group were the dominant 
residents of the ecological niche constituted by the healthy human vagina (48), an 
assumption later confirmed through DNA homology studies. In 1987, using genotypic 
studies of isolates from 27 women, Giorgi et al. (142) suggested that the identification of 
L. acidophilus was erroneous and that L. crispatus, L. jensenii, L. fermentum, L. gasseri and 
an unidentified species were the predominant vaginal species. In 1999, two DNA-based 
studies of 97 vaginal specimens from Japan and 215 from the United States gave similar 
results (5, 345). Antonio et al. (5) indicated L. crispatus, L. gasseri, 1086V (later 
identified as being L. iners) and L. jensenii, as the four most common species 
encountered in the vagina, applying whole-chromosomal DNA probes.  L. iners was only 
recognized in 1999 (113) and was the last important vaginal Lactobacillus species thus 
far described.  
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The name L. acidophilus sensu lato is still in use to refer the name of a group of 
Lactobacillus species containing L. acidophilus sensu stricto (158), L. amylolyticus (27, 
134), L. amylovorus (262), L. crispatus (50), L. gasseri (222), L. gallinarum (133), L. 
helveticus (189), L. iners (113, 134), L. johnsonii (133) and L. kitasatonis (260). L. jensenii 
is part of the L. delbrueckii group. 
 
I.3.3. Lactobacilli and vaginal colonization resistance  
I.3.2.1.  Acid production 
Lactobacilli are acidotolerant, and the most frequently described mechanism for the 
control of growth of other populations by lactobacilli has been via the production of 
lactic acid. Because human metabolism can only produce L-lactate (39) whereas bacteria 
can produce both D- and L-lactate (28, 244, 341) the presence of D-lactate in serum has 
been found to be a marker for bacterial infection (339, 340), and the presence of D-
lactate can be similarly used as a marker for bacterial metabolism in other body fluids. 
The results reported by  Boskey et al. (30) support the hypothesis that vaginal bacteria, 
not epithelial cells, are the primary source of lactic acid in the vagina.  
With the onset of estrogen production during puberty, the amount of glycogen in the 
uterine wall and the vaginal epithelium increases. While it has been postulated that the 
breakdown of glycogen first to glucose, then to lactic acid by lactobacilli maintains the 
low pH characteristic of the healthy vaginal environment, the measured levels of lactic 
acid alone cannot account for the acid environment. Indeed, also the host releases many 
acidic secretions (249, 291) and therefore it is plausible that the predominance of 
lactobacilli reflects conditions provided by the host more than conditions created by the 
lactobacilli. The extent to which the microflora is determined by the environmental 
conditions provided by the host and the influence of microbial metabolites in 
determining the host environment remain to be established. In vitro studies showed that 
the concentrations of anaerobic bacteria increase with increasing pH, and that both G. 
vaginalis and Prevotella spp. are susceptible to low pH (31). McClean and McGroarty 
found that lactic acid and low pH had a greater inhibitory effect on G. vaginalis than 
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hydrogen peroxide. The in vitro experiments by Klebanoff et al. (205) showed that the 
hydrogen peroxide producing lactobacilli/myeloperoxidase/chloride system had 
maximum toxicity at a pH of between 5 and 6 (Figure 3). 
 
 
Figure 3: The inter-relation between lactobacilli, vaginal pH, and bacterial 
overgrowth in the etiology of bacterial vaginosis. 
 
I.3.2.2.  Hydrogen peroxide production 
Hydrogen peroxide is postulated to have a crucial role in protecting against the 
overgrowth of the pathogens in the vagina, since it can be inhibitory to bacteria, fungi, 
viruses and mammalian cells (29, 107). Hydrogen peroxide alone or in combination with 
halide and peroxidase, also present in vaginal secretions (205), has potent toxic 
properties. In vitro studies have documented that hydrogen peroxide producing 
lactobacilli are cidal to HIV 1 (204), G. vaginalis, Bacteroides sp. (205), Neisseria 
gonorrhoeae (350) and Candida albicans (121). The inhibition of the growth of one 
bacterial species by H202 generated by another species is a well-recognized mechanism 
of bacterial antagonism (71, 396). Lactobacilli, as well as other lactic-acid-producing 
bacteria, lack heme and thus do not utilize the cytochrome system (which reduces 
oxygen to water) for terminal oxidation. Lactobacilli utilize flavoproteins, which 
generally convert oxygen to H202. This mechanism, together with the absence of the 
heme protein catalase, generally results in the formation of H202 in amounts that are 
more than the capacity of the organism to degrade it. The H202 formed may inhibit or kill 
 22 
 
other members of the microflora (71, 396), particularly those which lack or have low 
levels of H202-scavenging enzymes, such as catalase peroxidase.  
The microbicidal activity of H202 is considerably increased by the enzyme peroxidase in 
the presence of a halide ion (202). Among the peroxidases, which can function in this 
way are those of milk and saliva (lactoperoxidase), neutrophils and monocytes 
(myeloperoxidase), eosinophils (eosinophil peroxidase) (191), and genital tract 
secretions (rat uterine fluid and human cervical mucus) (26, 206). The peroxidase and 
the halide ion greatly enhance the H202-dependent microbial antagonism between two 
bacterial species (203), between bacteria and viruses (204), between bacteria and 
spermatozoa, and between bacteria and mammalian cells (66). Hydrogen peroxide 
production of bacterial strains is easily measured on a culture medium called TMB 
(plus) agar (107, 249, 287), containing 3,3’,5,5’- tetramethylbenzidine dihydrochloride, a 
chromogen that colors blue in the presence of H2O2 and peroxidase, when exposed to 
(oxygen rich) air (Figure 4). 
  
Figure 4: Culture of a vaginal swab on TMBplus agar.  
Left: Bacteria positive for hydrogen peroxide production (blue colonies); Right: Bacteria 
negative for hydrogen peroxide production (white colonies). 
I.4. Bacterial vaginosis 
I.4.1. History and microbiology 
Bacterial vaginosis was first recognized in the late nineteenth century. In 1914, Curtis 
(70) reported an association between abnormal anaerobic vaginal microflora and 
vaginal discharge. In 1955, Gardner & Duke reported the clinical and bacteriological 
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aspects of a syndrome they termed Haemophilus vaginalis-vaginitis (nonspecific 
vaginitis), now renamed bacterial vaginosis (BV). Without using anaerobic culture 
techniques, the microaereophilic microorganism Haemophilus (later termed 
Corynebacterium, now renamed Gardnerella) vaginalis was said to be the sole etiological 
agent of BV, a claim that was almost immediately called into question (135). With 
today’s improved culture methods, it is generally recognized that anaerobic bacteria 
dominate the BV ecosystem, that G. vaginalis resides in small or moderate amounts in 
the vaginal ecosystem of every healthy woman, and that the bacteria tend to increase in 
number in a BV flora. But G. vaginalis has proved to be inadequate for accurate diagnosis 
of BV, even when semiquantitative culturing methods are used (179, 214). Because 
much of the vaginosis-associated microflora is anaerobic, the term ‘anaerobic vaginosis’ 
has been suggested (25). Several changes in nomenclature occurred over the years. In 
1984, the term bacterial vaginosis was proposed (237) and became widely accepted. 
The term ‘bacterial vaginosis’ indicates that bacteria rather than fungi or parasites 
apparently cause this syndrome. 
 
I.4.2. Definition 
Bacterial vaginosis is a polymicrobial syndrome in which the normal vaginal lactobacilli, 
particularly those producing hydrogen peroxide, have been replaced by a variety of 
anaerobic bacteria and mycoplasmas. Common bacterial species of bacterial vaginosis 
include G. vaginalis (49, 135, 149), Mobiluncus species (169), Bacteroides species (333), 
and Mycoplasma hominis (214) (Figure 5). 
Up to 50% of women with BV remain asymptomatic (410). Symptomatic BV on the other 
hand is most typically accompanied by foul-smelling, profuse vaginal discharge in the 
absence of any appreciable signs of inflammation(381). With bacterial vaginosis, 
concentrations of aerobes and anaerobes are generally elevated 100 to 1000-foldover 
levels in overtly healthy subjects (347). In addition to the microbiological alterations, 
biochemical changes, such as an increase in vaginal pH (4), production of volatile amines 
(62), bacterial sialidase (51), endotoxins (336) and cytokines (420), also occur in BV. 
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Immunoglobulins A (IgAs) against the hemolytic G. vaginalis toxin (Gvh) and sialidase 
and prolidase activities have been measured in the vaginal fluid of BV-positive women 
(52). 
 
Figure 5: Schematic overview of the transition from a healthy vaginal microflora 
to bacterial vaginosis. 
Despite the substantial microbial overgrowth, BV does not seem to be associated with 
signs of local inflammation. Polymorphonuclear leukocytes are usually absent or present 
in low numbers in the vaginal fluid of women with BV, and for this reason the term 
vaginosis has been used rather than vaginitis.  
 
I.4.3. Prevalence and epidemiology 
Bacterial vaginosis (BV) is a very common condition. Studies have revealed that the 
prevalence varies widely depending on the patient population. In the United States, the 
prevalence of BV was 29.2%, corresponding to 21 million women with BV and whereby 
only 15.7% of the women with BV reported vaginal symptoms. Prevalence was 51.4% 
among non-Hispanic blacks, 31.9% among Mexican Americans, and 23.2% among non-
Hispanic whites (212). BV is diagnosed in 9-38% of women attending gynecology clinics 
(73, 218, 418), in 61% of women attending sexually transmitted disease clinics (4, 103, 
108, 347), in 24 to 51% of lesbian women (178) and in up to 85% of female sexual 
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workers studied in Africa (106). Studies of pregnant women have documented similar 
prevalence rates to those seen in nonpregnant populations, ranging from 6% to 32% 
(171, 216, 252, 272, 280). Several risk factors for the acquisition of BV have been 
identified. Black race (145), smoking (192), sexual activity (42, 384), contraceptive 
practice and the use of  vaginal douching (161) have all been found to be associated with 
increased prevalence. 
 
I.4.4. Pathogenesis 
The massive overgrowth of vaginal anaerobes is associated with increased production of 
proteolytic carboxylase enzymes, which act to break down vaginal peptides to a variety 
of amines, which, at high pH, become volatile and malodorous, especially trimethylamine 
(16). The amines are associated with increased vaginal transudation and squamous 
epithelial cell exfoliation, creating the typical discharge (342). In conditions of elevated 
pH, G. vaginalis more efficiently adheres to the exfoliating epithelial cells, creating clue 
cells (i.e., vaginal epithelial cells studded with coccobacillary organisms) (135, 235, 342) 
(Figure 6). The presence of clue cells is the single most reliable predictor of BV (108).  
Amines further provide a suitable substrate for M. hominis growth. What remains 
unknown is whether the loss of lactobacilli precedes or follows this massive upheaval in 
anaerobic microflora (342). Since the original transmissible nature of BV was 
demonstrated by Gardner & Dukes in 1955 (135), several studies have confirmed that  
G. vaginalis and other BV-associated organisms may be transferred sexually (102, 180, 
279, 358). However, transmission alone is not sufficient to cause disease because most 
of the microorganisms are normally found in low numbers in the healthy vagina.  
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Figure 6: A clue cell (left) versus normal vaginal epithelial cell (right). 
 
I.4.5.  Complications of bacterial vaginosis 
In pregnant women, BV has been associated with an approximately twofold risk for 
premature rupture of membranes, and for giving birth to babies with low birth weight 
(171). BV is associated with chorioamnionitis and there is strong evidence of a causal 
relationship between ascending intrauterine infection and spontaneous preterm labor 
and delivery (144, 171, 173, 248, 380, 384), and with serious sequelae related to the 
first trimester miscarriage in women undergoing in vitro fertilization (289), amniotic 
fluid infections (334), postpartum and postabortal endometritis (390), and postabortal 
pelvic inflammatory disease (PID) (221).  
The aforementioned observations were the basis for recommending screening of all 
pregnant women for BV as a strategy to reduce the rate of preterm delivery (211). 
However, routine screening is not the present standard of care because of the highly 
contradictory results of prospective studies of treating pregnant women with BV (124). 
In non-pregnant women (357), bacterial vaginosis increases the risk of 
posthysterectomy infections (220, 346) and PID (171, 399), and increases the risk of 
transmission of sexually transmitted infections (161, 241, 400).  
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I.4.6.  Diagnosis of bacterial vaginosis 
I.4.6.1. Clinical features by Amsel criteria 
Bacterial vaginosis is a syndrome that can be diagnosed both clinically and 
microbiologically. In 1983, Amsel and colleagues (4) published a paper outlining clinical 
diagnostic criteria, and these are still in use today. The clinical diagnosis of bacterial 
vaginosis is made if three of the four following signs are present:  
1) An adherent and homogenous vaginal discharge 
2) Vaginal pH greater than 4.5  
3) Presence of clue cells  
4) positive whiff test (An amine odor after the addition of potassium hydroxide 
(10% KOH))  
Unfortunately, although these criteria are extremely useful in diagnosing symptomatic 
and asymptomatic BV, this method is unreliable because of the lack of microscopy-
related skills and availability of pH paper in the offices of most general practitioners, and 
therefore, thousands of women who complain of a malodorous discharge are invariably 
empirically diagnosed with BV without confirmation. A rapid, inexpensive point-of-care 
diagnostic test is, therefore, urgently required. 
 
I.4.6.2. Commercial point-of-care tests for the diagnosis of BV 
In clinical practice, different commercial point-of-care tests for diagnosing BV are 
available, based on biochemical reactions or on nucleic acid technology. 
I.4.6.2.1. pH measurements: 
Two point-of-care tests for assessment of vaginal pH have been commercialized: 
1- A self-test pH glove: A glove with an integrated pH indicator paper, developed in 
Germany in the early 1990s, by which women can monitor their vaginal pH by inserting 
one finger into the vagina. The glove has been broadly applied in population-based 
screening programs in Germany for the prevention of preterm birth, by which women 
were instructed to consult their physician if the pH was 4.7 or more (181).  
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2- Presence of trimethylamine in combination with vaginal pH assessment: This point-
of-care test, the FemExam® (CooperSurgical, Inc, CT, USA) test card, is based on 
determining of pH and trimethylamine levels in vaginal fluid for the diagnosis of BV; 
however the test did not compare favorably with Amsel’s criteria nor Nugent criteria in 
published studies (283, 293, 395). 
I.4.6.2.2. Presence of trimethylamine (electronic sensor array or electronic nose) 
The volatile organic amino acids responsible for the characteristic odor in BV have been 
used as a target in BV diagnosis. Osmetech Microbial AnalyserTM (OMATM) is an 
electronic nose system in which vaginal swabs are placed in a sample vial and analysed 
directly without the need for complex extraction procedures. The sample head space is 
passed over an application specific array of conducting polymer sensors, each of which 
has specific interactions to different volatile organic species based upon their size, shape 
and functional group (61). In a large diagnostic study, Hay et al. (162) obtained a 
sensitivity of 81.5% and specificity of 67.1% with the electronic nose compared with 
Amsel’s criteria, and a sensitivity and specificity 82.9 and 77.3% compared with Gram 
stain diagnosis.  
I.4.6.2.3. Testing for sialidase activity  
The BVBlue® Test (Gryphus Diagnostics, AL, USA) is a chromogenic diagnostic test based 
on the presence of elevated sialidase enzyme in vaginal fluid samples. The sialidase is 
produced by bacterial pathogens associated with BV, including Gardnerella and 
Mobiluncus (261). 
I.4.6.2.4. Testing for proline aminopeptidase activity 
Proline aminopeptidase activity (Pip Activity Test cardTM, Quidel Corp., CA and 
CooperSurgical, CT) is a rapid and reliable laboratory test for diagnosis of bacterial 
vaginosis and would be helpful in the clinical diagnosis of this disease. Elevated proline 
aminopeptidase activity has been shown to predict accurately women with a clinical 
diagnosis of bacterial vaginosis (319). However, this assay has significant practical 
disadvantages, the most notable of which is the production of a carcinogenic end 
product, alpha-naphthylamine (319).  
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I.4.6.2.5.  DNA probe for G. vaginalis rRNA 
The AffirmTM VP III Microbial Identification Test (BD Diagnostic Systems, NJ, USA) DNA 
hybridization assay is used for the detection and identification of Candida species, G. 
vaginalis and Trichomonas vaginalis from vaginal fluid specimens in both symptomatic 
and asymptomatic patients (41). It is based on the principles of nucleic acid 
hybridization and uses two distinct single-stranded probes for each organism, a capture 
probe and a color development probe. After completion of the test, the results of the 
assay can be visually observed  (41). The rapid turnaround time (between 30 and 45 
min) enables the availability of results to clinicians within 24 hours.  
I.4.6.3. Gram stain    
To perform a Gram stain, vaginal discharge is collected on a glass slide, allowed to air-
dry, Gram-stained in the laboratory, and examined under oil immersion at a 100 times 
magnification for the presence of bacteria. This diagnostic method has several 
advantages, including a permanent record, a high frequency of interpretable results, low 
cost, and ease of transport and storage (214). Over the past two decades, there have 
been several Gram stain diagnostic schemes used for the evaluation of BV.  
In 1892, Döderlein (84) described three grades of "vaginal cleanliness" based on 
microscopic examination of unstained vaginal fluid. Grade I indicates a "clean vagina" 
whereby lactobacilli predominate. Grade III is Döderlein's "pathological flora" where the 
discharge is described as "profuse and purulent or rather scanty and watery," and 
therefore appears to describe patients with bacterial vaginosis (BV) or trichomoniasis. 
Grade II is intermediate between Grades I and III and is associated with a mixed 
microflora including fewer lactobacilli than seen in Grade I.  
Numerous methods for microscopic diagnosis of BV have been described since that time. 
Dunkelberg (92) used the Gram stain to diagnose BV by the detection of clue cells. In 
1983, Spiegel and colleagues (348) published a paper describing an objective way to 
diagnose bacterial vaginosis by Gram’s stain. An inverse relationship between the 
quantity of the Lactobacillus cell morphology type, i.e. large gram-positive rods and of 
the Gardnerella cell morphology type, i.e. small gram-variable rods, was noted on Gram 
 30 
 
stain (P < 0.001)(348). When Gram stain showed a predominance (3 to 4+) of the 
Lactobacillus  cell type with or without the Gardnerella cell type, it was interpreted as 
normal. When Gram stain showed mixed flora consisting of gram-positive, gram 
negative, or gram-variable bacteria and the Lactobacillus cell type was decreased or 
absent (0 to 2+), the Gram stain was interpreted as consistent with BV (348). Spiegel 
and coworkers (348) demonstrated high intraobserver reliability for 20 specimens 
examined by three separate microbiologists. Although used for many years, the Spiegel 
system was criticized because there was no account for the spectrum of severity (266). 
 In 1991, Nugent and colleagues (266) addressed this problem and developed a scoring 
system, presented in The scoring criteria summed the weighted quantitation (0, 1 to 4+) 
of the following morphotypes to yield a score of 0 to 10 for each person: large gram-
positive rods (lactobacillus morphotypes) (weighted such that absence yielded the 
highest score), small gram-negative to -variable rods (G. vaginalis and Bacteroides spp. 
morphotypes), and curved gram-negative rods (Mobiluncus spp. morphotypes) (Table 
1).  
Table 1. Laboratory examination of vaginal smears and the determination of the 
Nugent Score. Cell types are scored as the average number seen per field by light microscopy 
of Gram stained smears at x1000 magnification with oil immersion. Total score= lactobacilli + G. 
vaginalis and Bacteroides spp. + curved rods.  
Score Lactobacillus cell types Number of Gardnerella 
and Bacteroides spp. cell 
types 
Number of Curved bacteria 
cell type (Mobilincus) 
0 > 30 0 0 
1 5-30 < 1 1-5 
2 1-4 1-4 > 5 
3 < 1 5-30  
4 0 > 30  
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The criterion for bacterial vaginosis is a score of 7 or higher. A score of 4 to 6 is 
considered intermediate, and a score of 0 to 3 is considered normal. Nugent scoring for 
Gram stained vaginal smears has shown high intercenter and intracenter reliability as 
well as high intraobserver and interobserver reproducibility (187, 243), but the reading 
of the slides needs to be done by trained staff and is rather time-consuming. Gram stain 
of vaginal secretions is more reliable than wet mount, with a sensitivity of 93% and 
specificity of 70%, but it is rarely used by practitioners (266). 
Another grading scheme for Gram stains was proposed in 2002 by Ison and Hay (185). 
The Ison and Hay criteria that were developed initially in a study of pregnant women 
just defined normal microflora, BV, and intermediate grades (185). It is based on the 
estimation the ratios of the observed cell types rather than on the exact number of the 
bacteria. This system was updated (185) to include two additional Gram stain categories 
(Table 2). Grade 0 was used to indicate smears with no bacteria and Grade IV those with 
only gram-positive cocci attached to epithelial cells. Both of these patterns may be most 
common in women who recently received antibiotic therapy. The scheme of Ison and 
Hay shows resemblances to the wet smear categorization (Reinheitsgrade) proposed by 
Schröder in 1921 (324).  
 
Table 2. Grading scheme according to Ison and Hay (163, 164, 185). 
 
Grade Categorization Gram stain microscopy 
0  Epithelial cells with no bacteria seen 
I Normal vaginal microflora Lactobacillus cell type 
II Intermediate vaginal 
microflora 
Reduced Lactobacillus cell type with mixed 
bacterial cell types 
III Bacterial vaginosis Mixed bacterial cell types with few or 
absent Lactobacillus cell types 
IV Gram positive cocci Epithelial cells covered with Gram positive 
cocci only 
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In 2005, Verhelst et al. (380) published a modification based on these Gram stain 
criteria. Grade I was divided into grade Ia, Ib and Iab and an additional category was 
created, called grade I-like. A grade Ia slide contains particularly thick (plump) and short 
Lactobacillus cell types whereas grade Ib consists mainly of long, small and less stained 
Gram positive rods. Grade Iab is a mixture of both types. In the additional category, 
grade I-like, especially diphtheroid cell types can be seen (Figure 7), and culture 
revealed Bifidobacterium species in 19 out of 36 grade I-like samples. 
 
Figure 7: Gram stain of vaginal swabs with grades according to (380).  
A: grade Ia; B: grade Ib; C: grade Iab; D: grade I-like; E: grade II; F: grade III.  
 
I.4.6.4. Fresh wet-mount microscopy 
Wet mounting has the advantage that it can be performed immediately and therefore 
allows immediate preventive, diagnostic, or therapeutic action where indicated. Using 
saline without additive colouring or fixation, Albert Döderlein (84) was able to show 
lactobacilli in vaginal secretions of healthy women and a Lactobacillus-deficient 
microflora in women with postpartum endometritis. His successor, Schröder, started to 
use this information in a broader clinical context, and the first VMF grading scheme was 
initiated (324).  
Schmidt et al. evaluated a scoring system (Table 3), weighting small bacterial 
morphotypes versus lactobacillary morphotypes.  The wet mount criteria of Schmidt and 
Hansen (314-316) resembles Nugent scoring (266) in that it ranks the quantities of 
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lactobacilli and cocci in the same way, although the demarcations of the intervals differ 
(105). Moreover, the Schmidt system does not incorporate the presence of Mobiluncus. 
The Schmidt method has been validated for diagnosis of BV in primary care populations 
(105). For wet mount, the numbers of lactobacilli and of G. vaginalis are evaluated, 
whereas for Nugent, next to these cell types (Gram positive rods: lactobacillary cell 
types, small Gram negative to variable rods: Gardnerella and Bacteroides spp. cell types) 
also curved Gram variable rods are taken into account but with a lower weight than the 
others. 
An international workshop on vaginal smear-based diagnosis of bacterial vaginosis 
showed that the interobserver reproducibility of interpretations of Nugent scores, Ison 
and Hay scores and wet smear scores for the diagnosis of bacterial vaginosis was high. 
(126). The scheme of Ison and Hay also showed resemblances to the wet mount 
categorization (Reinheitsgrade) proposed by Schröder in 1921 (Grade 1: Döderleins 
bacilli only, Grade II: Döderleins bacilli and other organisms, Grade III: organisms other 
than Döderleins bacilli) (324). 
Based on wet mount, Donders et al. (87) distinguishes lactobacillary grades I, IIa, IIb and 
III. They also compared the accuracy of lactobacillary grading screened by wet mount 
with that using Gram stained specimens in a small study and found a higher false 
positive rate in Gram stained specimens than in wet mounts (88). In addition, they use 
terms as aerobic vaginitis, desquamative vaginitis and BV and evaluate the presence of 
leukocytes and parabasal cells (86, 87).  
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Table 3. Scoring system for evaluation of bacterial cell types in wet mount preparation at x400 
magnification with phase-contrast microscopy 
Score Number of Lactobacillus 
Cell morphology types 
per field* 
Number of small 
bacterial cell  morphology 
types per field* 
0 > 30 0 
1 16-30 1-5 
2 6-15 6-15 
3 1-5 16-30 
4 0 > 30 
 
Bacterial cell morphology type (‘morphotype’) score (BMS) = lactobacillary  ‘morphotype’ score + small 
bacterial ‘morphotype’ score. A bacterial ‘morphotype’ score of 7–8 is indicative of bacterial vaginosis. 
* Number of ‘morphotypes’ is the average number observed  
 
I.4.6.5. Treatment 
The Centers for Disease Control and Prevention (CDC 2006) recommends testing all 
symptomatic women and treating those who are positive for BV. The recommended treatment 
for BV is metronidazole 500 mg orally twice daily for 7 days, or metronidazole gel 0.75% 
intravaginally daily for 5 days, or clindamycin cream 2% intravaginally once per day for 7 days 
(411). Alternative treatments include clindamycin, 300 mg orally twice a day for 7 days or 
clindamycin ovules 100 mg intravaginally once at bedtime for 3 days (411). The oral 
metronidazole can cause some minor but unpleasant side effects, but is believed to be the most 
effective treatment. The gels do not typically cause side effects, although yeast vaginitis can 
occur as a side effect of the medication. Tinidazole (Tindamax) is an antibiotic that appears to 
have fewer side effects than metronidazole and is also effective in treating bacterial vaginosis. In 
addition to being labeled for the treatment of trichomoniasis and bacterial vaginosis, it is also 
indicated for the treatment of giardiasis and amebiasis. Several studies (17, 231, 257) have 
indicated at least equivalent therapeutic efficacy compared with metronidazole, with 
some evidence of possible superior activity. However, additional studies will be required 
to support this claim. Secnidazole (267, 309) and ornidazole (104, 308, 309) have been 
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investigated in vivo, and seem to be as effective as metronidazole. Secnidazole has been 
also shown to be equally effective as metronidazole in vitro (74). An advantage of 
secnidazole over metronidazole is its longer half life time, such that only one dose needs 
to be taken, avoiding patient compliance related problems.  
I.5. Culture-dependent methods to study VMF 
I.5.1. Culture media 
Different media, selective, semi-selective and non-selective, have been used for culturing 
vaginal /rectal swabs. Non-selective media are generally used to estimate total numbers 
of both aerobic and anaerobic organisms. Media used for the recovery of facultative 
anaerobes are 5% sheep blood in tryptic soy agar, Columbia agar, mannitol salt agar, and 
MacConkey agar. Chocolate agar is used for the recovery of G. vaginalis, whereas the 
culture media for recovering anaerobes are prereduced Brucella-base agar with 5% 
sheep blood, enriched with hemin and vitamin K1 and prereduced Brucella-base agar 
with 5% laked sheep blood, 100 mg/mL kanamycin, and 7.5 mg/mL vancomycin,  
supplemented with hemin and vitamin K1 (81). Several selective/ semi selective media 
have been developed for cultivation of lactobacilli, i.e. Rogosa agar (300), de Man, 
Rogosa and Sharpe medium (MRS) (80), LBS (Lactobacillus selective agar (258)) and 
LAMVAB (Lactobacillus anaerobic MRS agar with vancomycin and bromocresol green 
(160)).  
HBT Bilayer Medium was described in 1982 by Totten et al. (367) for the selective 
isolation and detection of G. vaginalis from clinical specimens. It also supports the 
growth of the more fastidious Lactobacillus species, such as L. iners. Colonies of G. 
vaginalis may be differentiated by a diffuse, beta-hemolytic reaction, which they produce 
in the presence of human blood. Still, the fact that L. iners can grow on HBT, produces 
small colonies and stains Gram-negative (75) , is probably the main reason why several 
L. iners isolates have been misidentified as G. vaginalis (307). Gardnerella selective agar 
with 5% human blood is a partially selective and differential medium for the isolation of 
G. vaginalis from clinical specimens. It is based on Columbia CNA agar, which provides 
nutrients and the antimicrobials colistin and nalidixic acid, which inhibit Gram negative 
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but not Gram positive bacteria, and amphotericin B, which inhibits vaginal yeasts. The 
medium is supplemented with Proteose Peptone to improve the growth of Gardnerella. 
Human blood is added as a nutrient and to detect the characteristic diffuse beta 
hemolysis of the organism (373). A7 medium (Northeast Laboratory, Waterville, Maine) 
is used for the isolation of Mycoplasma and Ureaplasma species and Trichomonas 
vaginalis organisms can be detected with Diamond’s medium (PML Microbiologicals, 
Warwick, R.I.)  
The medium TMB-Plus consists of Brucella agar base, 3,3,5,5-tetramethylbenzidine, 
horseradish peroxidase, starch, vitamin K, hemin, magnesium sulfate, manganese 
sulfate, and horse serum. It is used for detecting H2O2 production by lactobacilli (287) 
(Figure 4). The disadvantage of selective media is their not absolute selectivity and their 
toxicity against certain isolates of the species, yielding some false positive and false 
negative results. 
I.5.2. Phenotypic identification methods 
Biochemical identification methods for vaginal bacterial species are cumbersome and 
have very limited discriminatory power. For example, there are no good biochemical 
reactivity identification schemes to discriminate between the different Lactobacillus 
species.  Also, based on a limited number of characteristics, L. iners has been 
misidentified as G. vaginalis (see also I.4.6.5.1). 
Boyd et al (36), evaluated the API 50 CH identification system for the identification of 97 
strains of commensal lactobacilli. They observed a high level of intraspecific phenotypic 
variability and a limited number of useful differences between species. This, in 
combination with a limited database for these species, limits the usefulness of 
phenotypic identification methods. 
I.5.3. Molecular identification and typing of cultured bacteria 
I.5.3.1. PCR-independent methods 
Using a DNA-hybridization method, Giorgi et al. (142) identified L. crispatus, L. jensenii 
and L. gasseri but not L. acidophilus, as the predominant vaginal Lactobacillus species 
colonizing the vagina of women with normal vaginal microflora. Song et al. (345) 
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identified Lactobacillus isolates from stool specimens of mothers and infants and from 
vaginal swabs of women to study the ecology of intestinal and vaginal lactobacilli (5).  
Also, Antonio et al. (5) used whole chromosomal DNA hybridization probes for known 
Lactobacillus species to identify isolates cultured from sexually active women. He 
identified L. iners as a member of the vaginal microflora and reported the species 
specificity of H2O2-production by lactobacilli. 
The most commonly employed target for molecular identification of bacteria is the small 
ribosomal subunit or 16S rRNA gene. Kullen et al. (215) and Tarnberg et al. (361) used 
sequencing of the V1-V3 region of the 16S rRNA gene for accurate identification of 
bacteria in the L. acidophilus group. 
I.5.3.2. PCR-dependent methods 
The combination of polymerase chain reaction (PCR) and denaturing gradient gel 
electrophoresis (DGGE) has been used to characterize the microflora isolated from 
different parts of the human body (43, 46, 246). Primers designed to amplify DNA have 
been largely based on universal bacterial 16S ribosomal subunit gene sequences (114, 
166, 297, 311, 423). DGGE and temporal temperature gradient gel electrophoresis 
(TTGE) have been successfully used for examination of the vaginal microflora (43, 46).  
Gancheva et al. (134) used molecular techniques such as Randomly Amplified 
Polymorphic DNA analysis (RAPD) and Amplification Fragment Length Polymorphism 
analysis (AFLP) for the identification on species level of members of the L. acidophilus 
group although these techniques are more commonly used for the typing of strains 
(intraspecies variability) than for identification. 
In our laboratory we use a technique that not only allows to unambiguously identify 
Lactobacillus species but also most cultivable species present in the vaginal microflora. 
tRNA-intergenic spacer length polymorphism PCR (tDNA-PCR), first described in 1991 
(393) allows rapid, discriminative and low cost identification of most cultivable bacteria.  
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I.5.3.2. Principle of tRNA intergenic polymorphism lenghth analysis (tDNA-
PCR). 
Baele et al.(10) applied tDNA-PCR using universal primers, followed by separation of the 
PCR products with capillary electrophoresis, in order to evaluate the discriminatory 
power of this technique within the genus Lactobacillus and were able to discriminate 21 
of 37 tested species.  It consists of the amplification of the spacer regions in between 
tRNA genes by use of consensus primers, which are complementary to the highly 
conserved edges of the flanking tRNA genes and are directed outwardly (Figure 8). The 
resulting PCR fragments can be separated by capillary electrophoresis. tDNA-PCR makes 
use of primers complementary to regions. 
It has been applied (combined or not with capillary electrophoresis) for e.g. 
Acinetobacter, (94, 398), Enterococcus  (9), Lactobacillus (10), Legionella (76), Listeria 
species (375), Staphylococcus (77, 232) and Streptococcus (77).  Verhelst et al. (379) 
combined culture with tDNA-PCR (9, 10, 393) and sequencing of the 16S rRNA-gene to 
characterize the vaginal microflora (5, 10, 45, 46, 377). Interestingly, tDNA-PCR is one of 
the few approaches that enables differentiation of most Lactobacillus species, including 
Lactobacillus crispatus, L. gasseri and L. iners, which were previously all lumped together 
into the L. acidophilus complex, moreover in a rapid and relatively cheap manner. We 
applied it for this doctoral research for the identification of rectal and vaginal microflora 
(100).  
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Figure 8: The principle of tRNA intergenic polymorphism length analysis (tDNA-
PCR). 
Several molecular techniques have been applied to study the genetic diversity of 
lactobacilli, such as restriction fragment length polymorphism analysis (RFLP) (143), 
ribotyping (299),  pulsed-field gel electrophoresis (PFGE) (378) and multilocus 
sequence typing (MLST) (47). Nigatu et al. (264) reported that RAPD can be used as a 
rapid, efficient and reproducible genetic tool for the classification and identification of 
Lactobacillus species.  
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I.5.3.3. Principle of RAPD (Random Amplification of Polymorphic DNA) 
RAPD (pronounced "rapid") stands for Random Amplification of Polymorphic DNA, 
whereby the fragments of DNA that are amplified are random. In this reaction, a single 
primer binds to the genomic DNA at two different sites on opposite strands of the DNA 
template. If these priming sites are within an amplifiable distance of each other, a 
discrete DNA product is produced through thermocyclic amplification (Figure 9). The 
presence of each amplification product identifies complete or partial nucleotide 
sequence homology, between the genomic DNA and the oligonucleotide primer, at each 
end of the amplified product. On average, each primer will direct the amplification of 
several discrete loci in the genome, making the assay an efficient way to screen for 
nucleotide sequence polymorphism between individuals. (392, 404). Because the RAPD 
technique is an amplification-based assay, only nanogram quantities of DNA are 
required, and automation is feasible. Because it relies on a large, intact DNA template, it 
has some limitations in the use of degraded DNA samples. Its resolving power is much 
lower than targeted, species specific DNA comparison methods, such as short tandem 
repeats. Despite producing simple patterns, RAPD has been used extensively to 
fingerprint bacteria (1, 115) and fungi (69, 147), to study phylogenetic and taxonomical 
relationships in plants (182), and to establish molecular relatedness and genetic 
variation in animals (271). 
I.6. DNA-based culture-independent methods to study VMF 
I.6.1. PCR-independent methods 
An approach complementing broad range PCR is characterization of the vaginal bacterial 
community by using nucleic acid probes, oligonucleotides complementary to rRNA gene 
targets. Probes are designed using sequences generated from broad range PCR and 
sequencing experiments which can have a wide range of phylogenetic specificities 
ranging from domain to strain levels. 
FISH (fluorescence in situ hybridization) is a cytogenetic technique used to detect and 
localize the presence or absence of specific DNA sequences on the genome of the 
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Figure 9: The principle of RAPD PCR analysis. 
 
bacteria in the sample. FISH uses fluorescent probes (often complementary to a 
sequence in the 16S or 23S rRNA gene) that bind to only those parts of the chromosome 
with which they show a high degree of sequence similarity. Fluorescence microscopy 
can be used to find out where the fluorescent probe bound to the bacteria. FISH 
evaluation of vaginal biopsy specimens demonstrates that the presence of an adherent 
vaginal biofilm that predominately hybridizes with a G vaginalis probe is sensitive and 
specific for detecting bacterial vaginosis (359). The main disadvantage of these probe-
based methods is their high workload, preventing fast analysis. In addition, these 
techniques can detect only species for which DNA probes have been prepared. An 
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advantage is that hybridization occurs without amplification, overcoming biases in 
quantification imposed by PCR amplification procedures and thus providing quantitative 
data. 
 
I.6.2. PCR-dependent methods 
Studies on many habitats have demonstrated the limitations of cultivation-dependent 
methods to assess microbial community composition. In most instances, this is because 
readily cultivated populations represent a small fraction of the extant community (245). 
In recent years, culture-independent methods based on the analysis of 16S and 18S 
rRNA gene sequences have been used to overcome many of these limitations (389). The 
16S rRNA gene which encodes a constituent part in bacterial ribosomes has a structure 
and size that makes it an excellent molecule to manage and manipulate, and has proven 
to be very useful in the study of vaginal lactobacilli. 16S rRNA gene has regions of 
sequence conservation that can be targeted with broad range PCR primers and areas of 
sequence heterogeneity that can be used to identify bacteria or infer phylogenetic 
relationships (13, 273, 317, 394). 
These methods have been successfully used in numerous studies to explore the 
microbial diversity in various habitats (46, 422, 424). Also they can reveal the existence 
of novel taxa and result in a perception of diversity that is quite different from that 
provided by cultivation-dependent methods (290). These studies have often included 
construction and analysis of 16S rRNA gene clone libraries to provide precise 
information as to the phylogeny of the constituent populations. In addition to being 
widely used for studies on the ecology of terrestrial and aquatic habitats (91, 95, 245), 
they are increasingly being used to study human and animal flora, including that of the 
colon and subgingival crevice (46, 177, 195, 213, 274, 356). 
Several manuscripts about cloning of the vaginal microflora have been published 
recently, using the 16S rRNA-gene (128, 183, 268, 379) or the chaperonin-60 gene 
(170). The gene encoding chaperonin-60 (cpn60) offers several advantages over the 
widely used 16S recombinant RNA (rRNA) gene as a target for microbial species 
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identification and phylogenetics. The cpn60 universal target region generally provides 
more discriminating and phylogenetically informative data than the 16S rRNA target, 
particularly between closely related species (40). Verhelst et al. (379)  published in 
2004 the results of a 16S rRNA-cloning experiment of the vaginal microflora of eight 
women and discovered the association between the previously not recognized bacteria 
A. vaginae, with G. vaginalis and BV. The association was confirmed by means of 
Terminal Restriction Fragment Length Polymorphism-analysis (tRFLP) (364, 383) and 
with DGGE (117). T-RFLP is a molecular technique for profiling of microbial 
communities based on the position of a restriction site closest to a labeled end of an 
amplified gene. The method is based on digesting a mixture of PCR amplified variants of 
a single gene using one or more restriction enzymes and detecting the size of each of the 
individual resulting terminal fragments using a DNA sequencer. The result is a graph 
image where the X axis represents the sizes of the fragment and the Y axis represents 
their fluorescence intensity. Verhelst et al, (380) reported that the agreement between 
Gram stain categorization as grade Iab and t-RFLP-analysis positive for L. crispatus was 
92.9% whereas L. crispatus was detected by tRFLP only in 27.3%, 20.0%, 22.5% and 0% 
for grades Ib, I-like, II and III, respectively. These results indicate the possiblity to 
recognize L. crispatus bacteria upon cell morphology, a finding that is of importance 
since this species is clearly associated with healthy microflora, and possibly better 
ensures stable healthy microflora than other lactobacilli (371). Verstraelen et al. (382) 
showed with tRFLP that the presence of L. crispatus, even when accompanied by the 
other Lactobacillus species, L. jensenii, L. gasseri and/or L. iners, is a prominent 
stabilizing factor to the vaginal microflora. 
Screening clones in a library by amplified ribosomal DNA restriction analysis (ARDRA) 
in order to limit the number of clones to be sequenced is also commonly used (376, 
379). ARDRA is based on the restriction digestion of 16S rRNA gene clones or amplified 
DNA and electrophoretic separation on high percent agarose or polyacrylamide gels 
(128). 
The recently available high-throughput 454 pyrosequencing now allows for in-depth 
sequencing and analysis of microbial community composition, and also for a dramatic 
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increase in throughput via parallel in-depth analysis of a large number of samples with 
limited sample processing and lower costs (156, 255, 385). This technique has been 
successfully used in various ecosystems including skin (120), chronic wounds (90), and 
oral microbiota (198). Ling et al. (229) confirmed that  the barcoded pyrosequencing 
approach can be a powerful tool for characterizing the microbiota in vaginal ecosystems 
compared with classical molecular ecological approaches, such as PCR-DGGE. They 
observed that at a high taxonomic level, the phylum of Bacteroidetes, Actinobacteria and 
Fusobacteria were significantly associated with BV. Also their data indicated that the 
vaginal communities including Gardnerella, Atopobium, Megasphaera, Eggerthella, 
Aerococcus, Leptotrichia/Sneathia, Prevotella and Papillibacter were clearly associated 
with BV. 
The broad-range bacterial PCR studies identified key organisms related to BV and 
opened the door for detection of these bacteria by either species specific PCR or 
quantitative real time PCR. Several assays for the detection of G. vaginalis, targeting 
respectively, the 16S-23S rRNA spacer region (269, 372, 421) or the 16S rRNA gene 
(263) were designed. In addition, species specific PCRs were developed for the 
fastidious anaerobic Mobiluncus spp. (269, 330) and Mycoplasma spp. (421), which is of 
special importance for the latter, as this species is not detected by Gram staining. 
Recently, several research groups applied species specific PCR for A. vaginae since this 
species was found to be more specific for BV than G. vaginalis (44, 118, 128, 379) 
Species specific PCR studies that applied combination of key organisms suggested that 
PCR-based amplification might potentially be used for molecular diagnosis of BV and 
resulted in the application of qPCR allowing also quantification of the bacteria. 
I.6.3. Quantitative real time PCR 
The first efforts to investigate the applicability of qPCR for the diagnosis of BV came 
from Zariffard et al. (421), who determined the feasibility of using this technique to 
detect and quantify Lactobacillus species, G. vaginalis and Mycoplasma hominis in the 
genital tract of 21 women using stored vaginal samples.The results show that samples 
from women that were diagnosed clinically as having BV had significantly higher 
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numbers of G. vaginalis but significantly lower numbers of lactobacilli. In another study, 
Sha et al. (332) compared Nugent score with Amsel criteria and quantitative bacterial 
PCR for diagnosing BV in 203 samples from women with Nugent scores of 7-10 (BV-
group) and 203 samples from women with Nugent scores of 0-3 (no-BV group). 
Although there was significant overlap in the log10 Lactobacillus counts between the two 
groups, their data demonstrate that quantitative bacterial PCR for G. vaginalis, M. 
hominis and lactobacilli significantly correlates with the Nugent Gram-stain method with 
regard to diagnosis of BV. 
Several research groups also applied an A. vaginae qPCR to study the role of this species 
in BV (38, 119, 360, 368). Bradshaw et al. (38) and Ferris et al. (117) studied the 
presence of A. vaginae before and after treatment with metronidazole. Bradshaw et al. 
found higher recurrence rates in women for whom both A. vaginae and G. vaginalis had 
been detected pretreatment, and Ferris et al. found that high pretreatment A. vaginae 
concentrations are predictive of adverse treatment outcomes for BV patients. De Backer 
et al. (75) used qPCR and found that the presence of A. vaginae seems to be 
diagnostically a more valuable marker for BV than the presence of G. vaginalis. 
Recently, a few research groups applied broader sets of qPCR for the diagnosis of BV. 
Menard et al. (254) used series of species-specific primers for qPCR targeting 
Lactobacillus species, G. vaginalis, Mobiluncus curtisii, M.  mulieris, Ureaplasma 
urealyticum, A. vaginae, M. hominis, and Candida albicans. They were able to document 
that the presence of A. vaginae at a level of 108 copies/ml or more and of G. vaginalis at a 
level of  109 copies/ml or more was highly predictive for BV (254). 
 
Fredricks et al. (129) used eight qPCR assays targeting both easily cultivated vaginal 
bacteria (G. vaginalis and L. crispatus) and fastidious bacteria (BVAB1, BVAB2, BVAB3, 
Leptotrichia/Sneathia, Atopobium and Megasphaera-like species) to determine how 
concentrations of vaginal bacteria change in women with BV by comparing women who 
cured to women with persistent BV one month following vaginal metronidazole 
treatment. Successful antibiotic therapy resulted in 3- to 4-log reduction in the median 
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bacterial loads of BVAB1, BVAB2, BVAB3, a Megasphaera-like bacterium, Atopobium 
species, Leptotrichia/Sneathia species and G. vaginalis. 
With the advent of qPCR, it has also become possible to quantify the bacterial loads of 
different species at different sites (e.g. vaginal vs rectal microflora)(96, 100) or at 
different time points (e.g. during different periods of the menstrual cycle (Lopes et al. in 
preparation). 
A huge range of qPCR formats has been described. Besides detection of the amplified 
DNA by means of the DNA binding dye SYBR Green (24, 75, 119), different probe-based 
formats have been described, using hybridization probes (8, 196, 208), a hydrolysis 
probe (22, 129, 194, 253)(Figure 10), molecular beacons (369, 370) and scorpions (302, 
397)(Figure 11).  
I.6.3.1. DNA binding dyes 
SYBR Green provides the simplest and most economical format for detecting and 
quantitating PCR products in real-time reactions. SYBR Green binds double-stranded 
DNA, and upon excitation emits light (Figure 10A). Thus, as a PCR product accumulates, 
fluorescence increases (259). The advantages of SYBR Green are that it is inexpensive, 
easy to use, and sensitive. The disadvantage is that SYBR Green will bind to any double-
stranded DNA in the reaction, including primer-dimers (298) and other non-specific 
reaction products, which results in an overestimation of the target concentration. For 
single PCR product reactions with well designed primers, SYBR Green can work 
extremely well, with spurious non-specific background only showing up in very late 
cycles. Accurate results demand a specific PCR, which can be confirmed via dissociation 
curve analysis, where the presence of different PCR products is reflected in the number 
of first-derivative melting peaks (298) or gel analysis (226).  
I.6.3.2. Hybridization probes 
In this technique (Figure 10C), one probe is labeled with a donor fluorochrome (e.g. 
FAM) at the 3’ end and a second probe is labeled with an acceptor fluorochrome (e.g. LC 
Red640, LC red 705) at its 5’ end. When the two fluorochromes are in close vicinity (i.e. 
within 1–5 nucleotides), the emitted light of the donor fluorochrome will excite the 
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acceptor fluorochrome, a process referred to as fluorescence resonance energy transfer. 
This results in the emission of fluorescence, which subsequently can be detected during 
the annealing phase and first part of the extension phase of the PCR reaction. After each 
subsequent PCR cycle more hybridization probes can anneal, resulting in higher 
fluorescence signals (374). 
I.6.3.3. Hydrolysis probe 
In the hydrolysis probe assay (Figure 10B), exemplified by the TaqMan chemistry, also 
known as the 5′ nuclease assay, fluorescence is generated upon probe hydrolysis to 
detect PCR product accumulation. TaqMan probes depend on the 5'- nuclease activity of 
the DNA polymerase used for PCR to hydrolyze an oligonucleotide that is hybridized to 
the target amplicon. TaqMan probes are oligonucleotides that have a fluorescent 
reporter dye attached to the 5' end and a quencher moiety coupled to the 3' end (139), 
which allows the quencher to reduce the reporter fluorescence intensity by FRET when 
the probe is intact (67). These probes are designed to hybridize to an internal region of a 
PCR product. In the unhybridized state, the proximity of the fluor and the quench 
molecules prevents the detection of fluorescent signal from the probe. During PCR, when 
the polymerase replicates a template on which a TaqMan probe is bound, the 5'- 
nuclease activity of the polymerase cleaves the probe. This decouples the fluorescent 
and quenching dyes and FRET no longer occurs. Thus, fluorescence increases in each 
cycle, proportional to the amount of probe cleavage. Several different fluorophores (e.g. 
6-carboxyfluorescein, acronym: FAM, or tetrachlorofluorescin, acronym: TET) and 
quenchers (e.g. tetramethylrhodamine, acronym: TAMRA, or dihydrocyclopyrroloindole 
tripeptide minor groove binder, acronym: MGB) are available (217). 
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Figure 10: Real-time PCR detection chemistries (374).  
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Figure 11: Molecular beacon (leftt) and scorpion technology (right). 
(Adapted from http://www.gibthai.com/services/technical_detail.php) 
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I.7. Prenatal screening of Group B streptococci 
I.7.1. Group B streptococci  
The Group B Streptococcus (GBS) (Streptococcus agalactiae) is an important cause of 
neonatal infection. In 1935, Rebecca Lancefield described asymptomatic vaginal carriage 
of GBS (219). Three years later, Fry reported three cases of fatal puerperal sepsis with 
GBS (132) and shortly thereafter, Hill and Butler described severe and fatal cases, 
following childbirth in Melbourne (168). In the 1970s, GBS emerged as the primary 
pathogen causing neonatal sepsis (127). This disease affects 0.6 per 1, 000 births (20). 
GBS is a Gram-positive diplococcus (Figure 12), which grows under both aerobic and 
anaerobic conditions (14). The organism has a polysaccharide capsule that defines the 
individual serotypes of GBS. Several serotypes of GBS have been identified and they are 
numbered Ia, Ib, II-VIII. The most common serotypes causing neonatal infections are Ia, 
III and V.  
 
Figure 12: Gram stain of Streptococcus agalactiae. 
 
I.7.2. The Streptococcus agalactiae pan-genome model 
A bacterial species can be described by its pan-genome, which is composed of a core 
genome containing genes present in all strains, and a dispensable genome containing 
genes present in two or more strains and genes unique to single strains (250). S. 
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agalactiae species can be described by a pan-genome consisting of a core genome shared 
by all isolates, accounting for 80% of any single genome, plus a dispensable genome 
consisting of partially shared and strain-specific genes. Mathematical extrapolation of 
the data suggests that the gene reservoir available for inclusion in the S. agalactiae pan-
genome is vast and that unique genes will continue to be identified even after 
sequencing hundreds of genomes. (363). Presently, the pan-genome of Group B 
Streptococcus (GBS), contains 2713 genes, of which 1806 belong to the core genome, and 
907 belong to the dispensable genome. The GBS pan-genome is predicted to grow by an 
average of 33 new genes every time a new strain is sequenced (250). The dispensable 
genome contributes to the species’ diversity and probably provides functions that are 
not essential to its basic lifestyle but confer selective advantages including niche 
adaptation, antibiotic resistance, and the ability to colonize new hosts (363). The 
genomes of multiple, independent isolates are required to understand the global 
complexity of bacterial species. The concept of the pan-genome is not just a theoretical 
exercise; it also has fundamental practical applications in vaccine research. Analysis of 
multiple GBS genomes was found to be instrumental for the development of vaccines 
(234) and for the functional characterization of important genetic determinants (223). 
Recently, it was shown that the design of a universal protein-based vaccine against GBS 
was only possible using dispensable genes (234). In addition, the sequencing of multiple 
genomes was instrumental in discovering the presence of pili in GBS, an essential 
virulence factor that had been missed by all conventional technologies (251). 
 
I.7.3. Epidemiology  
Both men and women can be colonized with GBS in the lower gastrointestinal and 
genital tract and the bacteria can be transmitted sexually. An estimated 20-30% of all 
pregnant women are GBS carriers and the colonization can be permanent but also 
intermittent or transient and 50–70% of infants born to these women will themselves 
become colonized with the bacterium. Selective culture methods are used to optimize 
the isolation of GBS from a complex microflora in the vagina and rectum (137, 224, 285). 
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Because colonization can be intermittent or transient, culture status can vary between 
pregnancies, and therefore screening during each subsequent pregnancy is advised. The 
predictive value of prenatal screening improves with shorter intervals between culture 
and delivery (37, 417), so that prenatal screening at 35–37 weeks of gestation is 
currently recommended. Chemoprophylaxis with penicillin at delivery should be based 
upon the 35–37 week culture even if earlier cultures were obtained (137). 
Cross-sectional studies in the United States have found GBS colonization rates to be 
higher in African-American women compared with Caucasians or Asians (292) and 
international reports confirm racial or ethnic differences are likely evident after 
accounting for methodological differences (323, 354, 365). Nearly 80% of all invasive 
GBS infections occur in the first few days of life (325). The CDC reported in 1997 that 
most of the cases were caused by bacteremia. Ten percent of those infected with GBS 
had meningitis, but not all cases of meningitis were associated with bacteremia. Gender 
does not appear to play a role in the development of either early- or late-onset GBS 
infection (14). 
The incidence of GBS infection varies geographically as well as from hospital to hospital 
(55, 148). This might be related to the presence or absence of formal policies about the 
selective use of intrapartum chemoprophylaxis(55). 
GBS infection has been known to recur. Estimates place the recurrence rate at 
approximately 1 % for newborns who were symptomatic and treated appropriately. 
Baker et al. (15) and Schuchat et al. (14, 325) noted that 50% of newborns with 
recurrent GBS infection have a new site of involvement with the second episode. 
 
I.7.4. Pathogenesis  
The gastrointestinal tract is the usual reservoir in females, whereas GBS can be isolated 
in 45% to 63% of male urethras (55, 56, 59). The bacteria are also found in the genital 
tract, urinary tract, throat, and respiratory tract. Genital tract colonization poses the 
most important threat to the newborn, because of exposure during the birth process, 
and to the mother, because of ascending infection after the membranes rupture. 
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Colonization is found in the rectum more often than the vagina, in the vagina more than 
the urethra, and in the urethra more than the cervix (Figure 13).  
 
Figure 13: GBS colonization in pregnant women. 
Vertical transmission with colonization of the newborn is reported to occur in 5-40% of 
all pregnancies (148, 197, 276, 312) with 38% of GBS-colonization in women with 
membranes ruptured less than 12 hours and 73% in women with a longer duration of 
membrane rupture (167, 296). Increased duration of internal monitoring and increased 
number of vaginal examinations also augment the risks for the laboring woman and her 
newborn (326, 415). Intrapartum fever is seen more frequently in women of affected 
newborns (327, 344). One to two percent of newborns exposed to GBS during the birth 
process subsequently develop GBS disease (82, 153, 344). The neonatal mortality rate 
with GBS sepsis is 5% to 6%, with major neurological sequelae in surviving newborns 
(247). Most mothers of neonates with early-onset disease did not receive intrapartum 
antibiotics (233). 
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I.7.5. Maternal complications and complications during pregnancy 
GBS colonization in women is rarely life threatening but can cause infections and 
complications during the antepartum, intrapartum, and postpartum. Approximately 
50,000 colonized women are affected annually with GBS-related illness in the United 
States (54, 55). Bacteremia is the primary symptom for 64% of pregnant women with 
GBS disease (323). Failure to recognize and treat bacteremia, which can be 
asymptomatic in about 6% of pregnant women, can lead to further urinary tract 
complications such as pyelonephritis (138, 419). Pregnancy-related infections are 
sepsis, amnionitis, urinary tract infection, and stillbirth.  
 
I.7.6. Clinical features 
In neonates two syndromes exist: early-onset (< 7 days old) and late-onset (7-90 days 
old). Both include sepsis, pneumonia and meningitis.  
I.7.6.1. Early-onset GBS 
Early-onset GBS infection is caused by vertical transmission whereby the organism 
ascends into the chorioamnionic space prior to birth. Between 75% and 80% of 
newborns with early-onset GBS infection are born at term. However, premature 
newborns are more likely to develop early-onset GBS infection than full-term newborns 
(14, 312). Information from the National Institute of Child Health and Human 
Development (NICHD) Neonatal Research Network (353) found that GBS is the cause of 
approximately 31 % of all infections in low-birthweight newborns. 
I.7.6.1.1. Manifestation of early-onset GBS 
The most common sign of newborns with early-onset GBS infection is respiratory 
distress. Their chest x-rays are often indistinguishable from those of newborns with 
respiratory distress syndrome. Only about one third of newborns with congenital 
pneumonia will have infiltrates apparent on chest x-rays; Pleural effusions also may be 
present (14). In addition, infected newborns may have other nonspecific symptoms such 
as lethargy, poor feeding, temperature instability, and glucose instability. More ominous 
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signs of severe invasive infection include hypotension, which may occur in up to 25% of 
all cases; fetal asphyxia, related to being infected in utero; rapidly worsening respiratory 
distress; and persistent pulmonary hypertension. Newborns with meningitis may not 
have signs different from those of newborns with GBS septicemia or pneumonia, 
although seizures can occur in the first 24 hours of life (14).  
I.7.6.1.2. Risk factors for early-onset GBS 
Risk factors for early-onset GBS disease have been well-characterized and include 
maternal GBS colonization, prolonged rupture of membranes (i.e. more than 18 hours), 
frequent vaginal examination during labor, preterm delivery, GBS bacteriuria during 
pregnancy, delivery of a previous infant with invasive GBS disease, maternal 
chorioamnionitis as evidenced by intrapartum fever, young maternal age, African or 
Hispanic ethnicity and low levels of antibody to type-specific capsular polysaccharide 
antigens (37, 328, 329, 416). It is possible for newborns with no known maternal 
predisposition for GBS to develop invasive disease. In addition, nosocomial early-onset 
GBS infection has been known to occur (14). 
I.7.6.2. Late-onset GBS infection 
Newborns who present with late-onset GBS do not have signs of infection in the first 
week of life. The symptoms also may be somewhat indistinct, such as lethargy, poor 
feeding, or irritability. Most of the isolates of late-onset GBS infection are serotype III, 
and approximately 30% to 40% of the newborns with late-onset GBS will have 
meningitis (14, 329). Newborns with meningitis will generally have fever, and 20% to 
30% will have had symptoms of an upper respiratory tract infection. Otitis media may 
be present. Permanent neurologic sequelae in varying degrees are evident in a large 
number of newborns with GBS meningitis (14). 
I.7.6.2.1. Manifestations of late-onset GBS 
Late-onset GBS infection also can have a focal presentation. Facial cellulitis is being seen 
with increasing frequency, more often in males than females. Septic arthritis and 
osteoarthritis also are seen more often in late-onset infection. Just as with early-onset 
GBS infection, there have been isolated reports of the infection occurring in almost every 
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organ (14). Late-onset GBS infection has a mortality rate of 2% to 6%, and the incidence 
has not changed following the advent of intrapartum chemoprophylaxis (55, 323). 
However, as with early-onset disease, the initial presentation may vary markedly. 
Newborns with late-onset infection who present with symptoms such as apnea, seizures, 
leukopenia, or neutropenia are more likely to have a fatal outcome. 
I.7.6.2.2. Risk factors for late-onset GBS 
Risk factors associated with late-onset GBS infection have not been well defined. Vertical 
transmission and nosocomial acquisition are the most likely sources (14, 325, 329). 
Prematurity and African ethnicity are recognized also as a risk factors for late onset GBS 
(228). Baker and Edwards (14) reported that although GBS can be acquired 
nosocomially, it does not appear to cause outbreaks in nurseries. Newborns who are 
colonized with GBS do not need to be isolated. Colonization has been reported to last for 
several months after birth, even in newborns treated for GBS infection (3). Newborns 
who present with late-onset GBS do not have signs of infection in the first week of life. 
 
I.7.7. Treatment 
The most recent treatment recommendations for newborns are ampicillin with the 
addition of an aminoglycoside (3). This broad-spectrum coverage allows the newborn to 
be treated for other causes of sepsis, including Escherichia coli, Listeria monocytogenes 
and Enterococcus fecalis (176, 310). Johnson et al. (188) suggested that ampicillin alone 
might be adequate empiric coverage for asymptomatic full-term newborns. Their review 
of more than 5,000 newborns found that only one benefited from the addition of 
gentamicin, whereas all were exposed to the ototoxic side effects of the drug. The 
American Academy of Pediatrics (3) recommends that antibiotics be discontinued after 
48 hours of treatment if laboratory results are negative and the clinical course is not 
consistent with invasive disease. Baker & Edwards (14) recommended not to continue 
antibiotic treatment for more than 72 hours, unless blood or cerebral spinal fluid 
cultures are positive or the clinical course is consistent with septicemia or pneumonia.  
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I.7.8. Prevention 
Schuchat et al. (325) suggested that GBS infection is now a public health concern and the 
focus should be primarily on prevention, not treatment. The US Centers for Disease 
Control and Prevention (53) suggests that prevention of GBS infection might be 
compared with other perinatal prevention strategies, such as the use of folic acid to 
prevent neural tube defects and vaccination to prevent transmission of hepatitis B 
infections. The dramatic decrease in the incidence of early-onset GBS infection since the 
adoption of guidelines for selective intrapartum chemoprophylaxis supports this view 
(321). 
It is important to note that, the decrease in incidence has occurred only in early-onset 
cases. Further prevention strategies that address late-onset GBS infection, the incidence 
of which has remained stable, are necessary. It has been suggested that intrapartum 
chemoprophylaxis interrupts the vertical transmission of GBS from mother to newborn 
but has no effect on infection by GBS to which the newborn may subsequently be 
exposed (55). The concept of a vaccine for GBS is based on the finding that the absence 
of antibodies to the GBS capsule is correlated with the development of invasive infection 
(13). Because there are multiple capsular serotypes of GBS, vaccine development will 
most likely need to be specific to the serotypes causing the (late-onset) infections. 
 
I.8. Laboratory diagnosis of Group B streptococci 
I.8.1. Culture 
In 2002, the Centers for Disease Control and Prevention (CDC) recommended that all 
pregnant women be screened for carriage of GBS at between 35 and 37 weeks of 
gestation (57, 58). The CDC currently recommends screening cultures using selective 
broth medium for the recovery of GBS from vaginorectal specimens. Because the 
sensitivity of selective culture methods for detection of GBS colonisation depends on the 
timing and method of collection and on the processing of the specimens, the protocols 
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for sample collection, as recommended by the CDC, should be strictly followed (327). A 
good laboratory algorithm includes inoculation - whereby the inoculum size has not 
been specified by the CDC, into a selective broth medium, i.e. Todd–Hewitt broth 
supplemented either with 15 μg colistin and 10 μg nalidixic acid (Lim broth)(227) or 
with 8 μg gentamicin and 15 μg nalidixic acid (12), and incubation for 18–24 h, followed 
by inoculation onto sheep-blood agar and incubation for an additional 18–24 h. If no GBS 
are identified, the plate should be re-incubated for an additional 24 h (59). Culturing 
GBS to sufficient numbers to carry out subsequent identification can therefore take 2–3 
days. However, this method has a slow turnaround time requiring 36—72 h before 
results can be issued. Also, this method requires an experienced technician to identify 
suspect colonies, which are not always β-hemolytic.  
In the recent guidelines (2010) of the Centers for Disease Control and Prevention 
(CDC)(58), the following key changes were made from the 2002 guidelines: GBS 
identification options were expanded to include a positive identification from 
chromogenic media and identification directly from enriched broth (Figure 14). Nucleic 
acid amplification tests (NAAT), such as commercially available PCR assays, can also be 
used after enrichment, if laboratories have validated NAAT performance and included 
appropriate quality controls. Also the direct plating option can be included in addition to 
enriched culture, although it has lower sensitivity than enriched culture and should not 
be used as sole means to detect GBS. 
Group B streptococci can be confirmed using biochemical tests like a positive catalase or 
hippurate hydrolysis reaction, the CAMP test (Figure 15), a positive bile esculin test 
(111) and serological tests. The CAMP test (named after Christie, Atkins and Munch-
Petersen) is used for the presumptive identification of GBS, yielding positive results for 
up to 98% of GBS isolates (209). 
It is based on the fact that GBS produce an extracellular protein called the CAMP factor. 
This protein acts synergistically with Staphylococcus aureus β-toxin to hydrolyse red 
blood cells. However, a small percentage of group A streptococci and some strains of 
Listeria monocytogenes are also CAMP-positive (209). Hippurate hydrolysis, for which 
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approximately 96% of GBS isolates are positive  (112) is another physiological 
characteristic used for the presumptive identification of GBS (306).  
More recently, a selective and differential agar , known as Granada agar, has also been 
used for the presumptive identification of GBS (78, 140). In principle only GBS produce a 
red–orange carotenoid pigment when grown anaerobically on this starch containing 
medium (79, 304). Pigment is produced in 93.0–98.5% of GBS human isolates (140, 
303). The production of the carotenoid pigment is linked to the GBS β-
hemolysin/cytolysin (βH/C) which is encoded by cylE (230). Several in-vitro and animal 
model studies have demonstrated the important role of βH/C in the virulence of GBS 
(230) and showed that non-hemolytic strains are less virulent. Non hemolytic GBS and 
non pigmented GBS occur in 1-2% of pregnant women. Several studies reported GBS 
infection with non hemolytic strains of GBS(65, 98, 151, 270, 386). 
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Figure 14: Algorithm for recommended prenatal group B streptococcal laboratory 
testing(CDC 2010). 
Vaginal rectal swab 
Enrichment broth (non-pigmented or pigmented). Incubate 18-24hrs at 35-37°C 
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Figure 15: CAMP test for S. agalactiae (positive, upper left streak) and 
Enterococcus faecalis (negative, lower right streak), with vertical streak of 
Staphylococcus aureus on blood agar. 
 
A major limitation of Granada agar is the requirement for anaerobic culture conditions, 
although the requirement for anaerobic incubation can be circumvented by the 
application of a cover slide on the inoculum (303). Another selective and chromogenic 
medium, known as ChromID™ Strepto B agar (ChromAgar) developed by bioMérieux, it 
is based on the detection of enzymatic activity, not specified by the company, using 
chromogenic substrates. It consists of a nutritive base combining different peptones, 3 
chromogenic substrates and antibiotics. These components enable the screening, under 
aerobic conditions, of S. agalactiae by the spontaneous appearance of pink to red, round 
and pearly colonies. Most other bacterial species are either inhibited or the colonies 
produced are of a different color (e.g. violet, blue, colorless etc.). During this doctoral 
research we compared applicability, sensitivity and specificity of both media (98). 
 
I.8.2. Immunological methods 
GBS isolates are identified reliably by the production of group B Lancefield antigen 
(306). Consequently, many latex agglutination tests and immunoassays that detect this 
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antigen for GBS identification have been developed (11, 149, 387, 413). The ability to 
identify GBS by these methods depends on the amount of the bacteria inoculated in the 
assay. Their sensitivities for detection of GBS directly from clinical specimens varied 
from 19% to 82% when selective broth media were used to recover GBS from clinical 
samples (413). In general, these immunological tests are not sufficiently sensitive for the 
direct detection of GBS from clinical samples, and only women with heavy colonisation 
can be readily identified by these methods (11, 210). 
 
I.8.3. DNA hybridisation-based methods 
The most widely used hybridisation-based test to date is the Accuprobe Group B 
Streptococcus Identification Test (Gen-Probe, San Diego, CA). This assay, which targets 
specifically the GBS ribosomal RNA, is suitable to identify GBS from 18 h to 24 h cultures 
in selective enrichment broth (33, 200, 403). Compared with the standard culture 
method, this probe-based assay had a sensitivity of 94.7–100% and a specificity of 96.9–
99.5% for screening for GBS colonization in pregnant women (33, 200, 403). When 
shorter pre-incubation periods were used, the sensitivity of this test was 44% for a 2.5 h 
incubation (94% specificity) and 71% for a 3.5 h incubation (90% specificity) (33, 414). 
Bourbeau et al. (34) demonstrated significant potential labour savings utilizing this 
product, compared with the traditional culture methods.  
Another test based on DNA hybridisation is the Affirm GBS Microbial Identification 
System (MicroProbe, Bothell, WA, USA) (34), However, even after a 16–24 h pre-
incubation, the sensitivity of the test was only 81%. Such a test does not offer any 
advantages over culture methods (305). Thus, available probe hybridization methods 
are suitable for GBS identification from overnight cultures in selective enrichment broth 
but are poorly sensitive for direct detection and identification of GBS from vaginorectal 
swabs obtained from pregnant women. 
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I.8.4. Conventional PCR-based methods 
Polymerase chain reaction (PCR)-based assays offer promising tools for sensitive, 
specific and rapid detection of GBS directly from clinical specimens. A number of PCR 
assays targeting different genes for the specific detection of GBS have been developed. 
These include genes encoding C protein (7, 242, 388), the 16S rRNA , and the 16S–23S 
spacer region (154). Ke et al. (196)developed a GBS-specific PCR assay that targets the 
cfb gene, which encodes the CAMP factor (21, 196) that is present in virtually every 
strain of GBS (401). It allows the detection of as little as one genomic copy of GBS. This 
PCR assay achieves almost the same sensitivity as standard culture methods when 
vaginal and/or rectal specimens from pregnant women are tested for GBS colonization 
(21). Although 2% of GBS isolates were phenotypically negative for the CAMP test (209), 
molecular characterisation of the cfb gene showed that this gene was present in virtually 
every isolate (281).  
 
I.8.5. Real-time PCR-based methods 
Several PCR-based assays for the detection of GBS have been developed, but these 
require procedures not applicable readily to clinical laboratories (7). However, the 
development of real-time PCR (qPCR) has provided new platforms for bacterial 
detection and identification. qPCR technology offers several advantages over 
conventional PCR methods, such as a lower risk of PCR contamination, shorter 
turnaround time, less labour, less biosafety risk (no pouring of gels and staining with 
EtBr) and quantitative results (165). Some of the most popular commercially available 
systems coupling PCR technology with real-time detection of PCR products include the 
ABI PRISM 7700 Sequence Detection System (PE Applied Biosystems, Foster City, CA), 
the LightCyclerTM (Idaho Technologies, Idaho Fall, ID; and Roche Diagnostics, 
Indianapolis, IN), and the Smart Cycler® (Cepheid, Sunnyvale, CA). GBS-specific PCR 
assays have been developed using the latter two platforms.  
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I.8.5.1. GBS-specific qPCR with the LightCycler 
The LightCycler is a real-time amplification-detection apparatus with air thermal cycling 
and fluorescently monitored product analysis in a closed-tube assay format  (184, 407, 
408). An important advantage of the LightCycler is its rapid temperature transition rate 
of up to 20 °C per second, allowing completion of 45 cycles of amplification in 20–30 min 
(409). Bergeron et al. (21) developed a qPCR assay that targets the cfb gene and thatis 
able to identify pregnant women colonized by GBS in 30–45 min, with a sensitivity of 
97% and a specificity of 100% as compared with the standard culture method. In 
another study, Bergh et al. (22) developed a qPCR assay that targets the sip gene, which 
encodes the sip surface immunogenic protein. It is universally present across all 
serotypes of GBS (22). Bergseng et al. (23)reported that the qPCR assay targeting the sip 
gene is fast, highly sensitive and specific for detecting GBS colonization in pregnant 
women at delivery, and has the potential for intrapartum detection of GBS colonization. 
During this doctoral research, we compared two different targets (sip and cfb genes), 
using two different real-time PCR (qPCR) approaches, i.e. the hydrolysis probe assay 
(Taqman, Roche) and the hybridisation probes assay (Hybprobe, Roche) with  standard 
culture to detect GBS colonization in pregnant women (Figure 16).  
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Figure 16: Real time PCR analysis of GBS (serial dilution) using the LightCycler. 
I.8.5.2. GBS-specific qPCR with the Smart Cycler 
The Smart Cycler is a miniature analytical thermal cycling instrument designed for 
qPCR. It was first described by Northrup et al. (265) and is manufactured by Cepheid. 
The system is designed to allow low-power operation, high-temperature transition 
speed and thermal uniformity (64). The BD GeneOhm StrepB test (BD GeneOhm 
Sciences, San Diego, CA; formerly IDI-StrepB), the Cepheid GeneXpert GBS and Smart 
GBS (Cepheid, Sunnyvale, CA) offer detection of GBS directly from rectovaginal swabs 
for antepartum or intrapartum detection of GBS colonization. 
I.8.5.2.1. BD GeneOhm™ StrepB assay  
The BD GeneOhm™ StrepB Assay (previously marketed as IDI Strep B) is a qualitative in 
vitro diagnostic test for the rapid detection of Group B Streptococcus (GBS) in pregnant 
women at the time of delivery or at any other stage of their pregnancy. The BD 
GeneOhm™ StrepB test results can be available in less than one hour (338), enabling 
new capabilities for earlier and more definitive treatment of mother and newborn. The 
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test can be performed on the SmartCycler automated analyzer. The PCR master mixture 
contained all reagents necessary for amplification of the GBS cfb gene, if present, and of 
the internal control template. The GBS amplicon is a 154-bp DNA fragment. The internal 
control is a 180-bp DNA fragment, consisting of a 134-bp sequence not found in GBS 
flanked by the complementary sequence of each of the 2 GBS-specific primers. Amplified 
DNA is detected with hybridization probes labeled with quenched fluorophores 
(molecular beacons). The fluorophores attached at the 5'  end of the beacons are 5'-
carboxyfluorescein and tetrachlorofluorescein, for the detection of GBS amplicons and 
internal control amplicons, respectively. The beacon-target hybrids fluoresce at wave 
lengths characteristic of the fluorophore used in each of the particular molecular 
beacons used. The concomitant amplification of the internal control allows for 
verification of the efficiency of the PCR and alerts the user to the presence of significant 
PCR inhibition within the test sample. 
Comparison of the LightCycler assay and the GeneOhm StrepB Test, starting from Lim 
broth cultures showed sensitivities of 100% and 92.5%, respectively, and specificities of 
95.9% and 92.5%, respectively, with culture as the gold standard (146). In a multicenter 
study, the sensitivity and specificity of the IDI-StrepB assay, at the time of labor, was 
94% and 95.9% respectively, compared to culture (72). When compared to either the 
sensitivity of antenatal cultures (54%) or of risk factor analysis (42%), the sensitivity of 
the IDI-StrepB assay was superior (72). 
I.8.5.2.2. Cepheid GeneXpert GBS assay 
The Cepheid Xpert GBS™ assay, performed on the GeneXpert System, is another 
qualitative in vitro diagnostic test designed to detect GBS DNA in vaginal/rectal 
specimens using qPCR technology. This new assay is intended for use as a method for 
rapid detection of GBS colonization in antepartum and intrapartum women with results 
available in just over an hour. Its automated system allows for sample DNA purification, 
nucleic acid amplification, and detection of the target sequence in the biological samples 
using qPCR (60). Single-use GeneXpert cartridges hold the sample and PCR reagents and 
host the PCR process. The GBS assay is based on the principle that GBS can be 
distinguished from other streptococci by the cell wall  associated group B carbohydrate. 
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The assay reagents concurrently amplify and detects a target within a 3’ DNA segment 
adjacent to the cfb gene of S. agalactiae. Each cartridge includes internal controls to 
validate sample processing and PCR performance. The sample swab and the 2 reagent 
solutions are placed into the appropriate chambers of the GeneXpert GBS cartridge, 
which is then loaded into the machine, a 2-minute process. In a completely automated 
fashion, the GeneXpert system elutes the bacteria from the swab, mixes the sample 
reagent with a sample-processing control (Bacillus globigii) and the treatment reagent, 
and captures and lyses the bacterial cells with subsequent elution of the DNA. The DNA 
solution is mixed with dry PCR reagents and transferred into the reaction tube for qPCR. 
The process is completed in less than 75 minutes while the computer collects cycle data 
to detect the presence or absence of the GBS target. As a point-of-care intrapartum 
screening test, the Xpert GBS had a sensitivity of 95.8% and a specificity of 64.5%, 
whereas the antenatal culture was 83.3% sensitive and 80.6% specific when 
intrapartum culture was used as the gold standard (136).  
I.8.5.2.3. Cepheid Smart GBS 
The Cepheid Smart GBS test, performed on the SmartCycler, is a qualitative in vitro 
diagnostic test, designed to detect Group B Streptococcus (GBS) DNA in vaginal/rectal 
specimens using proven real-time PCR technology. The test can be performed directly 
from antepartum and intrapartum vaginal-rectal swabs and from Lim broth cultures. 
The test uses PCR primers specific to a unique sequence region of S. agalactiae, followed 
by fluorogenic target-specific hybridization to detect the amplified DNA. Specimens are 
collected using the Cepheid GBS collection device, and verification and validation of 
performance characteristics of specimen transport and storage conditions using such is 
an important component of test implementation. The manufacturers reported assay 
sensitivity from a multisite study of antepartum and intrapartum women to be 81.6% 
for direct vaginorectal swabs compared to results obtained using the CDC culture 
method (57). Jordan et al. (193) reported that the Smart GBS assay had excellent 
performance characteristics compared to broth-based culture and was found to be 
substantially equivalent or better than the BD Genome StrepB direct assay based on 
sensitivity, specificity and accuracy.  
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Abstract
Background: The vaginal microflora is important for maintaining vaginal health and preventing
infections of the reproductive tract. The rectum has been suggested as the major source for the
colonisation of the vaginal econiche.
Methods: To establish whether the rectum can serve as a possible bacterial reservoir for
colonisation of the vaginal econiche, we cultured vaginal and rectal specimens from pregnant
women at 35-37 weeks of gestation, identified the isolates to the species level with tRNA intergenic
length polymorphism analysis (tDNA-PCR) and genotyped the isolates for those subjects from
which the same species was isolated simultaneously vaginally and rectally, by RAPD-analysis.
One vaginal and one rectal swab were collected from a total of each of 132 pregnant women at 35-
37 weeks of gestation. Swabs were cultured on Columbia CNA agar and MRS agar. For each subject
4 colonies were selected for each of both sites, i.e. 8 colonies in total.
Results: Among the 844 isolates that could be identified by tDNA-PCR, a total of 63 bacterial
species were present, 9 (14%) only vaginally, 26 (41%) only rectally, and 28 (44%) in both vagina
and rectum. A total of 121 (91.6%) of 132 vaginal samples and 51 (38.6%) of 132 rectal samples
were positive for lactobacilli. L. crispatus was the most frequently isolated Lactobacillus species from
the vagina (40% of the subjects were positive), followed by L. jensenii (32%), L. gasseri (30%) and L.
iners (11%). L. gasseri was the most frequently isolated Lactobacillus species from the rectum (15%),
followed by L. jensenii (12%), L. crispatus (11%) and L. iners (2%).
A total of 47 pregnant women carried the same species vaginally and rectally. This resulted in 50
vaginal/rectal pairs of the same species, for a total of eight different species. For 34 of the 50 species
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BMC Infectious Diseases 2009, 9:167 http://www.biomedcentral.com/1471-2334/9/167pairs (68%), isolates with the same genotype were present vaginally and rectally and a high level of
genotypic diversity within species per subject was also established.
Conclusion: It can be concluded that there is a certain degree of correspondence between the
vaginal and rectal microflora, not only with regard to species composition but also with regard to
strain identity between vaginal and rectal isolates.
These results support the hypothesis that the rectal microflora serves as a reservoir for 
colonisation of the vaginal econiche.
Background
The composition of the human vaginal microflora is
affected by several host factors, including, among others,
age, menarche, sexual activity, pregnancy and the use of
contraceptives or spermicides, as well as individual habits
such as douching [1]. Several bacterial species are known
to colonize both the gastrointestinal and the reproductive
tract, and the rectum has been suggested to play an impor-
tant role as a source or reservoir for organisms that colo-
nize the vagina [2,3]. It is important to establish to which
degree this is also the case for lactobacilli, the predomi-
nant group of microorganisms of the normal vaginal
microflora, because these bacteria are generally known to
produce endogenous microbicides such as lactic acid,
which acidifies the vagina, and hydrogen peroxide
(H2O2), toxic to other bacteria and viruses, including HIV
[4]. Studies of vaginal lactobacilli have demonstrated that
L. crispatus, L. jensenii, L. gasseri and L. vaginalis are the
most commonly recovered species of H2O2-producing
lactobacilli [5-9] and the absence of H2O2-producing
lactobacilli in the vagina has been associated with an
increased risk for bacterial vaginosis (BV) [10,11]. BV has
been linked to increased shedding of HIV in the female
genital tract [12], increased acquisition of HIV [10] and
herpes simplex virus type 2 [10,12] and with preterm
birth [13].
In order to document in more detail a possible rectal ori-
gin of the vaginal microflora, this study was set up not
only to compare the bacterial species present in vagina
and rectum, but in addition, to compare the genotypes of
those strains belonging to species that were present simul-
taneously at both sampling sites of the same subject.
Methods
Patients
The study was approved by the research ethics committee
(IRB protocol nr 2007/096) of Ghent University Hospital,
Belgium. All women attending the clinic were included
and participating women gave a written informed con-
sent. Between April and December 2007, 132 paired vagi-
nal and rectal swabs were collected from pregnant women
at 35 - 37 weeks of gestation.
Sampling procedures
All specimens were collected using nylon flocked swabs
that were submerged into 1 ml of liquid Amies transport
medium (eSwab, Copan Diagnostics, Brescia, It.). For rec-
tal specimens, a swab was carefully inserted approxi-
mately 1.5 - 2 cm beyond the anal sphincter and then
gently rotated to touch anal crypts.
Vaginal samples were collected by inserting a swab into
the vagina. The swab was rolled round through 360
degrees against the vaginal wall at the midportion of the
vault. At Ghent University Hospital, the routine screening
for group B streptococci of pregnant women is always per-
formed during the prenatal consultation at 35-37 weeks'
gestation according to the CDC guidelines for the preven-
tion of perinatal Group B streptococcal disease [14]. All
study samples were collected by midwives and trans-
ported to the Laboratory for Bacteriology Research of the
University of Gent within 4 hours.
Culture and Gram staining
A total of 70 l from the Amies liquid transport medium
of each of the vaginal and rectal swabs was inoculated
onto Columbia CNA agar with 5% sheep blood (Colum-
bia CNA agar, Becton Dickinson, Erembodegem, Bel-
gium) respectively De Mann Rogosa Sharp Agar (MRS,
Oxoid, Hampshire, UK) and then incubated at 37°C in an
anaerobic chamber (10% H2, 10% CO2, 80% N2) (Bug-
Box, LedTechno, Heusden-Zolder, B.) for 72 h. Another
50 l of the vaginal swab suspension was taken for smear
preparation for the Gram stain.
Gram stain based grading was carried out according to
modified Ison & Hay criteria [15], as described by Verhelst
et al. [16].
Grade Ia specimens contained mainly Lactobacillus crispa-
tus cell types, i.e. plump, quite homogeneous lactobacilli,
grade Ib contained non-L. crispatus cell types, i.e. long or
short, thin lactobacilli, grade Iab contained mixtures of L.
crispatus and non-L. crispatus cell types, grade I-like con-
tained irregular-shaped Gram positive rods, grade II con-
tained a mixture of Lactobacillus cell types and bacterialPage 2 of 14
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Prevotella and Mobiluncus cell types), whereas samples
devoid of Lactobacillus cell types with the presence of only
Gardnerella, Bacteroides- Prevotella or Mobiluncus cell types
were classified as grade III. Finally, samples were classified
as grade IV when Gram positive cocci were predominantly
present and as grade 0 when no bacterial cells were
present [16].
DNA-extraction from isolates
DNA was extracted from cultured isolates by alkaline lysis
as follows: One bacterial colony was suspended in 20 l
of lysis buffer (0.25% sodium dodecyl sulfate, 0.05 N
NaOH) and heated at 95°C for 15 min. The cell lysate was
diluted by adding 180 l of distilled water. The cell debris
was spun down by centrifugation at 16,000 g for 5 min.
Supernatants were used for PCR or frozen at -20°C until
further use.
Identification of isolates
From all 132 women, 8 colonies per subject, i.e., one col-
ony of each of the two most abundant colony types from
both Columbia CNA and MRS agar plates and for both
rectal and vaginal swabs were picked, i.e. a total of 1056
isolates. Isolates were identified by tRNA intergenic length
polymorphism analysis (tDNA-PCR) as described before
[8,17-19]. Briefly, the tRNA-intergenic spacer regions were
amplified by PCR using consensus primers, applicable to
most bacterial species, and the resulting fingerprints,
obtained by separation of the amplified spacers by capil-
lary electrophoresis on an ABI310, were compared with
those of a large library of reference strains of the different
species, shown in previous studies to be part of the vaginal
microflora. Isolates with fingerprints that did not match
fingerprints already present in the library were considered
as not identifiable.
Genotyping of isolates
Isolates of species present in both vagina and rectum of
the same subject were genotyped using RAPD-analysis
with RAPD Ready-to-Go beads (GE Healthcare, Bucking-
hamshire, UK) as described previously [20] with primer
OPM1 (5' GTT GGT GGC T) at a final concentration of 2
M, including 0.2 M of fluorescent TET-labeled OPM1
primer. After 5 min at 94°C, 5 min at 35°C and 5 min at
72°C, reaction mixtures were cycled 30 times in a Veriti™
Thermal Cycler (Applied Biosystems, Foster City, Ca.),
with the following conditions: 30 s at 94°C, 1 min at
35°C, and 1 min at 72°C, with a final extension period of
5 min at 72°C. Reaction vials were then cooled to 10°C
until electrophoresis.
Capillary electrophoresis
A volume of 11.9 l of deionized formamide (ACE forma-
mide, Lucron, De Pinte) was mixed with 0.6 l of an inter-
nal size standard mixture containing 0.3 l of the ROX-
400 high-density size standard (Applied Biosystems, Fos-
ter City, Ca.) and 0.3 l of Map marker 1000 size standard
(BioVentures, Murfreesboro, Tn.). One l of RAPD-PCR
product was added. The mixtures were denatured by heat-
ing at 95°C for 3 min and placed directly on ice for at least
10 min. Capillary electrophoresis was carried out using an
ABI-Prism 310 genetic analyzer (Applied Biosystems) at
60°C, at a constant voltage of 1.5 kV, and at a more or less
constant current of approximately 10 mA. Capillaries with
a length of 47 cm and diameter of 50 m were filled with
performance-optimized polymer 4. Electropherograms
were normalized using Genescan Analysis software, ver-
sion 2.1 (Applied Biosystems).
Data analysis
tDNA-PCR and RAPD fingerprints were obtained as table
files from the GeneScan Analysis software (Applied Bio-
systems) and analyzed with BaseHopper, an in house soft-
ware program [17]. The obtained tDNA fingerprints were
compared with those of a library of tDNA fingerprints
obtained from reference strains, representing most vaginal
species isolated in previous studies and previously identi-
fied by 16S rRNA gene sequencing [8].
Similarity between RAPD fingerprints was calculated
using the Dice algorithm. Clustering analysis was done
with the Neighbor module of the Phylip software http://
evolution.genetics.washington.edu/phylip.html, using
the Neighbour joining algorithm. Isolates of which the
RAPD fingerprints were clustered together, were inspected
visually to confirm similarity.
Results
Categorization of vaginal microflora
Samples were categorized as grade Ia for 55 subjects
(41.6%), grade Ib for 37 (28.0%), grade Iab for 13
(9.8%), grade I-like for 5 (3.8%), grade II for 14 (10.6%),
grade III for 6 (4.5%) and grade 0 for 2 (1.5%).
The most common genus recovered from grade Ia, Ib and
Iab specimens was Lactobacillus. Grade Ia samples con-
tained predominantly L. crispatus (75.0%) and L. jensenii
(43.6%), whereas L. gasseri (40.5%) and L. iners (27%)
were the most frequently present species in grade Ib spec-
imens. The five grade I-like specimens were found to con-
tain respectively Bifidobacterium bifidum and Enterococcus
faecalis, L. gasseri and E. faecalis, L. jensenii, L. gasseri and
Gardnerella vaginalis or L. rhamnosus.
The most characteristic cultured organisms in grade II and
grade III specimens were G. vaginalis (28% and 33%,
respectively), Actinomyces neuii, Aerococcus christensenii,
Atopobium vaginae and Finegoldia magna. The lactobacilli
cultured from the six grade III specimens were respectivelyPage 3 of 14
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a combination of L. gasseri and L. vaginalis.
Rectal and vaginal prevalence of different bacterial 
species
For a total of 132 women, 4 colonies each were picked
from the vaginal and rectal sites, i.e. a total of 1056 colo-
nies were picked and subjected to identification by tDNA-
PCR. Of these, 844 could be identified.
A total of 103 isolates gave no amplification or tDNA-PCR
patterns composed of only a few and short tRNA inter-
genic spacers. Most of the isolates for which no amplifica-
tion or only a few fragments could be obtained, are
probably corynebacteria, which yield poor tDNA-PCR fin-
gerprints (unpublished data).
Finally, 109 isolates gave uninterpretable patterns, due to
mixed cultures, as was confirmed by 16S rRNA gene
sequencing for 20 of these, whereby the sequences could
not be interpreted because of ambiguities, pointing to
mixtures.
The frequency of vaginal and rectal colonization by lacto-
bacilli and the other most prominent bacterial species is
shown in Table 1. A total of 63 bacterial species were iden-
tified, 9 (14%) occurring only vaginally, 26 (41%) only
rectally and 28 (44%) in both vagina and rectum, with 8
species that could be isolated simultaneously from rectum
and vagina of 47 subjects.
Overall, 121 of 132 pregnant women (92%) carried vagi-
nal lactobacilli and 52 (39%) carried rectal lactobacilli.
Seventy two pregnant women (54.5%) carried lactobacilli
only vaginally, three only rectally (2%) and 49 (37%) in
both sites, i.e. only three women out of 52 from whom
lactobacilli could be isolated rectally, did not carry lacto-
bacilli vaginally. L. crispatus was the most frequently iden-
tified Lactobacillus species isolated from the vagina (40%,
i.e., 53/132 subjects positive of which 10 also carried L.
crispatus rectally), followed by L. jensenii (32%), L. gasseri
(30%), L. iners (11%) and L. vaginalis (10%).
Besides these five Lactobacillus species, all other species
were encountered in no more than five subjects, except for
G. vaginalis (8% of subjects positive).
L. gasseri was the most frequently isolated Lactobacillus
species from the rectum (20/132 subjects positive), fol-
lowed by L. jensenii (16) and L. crispatus (14). L. iners was
isolated rectally from only 2 subjects. L. vaginalis was iso-
lated only from the vagina, whereas L. fermentum, L. cole-
ohominis and L. fermentum were only isolated from the
rectum, at a frequency of  1%. Rectally, the most abun-
dant species that could be cultured, were Streptococcus
anginosus group (47/132 subjects positive), Finegoldia
magna (40), Peptoniphilus indolicus (25) and E. faecalis
(21).
Fourty six pregnant women (35%) were colonized by at
least 2 different Lactobacillus species, with 42 of them only
vaginally, two only rectally and another two both in the
vagina and rectum. Taking into account vaginal and rectal
colonization by more than one Lactobacillus species, 18
women (13.6%) were colonized by both L. crispatus and
L. jensenii, of which 17 vaginally and one rectally, five
(4%) by L. jensenii and L. gasseri of which 3 vaginally and
2 rectally and another 18 (13.6%) with other combina-
tions of Lactobacillus species. Seven subjects (5.3%) were
colonized vaginally by more than two Lactobacillus spe-
cies. In total, of the 121 women colonized vaginally by
lactobacilli, 42 (32%) were colonized by two or more
Lactobacillus species and of the 52 women colonized by
lactobacilli rectally, two (1.5%) were colonized by two
Lactobacillus species. A total of 47 (35%) of 132 pregnant
women were colonized both vaginally and rectally with
the same species and 3 of these 47 women carried two spe-
cies both vaginally and rectally. The species found to be
simultaneously present in the same subject both rectally
and vaginally were L. crispatus (n = 10 subjects), L. jensenii
(14), L. gasseri (16), S. anginosus (3), S. agalactiae (3), S.
salivarius (1), E. faecalis (2) and Bifidobacterium species (1).
In summary, 50 vaginal/rectal pairs of the same species
were observed in 47 subjects, for a total of eight different
species.
Genotyping of bacterial isolates from the vagina and the 
rectum
For 34 of the 50 vaginal/rectal species pairs, isolates with
the same genotype were present vaginally and rectally.
Table 2 presents the genotyping results for each of the 50
vaginal/rectal species pairs. We found the same genotype
for both rectal and vaginal L. crispatus isolates in 7/10 sub-
jects, for L. gasseri in 14/16, for L. jensenii in 7/14, for Bifi-
dobacterium species in 1/1, for E. faecalis in 1/2, for S.
agalactiae in 2/3, and for S. anginosus in 2/3.
Figure 1 shows the genotyping results for four pregnant
women for which rectal and vaginal isolates belonged to
a single genotype, for L. gasseri (Figure 1), L. crispatus (Fig-
ure 2), L. jensenii (Figure 3) and E. faecalis (Figure 4).
Genotyping results: variability among multiple isolates per 
subject
For only 2 of the 9 vaginal samples of which more than
one L. crispatus isolate was picked, all the isolates
belonged to the same genotype. For the 7 other vaginal
samples, 2 to 3 genotypes of L. crispatus were present. In 7
of the 10 cases for which rectal/vaginal pairs of L. crispatusPage 4 of 14
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Table 1: Vaginal and rectal prevalence of 63 bacterial species among 132 pregnant women
Species Only
vaginala
Only rectal Vaginal + rectal Overall
1 Acinetobacter baumannii group 0 8 0 8
2 Actinomyces meyeri 0 2 0 2
3 Actinomyces neuii 2 0 0 2
4 Actinomyces radingae 0 1 0 1
5 Actinomyces urogenitalis 0 1 0 1
6 Aerococcus christensenii 3 2 0 5
7 Aerococcus viridans 0 1 0 1
8 Agrobacterium radiobacter 0 2 0 2
9 Alloscardovia omnicolens 0 1 0 1
10 Anaerococcus tetradius 0 1 0 1
11 Anaerococcus vaginalis 0 4 0 4
12 Atopobium vaginae 2 2 0 4
13 Bacteroides uniformis 1 1 0 2
14 Bifidobacterium bifidum 2 6 1 9
15 Bifidobacterium longum subsp. longum 2 5 0 7
16 Bifidobacterium longum subsp. infantis 0 2 0 2
17 Bifidobacterium breve 0 1 0 1
18 Corynebacterium accolens 0 1 0 1
19 Dialister sp. 5 0 0 5
20 Enterococcus faecalis 5 19 2 26
21 Enterococcus faecium 1 3 0 4
22 Enterococcus avium 0 1 0 1
23 Escherichia coli 1 7 0 8
24 Finegoldia magna 2 40 0 42
25 Fusobacterium gonidioformans 0 3 0 3
26 Gardnerella vaginalis 10 2 0 12
27 Klebsiella planticola 0 1 0 1
28 Lactobacillus casei 2 1 0 3
29 Lactobacillus fermentum 1 0 0 1
30 Lactobacillus coleohominis 2 0 0 2
31 Lactobacillus crispatus 43 4 10 57
32 Lactobacillus fermentum 2 0 0 2
33 Lactobacillus gasseri 24 4 16 44
34 Lactobacillus helveticus 1 1 0 2
35 Lactobacillus iners 14 2 0 16
36 Lactobacillus jensenii 28 2 14 44
37 Lactobacillus mucosae 0 1 0 1
38 Lactobacillus rhamnosus 3 3 0 6
39 Lactobacillus salivarius 1 1 0 2
40 Lactobacillus vaginalis 13 0 0 13
41 Lactobacillus coleohominis 1 0 0 1
42 Pediococcus acidilactici 1 0 0 1
43 Peptoniphilus indolicus 1 25 0 26
44 Peptostreptococcus anaerobius 1 4 0 5
45 Peptostreptococcus sp. 0 8 0 8
46 Prevotella bivia 4 2 0 6
47 Pseudomonas stutzeri 0 1 0 1
48 Staphylococcus aureus 0 1 0 1
49 Staphylococcus capitis 1 4 0 5
50 Staphylococcus epidermidis 3 13 0 16
51 Staphylococcus haemolyticus 2 1 0 3
52 Staphylococcus hominis 1 4 0 5
53 Staphylococcus warneri 0 2 0 2
54 Streptococcus agalactiae 1 4 3 8
55 Streptococcus anginosus 3 44 3 50
56 Streptococcus bovis 0 8 0 8
57 Streptococcus intermedius 0 1 0 1
58 Streptococcus mitis group 0 7 0 7
59 Streptococcus mutans 1 0 0 1
60 Streptococcus parasanguinis 0 1 0 1
61 Streptococcus salivarius 3 2 1 6
62 Varibaculum cambriense 0 1 0 1
63 Weissella paramesenteroides 0 1 0 1
193 270 50 513
a: Number of pregnant women carrying this species.
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had the same genotype of at least one of the one to four
vaginal isolates. For only two of the 11 women for which
more than one vaginal L. jensenii isolate was present, the
genotype of all isolates was identical. For another two of
these 11 women, all four isolates were genotypically dif-
ferent. For half (7/14) of the subjects with L. jensenii, the
presence of identical rectal and vaginal isolates could be
established.
For the other species, a similar pattern of large heteroge-
neity among the vaginal strains of the same species was
also observed and about half of the women were found to
carry at least one vaginal isolate genotypically identical to
at least one rectal isolate.
Discussion
During the last decade, the composition of the vaginal
microflora has been well characterised, using culture
based and culture independent methods [8,21-27]. How-
ever, the origin of lactobacilli and BV associated bacteria
remains less well-understood and different opinions exist
as to whether the vaginal bacteria are largely endogenous
or whether there is continuous recolonizaton from the
rectum. Few studies have addressed the species composi-
tion of both vagina and rectum in the same subjects
[2,3,5] and only the study of Marrazzo et al. [3] genotyped
paired rectal/vaginal isolates, from lesbian women. To our
knowledge, this is the first study among pregnant women
to address the relatedness of vaginal and rectal strains to
the degree of clonal identity of the strains.
Rectal and vaginal occurrence of lactobacilli
Table 3 compares the findings of this study with those of
two other groups with respect to rectal and vaginal coloni-
zation by lactobacilli. The four species predominant in the
vagina, as established in this study, i.e. L. crispatus, L. jense-
nii, L. gasseri and L. iners are in correspondence with pre-
vious studies [2,3,6,16,28-30].
Both Antonio et al. [2] and Marrazzo et al. [3] reported L.
crispatus and L. jensenii twice as much vaginally compared
to their rectal occurrence, whereas we report four, respec-
tively three times higher abundance of these species vagi-
nally. Both groups also found approximately equal
abundance for L. gasseri in rectum and vagina, whereas we
could isolate twice as much L. gasseri from the vagina. L.
iners was found ten times more often vaginally than rec-
tally in this study and 20 times more vaginally than rec-
tally in that of Antonio et al. [2], while this species was
virtually absent from the study of Marrazzo et al. [3]. L.
vaginalis was not found by Marrazzo et al. [3] and virtually
absent in the study of Antonio et al. [2], whereas we found
a vaginal carriage rate of approximately 10%.
The differences in Lactobacillus vaginal microflora between
studies may be attributed to several factors. One sugges-
tion is that the intestinal lactobacilli differ geographically
[5], and the same may be true for the vaginal lactobacilli
[31]. Also the populations studied differ, e.g. pregnant
women in our study vs. nonpregnant women in the study
of Antonio et al. [2] and lesbian women in the study of
Marrazzo et al. [3]. Strong differences may exist between
women, e.g. on average only 30% of the women carry L.
crispatus, differences between Caucasian and black women
have been reported [32], and differences may be present
for each woman because samples can be taken during dif-
ferent phases of the menstrual cycle. More technically
related factors concern variations in the way that samples
are taken, transported and treated, the fact that culture
media and incubation methods may strongly influence
the outcome, e.g. incubation in an anaerobic chamber
yields more L. vaginalis than incubation in an anaerobic
jar (see below) and the use of MRS agar precludes isola-
tion of L. iners, and that identification has often been
based on phenotypic methods [33,34].
In addition, Kim et al. [35], reported that the vaginal
microflora is not homogeneous throughout the vaginal
tract but differs significantly within an individual with
regard to anatomical site and sampling method used.
Apparently, when based on culture, the vaginal carriage
rate for L. crispatus ranges between 20 and 40% (Antonio
et al. [6], Kiss et al. [28], this study), although Marrazzo et
al. [3] report a carriage rate of approximately 65%. The
high percentage reported by the latter group could be
related to the study of a different population (lesbian
women), to the use of culture methods better suited for L.
crispatus and corresponds better with results obtained by
non culture based methods, as reported previously
[16,22,26,27,32,36-38].
Interestingly, in a previous study of our group [8], we iso-
lated almost no L. vaginalis, using anaerobic jars and
GasPak (Becton Dickinson), yielding an atmosphere of
15% CO2, 80% N2, and less than 1% O2. Since we started
using an anaerobic chamber, with an atmosphere of 10%
H2, 10% CO2, and 80% N2, the number of L. vaginalis iso-
lations has increased significantly and this species is now
among the five most abundant vaginal species. Possibly,
the virtual absence of L. vaginalis in the studies of Antonio
et al. [2] and Marrazzo et al. [3] might be explained by the
use of anaerobic culture in jars.
Comparing the reported culture results for L. iners remains
also problematic, because this species does not grow on
MRS agar, specifically designed to culture lactobacilli, and
the small colonies it forms on most media may be more
easily overlooked.Page 6 of 14
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Table 2: Genotyping results for the 50 cases in which the same species could be isolated from vagina and rectum of the same subject
Subjects, arranged per species V1a V2 V3 V4 R1 R2 R3 R4 V = Rc
Lactobacillus crispatus
1 RVS003 Bb A C A 1
2 RVS011 A A A 2
3 RVS013 A B A 3
4 RVS020 A B C
5 RVS023 A B C
6 RVS028 A B C D
7 RVS043 A A 4
8 RVS061 A A A A A 5
9 RVS069 B A C A A 6
10 RVS099 B A A 7
Lactobacillus jensenii
11 RVS015 B C D A A 8
12 RVS019 B A C A D E
13 RVS022 A A B A A 9
14 RVS023 A B
15 RVS038 A B C
16 RVS040 A B C
17 RVS057 B C A A D
18 RVS058 A A A B
19 RVS080 A B A B 10
20 RVS092 A A 11
21 RVS093 A A A A 12
22 RVS097 C A B A A 13
23 RVS111 A A A 14
24 RVS113 A B
Lactobacillus gasseri
25 RVS024 A A A A 15
26 RVS025 B A A C
27 RVS031 A A B C
28 RVS035 A A A 16
29 RVS044 A A 17
30 RVS051 A A A 18
31 RVS054 A A 19
32 RVS060 A A 20
33 RVS072 A A 21
34 RVS084 B A A 22
35 RVS090 A A A A 23
36 RVS091 A A A B 24
37 RVS095 B A A A 25
38 RVS109 A B A 26
39 RVS110 A A B B B A 27
40 RVS136 A A A A A 28
Streptococcus anginosus
41 RVS003 A B
42 RVS058 A A B 29
43 RVS068 A A A 30
Streptococcus agalactiae
44 RVS027 B A A A 31
45 RVS064 A A A A A 32
46 RVS076 A B C D
Enterococcus faecalis
47 RVS086 A A A A A A A A 33
48 RVS122 B A A
Streptococcus salivarius
49 RVS075 A B
Bifidobacterium bifidum
50 RVS033 A A A 34
a: V: vaginal isolates 1-4, R: rectal isolates 1-4.
b: Different genotypes are designated A, B, C, D or E per subject. Genotypic similarity/difference only relates to the other isolates of the same subject, i.e. 
genotype A of subject 1 does not indicate similarity to genotype A of subject 2.
c: Women for which the genotype of at least one vaginal isolate was identical to that of at least one rectal isolate.
BMC Infectious Diseases 2009, 9:167 http://www.biomedcentral.com/1471-2334/9/167The rectal occurrence of lactobacilli in culture-based stud-
ies may be underreported. Because of lactobacilli are the
predominant species vaginally, they can be easily over-
grown by the predominant rectal bacteria as they repre-
sent about 0,01% of the overall cultivable bacterial
intestinal population [39,40]. However, high occurrence
of intestinal lactobacilli has been reported [41,42]. The
difference with our study might be explained by the fact
that these studies used fecal samples, whereas we started
from rectal swabbing.
The virtual absence of L. iners from the rectum in this cul-
ture-based study is in correspondence with the findings of
the other culture-based studies [2,3]. However, prelimi-
nary data, obtained by analyzing the same samples using
L. iners specific realtime PCR, indicate that for most
women for which this species could be isolated by culture
from the vagina, also the rectal sample is L. iners PCR pos-
itive (data not reported).
In this population of pregnant women, we isolated lacto-
bacilli more frequently from the vagina (121 subjects,
91.6%) than from the rectum (52 subjects, 39.3%), which
is in correspondence with the findings of Antonio et al.
[2], who reported vaginal recovery of lactobacilli in 74%
and rectal recovery in 51% of a total of 531 nonpregnant
females.
Although for many women from which lactobacilli could
be isolated from the vagina, no lactobacilli were isolated
rectally, most of the women that carried lactobacilli rec-
tally, also had vaginal lactobacilli, i.e. few women carried
lactobacilli only rectally.
RAPD fingerprints of vaginal and rectal L. gasseri isolates of subject RVS090. Vaginal isolates: V3 and V4; rectal isolates: R3 and 4Figure 1
RAPD fingerprints of vaginal and rectal L. gasseri isolates of subject RVS090. Vaginal isolates: V3 and V4; rectal 
isolates: R3 and R4. x-axis: length of amplified DNA fragments expressed in bps. y-axis: peak height (fluorescence intensity of 
DNA-fragment as measured by ABI310 capillary electrophoresis).Page 8 of 14
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In our study, a total of 46 (35%) of 132 pregnant women
carried two or more Lactobacillus species vaginally and/or
rectally. Marrazzo et al. [3] reported 72% of 237 partici-
pants to be colonized overall by lactobacilli and 24% to
be overall colonized with more than one Lactobacillus spe-
cies. Antonio et al. [6] reported that 8% carried more than
one Lactobacillus species in the vagina.
A total of 18 women in this study were colonized by both
L. crispatus and L. jensenii (17 vaginally and one rectally).
Vaginal colonization of women with L. crispatus and L.
jensenii has been suggested to be advantageous in the
maintenance of a normal microflora and the prevention
of sexually transmitted diseases [2,6].
Genotyping results: clonal identity between vaginal and 
rectal isolates
RAPD was used in this study to detect genotypic similarity
of vaginal and rectal strains of the same bacterial species.
We could show that for 34 of the 50 pairs (68%) for which
several isolates of the same species were present both in
vagina and rectum, genotypic identity could be observed
between at least one of the vaginal and at least one of the
rectal isolates. In another study, on the same population
of women, we compared the genotypes of rectal and vag-
inal Streptococcus agalactiae (group B streptococci: GBS)
isolates and found clonal identity between isolates from
both sites in 18 of the 19 subjects [43], confirming that
also for GBS the rectally occurring strains are frequently
identical to their vaginal counterparts. Because of the
close proximity of the rectum to the vagina, the isolation
of H2O2-producing vaginal Lactobacillus species from the
RAPD fingerprints of vaginal and rectal L. crispatus isolates of subject RVS011. Vaginal isolates: V3 and V4; rectal isolate: R3Figure 2
RAPD fingerprints of vaginal and rectal L. crispatus isolates of subject RVS011. Vaginal isolates: V3 and V4; rec-
tal isolate: R3. x-axis: length of amplified DNA fragments expressed in bps. y-axis: peak height (fluorescence intensity of 
DNA-fragment as measured by ABI310 capillary electrophoresis).Page 9 of 14
(page number not for citation purposes)
BMC Infectious Diseases 2009, 9:167 http://www.biomedcentral.com/1471-2334/9/167rectum suggests that it may play a role as a reservoir for
these microorganisms [2].
Vaginal colonization by Lactobacillus species was found to
be transient in many females [7], and the rectum may be
a source for vaginal recolonisation by lactobacilli after a
disturbance of the ecology that follows douching, menses
or sexual intercourse. Studies conducted between 1960
and 1980 indicated that while most Lactobacillus strains
found in the human intestinal tract are allochthonous, L.
acidophilus, L. fermentum (now L. reuteri) and L. salivarius
can be isolated from individuals over longer periods [44-
48]. Since on the basis of current taxonomy L. crispatus
[49], L. gasseri [50] and L. iners [51] belong to the L. acido-
philus complex the rectum may be a source for vaginal rec-
olonization by these Lactobacillus species.
Genotyping results: variability among multiple isolates per 
subject
We found a surprising high genotypic heterogeneity
within species. For the 50 species for which isolates were
available from both vagina and rectum of a total of 47
pregnant women, on average of 2.2 vaginal respectively
1.3 rectal isolates were genotyped and on average 1.6 vag-
inal genotypes and 1.1 rectal genotypes were found for
these species. It can be expected that more species pairs,
more intraspecies genotypic diversity and more identical
genotypes in rectum and vagina will be found, when more
isolates would be picked. Although we did not sample the
same subjects at different time intervals, this finding sug-
gests the occurrence of changes in the composition of the
vaginal microflora, whereby different strains of a limited
number of species may replace each other, and are may be
exchanged between vagina and rectum.
RAPD fingerprints of vaginal and rectal L. jensenii isolates of subject RVS111. Vaginal isolate: V4; rectal isolates: R3 and R4Figure 3
RAPD fingerprints of vaginal and rectal L. jensenii isolates of subject RVS111. Vaginal isolate: V4; rectal iso-
lates: R3 and R4. x-axis: length of amplified DNA fragments expressed in bps. y-axis: peak height (fluorescence intensity of 
DNA-fragment as measured by ABI310 capillary electrophoresis).Page 10 of 14
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BMC Infectious Diseases 2009, 9:167 http://www.biomedcentral.com/1471-2334/9/167The high transmissibility of strains was also established in
the study of Marrazzo et al. [3] by the observation that
many sexual partners carried genotypically identical
strains. This hypothesis may be confirmed by long term
follow up of individual women, e.g. during subsequent
menstrual cycles, and by picking more isolates per subject
and per site at multiple time points.
Conclusion
Although it has been claimed that the vaginal microflora
originates from the rectal microflora, this is to our knowl-
edge only the second study, besides the recent study of
Marrazzo et al. [3] to address this in detail at the strain
level. Several of the total of 63 species identified were
found only vaginally (9, i.e. 14.3%) or only rectally (26,
i.e. 41.3%), but 29 species (44.4%) were isolated from
both sites, indicating that many species can colonize the
vagina from the rectum or migrate to the rectum from the
vagina. For the 8 species for which isolates were present
simultaneously in the same subject in vagina and rectum,
we found considerable genotypic diversity within the spe-
cies (i.e. on average 1.36 genotypes for on average 1.79
isolates per subject), both in rectum and vagina, as well as
identical genotypes present simultaneously in rectum and
vagina for 70% of the 50 species pairs studied. All these
data indicate a strong correlation between vaginal and rec-
tal microflora, not only at the species level but also at the
strain level.
It is possible that the rectal colonization by lactobacilli
may function as a reservoir for the maintenance of a nor-
mal vaginal flora and that this may be associated with a
RAPD fingerprints of vaginal and rectal E. faecalis isolates of subject RVS086. Vaginal isolates: V1 and V2; rectal isolates: R1 - R4Figure 4
RAPD fingerprints of vaginal and rectal E. faecalis isolates of subject RVS086. Vaginal isolates: V1 and V2; rec-
tal isolates: R1 - R4. x-axis: length of amplified DNA fragments expressed in bps. y-axis: peak height (fluorescence intensity 
of DNA-fragment as measured by ABI310 capillary electrophoresis).Page 11 of 14
(page number not for citation purposes)
BMC Infectious Diseases 2009, 9:167 http://www.biomedcentral.com/1471-2334/9/167decreased incidence of BV-associated adverse effects, as
has been suggested [3].
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Abstract  
Background 
To further establish the potential role of the rectum as a reservoir for the vaginal 
microflora, both sites were sampled and the bacterial loads of six species were 
established by quantitative PCR (qPCR).  
Methods 
Vaginal and rectal occurrence of Lactobacillus crispatus, L. jensenii, L. gasseri, L. 
iners, Gardnerella vaginalis and Atopobium vaginae was detected by culture and 
qPCR, for 71 pregnant women at 35-37 weeks of gestation. Vaginal and rectal 
swabs were cultured anaerobically on Columbia CNA agar and MRS agar. DNA 
was extracted from the swabs and existing qPCR formats for the quantification of 
the six species mentioned, was carried out.  
Results 
Culture and qPCR results differed substantially with regard to the evaluation of 
the vaginal and rectal occurrence of the six species tested. The vaginorectal 
prevalence of L. crispatus, L. jensenii, L. iners, L. gasseri, G. vaginalis and A. vaginae 
as established by culture versus PCR was 32.3 vs 91.5%, 32.3 vs 77.4%, 12.6 vs 
68.5%, 28.1 vs 91.5%, 12.6 vs 74.6% and 5.6  vs 69.0%, respectively. 
Using qPCR, significant positive correlation was found between vaginal and 
rectal loads of A. vaginae (r = 0.60, p = 0.002), L. crispatus (r = 0.80, p < 0.0001), 
L. gasseri (r = 0.45, p = 0.005), L. iners (r = 0.51, p = 0.003) and L. jensenii (r = 
0.85, p < 0.0001). Further significant positive correlation was found between the 
vaginal presence of G. vaginalis and that of A. vaginae (r = 0.396, p = 0.0006), 
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whereas the vaginal presence of L. crispatus was negatively correlated with that 
of G. vaginalis (r = - 0.363, p = 0.001) and that of A. vaginae (r = - 0.261, p < 0.05). 
Conclusion 
We established significant differences between detection of six bacterial species 
of the vaginal and rectal microflora using culture or qPCR. Using qPCR, 
significant correlations between quantities of vaginal and rectal lactobacilli and 
of Atopobium vaginae were established, indicating important correspondence of 
the vaginal and rectal microflora, not only in the occurrence of certain species in 
both niches, but also of cell densities per bacterial species, and confirming the 
possible role of the rectum as a reservoir for vaginal colonization. 
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Background  
The vaginal microflora plays an active role in preventing genital infections [1-
4].This protective function, i.e., colonisation resistance, is especially related to 
the presence of bacteria belonging to the genus Lactobacillus, which are able to 
prevent the overgrowth of pathogenic and opportunistic organisms [5]. Four 
species of lactobacilli are now considered to be predominantly linked to the 
vaginal microflora: Lactobacillus crispatus, L. jensenii, L. gasseri and L. iners, with 
the latter only recently being recognized as it was long overlooked, also because 
it does not grow on de Man Rogosa Sharpe agar, the medium typically used to 
culture lactobacilli [6, 7]. Bacterial vaginosis (BV) is a common disorder that 
involves an alteration in the vaginal microflora, whereby the predominant 
lactobacilli are replaced by Gardnerella vaginalis and anaerobic bacteria [8-10]. 
Recently, Atopobium vaginae has been strongly associated with BV, 
independently by different groups [11-16]. Several bacterial species are known 
to colonize both the gastrointestinal and the reproductive tract, and the rectum 
has been suggested to play an important role as a source or reservoir for 
organisms that colonize the vagina [6, 17-20].  Recently, we showed that rectum 
and vagina not only harbour the same bacterial species in 36% of 132 pregnant 
women studied, but also the same genotypes for 34 of the 50 species pairs (68%) 
[21]. The ingestion of Lactobacillus-containing products for the treatment or 
prevention of vaginal infections has shown that vaginal colonization can be 
obtained with these strains within days after oral application [22, 23]. 
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In this study, we compared culture with qPCR to detect and quantify four 
Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae in the vagina 
and rectum of pregnant women. 
Materials and Methods 
Patients. The study was approved by the research ethics committee (IRB 
protocol nr 2007/096) of the Ghent University Hospital, Belgium. Participating 
women gave a written informed consent. Between April and December 2007, 
paired vaginal and rectal swabs were collected from 71 pregnant women at 35 – 
37 weeks of gestation. 
Sampling procedures. All specimens were collected using nylon flocked swabs 
that were submerged into 1 ml of liquid Amies transport medium (eSwab, Copan 
Diagnostics, Brescia, Italy). For rectal specimens, a swab was carefully inserted 
approximately 1.5 - 2 cm beyond the anal sphincter and then gently rotated to 
touch anal crypts. Vaginal samples were obtained through blind swabbing by 
which the swab was rolled around 360 degrees against the vaginal wall at the 
midportion of the vault. All study samples were collected by midwives and 
transported to the Laboratory for Bacteriology Research of the University of 
Gent, inoculated on culture media and submerged in DNA extraction buffer 
within 4 hours.  
Culture and Gram staining 
A total of 70 µl from the Amies liquid transport medium of each of the vaginal 
and rectal swabs was inoculated onto Columbia CNA agar with 5% sheep blood 
(Columbia CNA agar, Becton Dickinson, Erembodegem, Belgium) and de Man 
Rogosa Sharp Agar (MRS, Oxoid, Hampshire, UK) and then incubated at 37 °C in 
an anaerobic chamber (10% H2, 10% CO2, 80% N2) (BugBox, LedTechno, 
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Heusden-Zolder, Belgium) for 72 h. Another 50 µl of the vaginal swab suspension 
was taken for Gram stain smear preparation.  
Gram stain based grading was carried out according to modified Ison & Hay 
criteria [24], as described by Verhelst et al. [25]. Grade Ia specimens contained 
mainly Lactobacillus crispatus cell types, i.e., plump, quite homogeneous 
lactobacilli, grade Ib contained non-L. crispatus cell types, i.e., long or short, thin 
lactobacilli, grade Iab contained mixtures of L. crispatus and non-L. crispatus cell 
types, grade I-like contained irregular-shaped Gram positive rods, grade II 
contained a mixture of Lactobacillus cell types and bacterial vaginosis-associated 
bacteria (Gardnerella, Bacteroides-Prevotella and Mobiluncus cell types), whereas 
samples devoid of Lactobacillus cell types with the presence of only Gardnerella, 
Bacteroides- Prevotella or Mobiluncus cell types were classified as grade III. 
Finally, samples were classified as grade IV when Gram positive cocci were 
predominantly present and as grade 0 when no bacterial cells were present [25]. 
DNA-extraction from samples 
DNA extraction from the samples was performed using the NucliSENS EasyMAG 
platform according to the manufacturer’s instructions. Briefly, 200 µl of the 
Amies transport medium from each the vaginal and rectal swab was added to the 
easyMAG lysis buffer and incubated for 10 min at room temperature and stored 
at -80°C until extraction. Total nucleic acid extraction of the samples was carried 
out and nucleic acids were eluted in 100 µL of elution buffer. 
DNA-extraction from isolates 
DNA was extracted from cultured isolates by alkaline lysis as follows: One 
bacterial colony was suspended in 20 µl of lysis buffer (0.25% sodium dodecyl 
sulfate, 0.05 N NaOH) and heated at 95 °C for 15 min. The cell lysate was diluted 
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by adding 180 µl of distilled water. The cell debris was spun down by 
centrifugation at 16,000 g for 5 min. Supernatants were used for tDNA-PCR or 
frozen at -20 °C until further use. 
Identification of isolates by tRNA intergenic length polymorphism analysis 
(tDNA-PCR) 
From 71 women, 8 colonies per subject, i.e., one colony of each of the two most 
abundant colony types from both Columbia CNA and MRS agar plates and for 
both rectal and vaginal swabs were picked, i.e., a total of 568 isolates, 284 vaginal 
and 284 rectal. Isolates were identified by means of tRNA intergenic length 
polymorphism analysis (tDNA-PCR) as described previously [13, 26, 27]. For 
some isolates, no clearcut identification was obtained by tDNA-PCR. These 
isolates were identified by 16S rRNA gene sequencing  [13]. 
Primers for qPCR 
qPCR primer sets targeting L. crispatus L. jensenii, L. gasseri L. iners, G.vaginalis, 
and A. vaginae were used as described previously  [28]. 
Construction of the standard curves for qPCR 
To construct standard curves for the qPCR's, A. vaginae (PB2003/189-T1-4), L. 
crispatus (PB2003/125-T1-1), L. gasseri (PB2003/088-T2-1) and L. jensenii 
(PB2003/204-T1-1) were cultured on TSA + 5% sheep blood (Becton Dickinson) 
and G. vaginalis (BVS026) and L. iners (BVS11) were cultured onto Columbia CNA 
agar with 5% sheep blood (Columbia CNA agar, Becton Dickinson, 
Erembodegem, Belgium). A suspension was made in MRS Broth (Oxoid, Drongen, 
Belgium) and DNA was extracted with  Roche extraction method. The DNA 
concentration of this stock was determined ten times by using the Nanodrop ND-
1000 (Nanodrop Technologies, Wilmington, USA) and the mean value was used 
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to determine the number of bacterial cells in the initial suspension, using the 
genome weight per cell, as calculated for each species on the basis of GC-content 
and genome size of these species. For, each strain a tenfold dilution series of the 
DNA was prepared by dilution of the stock in HPLC grade water. Dilutions were 
aliquoted and stored at -20°C. 
Quantitative PCR (qPCR) 
The qPCR Core Kit for SYBR Green I (Eurogentec) was applied and analysis was 
performed on the ABI 7000 Sequence Detection System (Applied Biosystems, 
Foster City, CA). PCR mixtures contained 2.5 μl of DNA extract, 2.5 μl of 10 × 
Reaction Buffer, 3.5 mM MgCl2, 0.2 mM dNTP mixture, 0.625 U HotGoldStar Taq 
polymerase, 0.75 μl SYBR® Green I, diluted 10-fold in DMSO and primers at a 
concentration of 0.2 µM, except for G. vaginalis where the primer concentration 
was 0.1 µM and were adjusted with HPLC grade water to 25 μl. Each sample was 
analyzed in duplicate with each of the six different primer sets, i.e., one for each 
of the six species tested, and each run included a standard curve for the species 
tested. In case the result was not in the range of the standard curve, the samples 
were diluted tenfold and analyzed in duplicate again.  
Statistical analysis 
Data were analyzed using the Mann-Whitney U-test for two groups and with the 
Kruskal Wallis test for multiple groups. Correlations between the different 
species were determined by the Spearman (rank) test and reported as 
Spearman's rho value (r). All analyses were performed using Graphpad Prism 
software (http://www.graphpad.com) 
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Results  
Culture results 
Table 1 and Figure 1 present the occurrence of four Lactobacillus species and G. 
vaginalis and A. vaginae vaginally, rectally and both vaginally and rectally, as 
estimated by using culture and qPCR. 
Based on culture data, all six species were recovered more frequently from the 
vagina (ranging from 4.2% for A. vaginae to 30.9% for L. crispatus and L. jensenii) 
than from the rectum (ranging from 1.4% for A. vaginae to 11.2% for L. crispatus 
and L. jensenii). For most women for whom a species could be cultured rectally, it 
could also be cultured from the vagina. The number of women with one of the six 
species only in the rectum was low (0-2.8%), compared to the number of women 
with these species only in the vagina (ranging from 4.2% for A. vaginae to  21.1% 
for L. crispatus and L. jensenii). A. vaginae was cultured least frequently, i.e., from 
only 1.4% of the women rectally and only 4.2% of the women vaginally. The 
species most abundantly present overall, according to culture, were L. crispatus, 
L. jensenii and L. gasseri, i.e., in approximately 30% of the women. 
qPCR results 
qPCR yielded a much higher number of women positive rectally and/or vaginally 
for any of the six species, compared to culture. The overall prevalence of L. 
crispatus, L. jensenii, L. iners, L. gasseri, G. vaginalis and A. vaginae as established 
by culture versus qPCR was 32.3 vs 91.5%, 32.3 vs 77.4%, 12.6 vs 68.5%, 28.1 vs 
91.5%, 12.6 vs 74.6% and 5.6  vs 69.0%, respectively (Table 1). 
The higher number of qPCR positive women is also reflected when looking at the 
number of women carrying the same species simultaneously vaginally and 
rectally: according to qPCR these percentages range from 30.9% for A. vaginae to 
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60.0%  for L. crispatus, whereas, according to culture the percentage of positives 
ranges from 0% for A. vaginae, G. vaginalis and L. iners to 9.8% for L. crispatus 
and L. jensenii. 
Moreover, when using qPCR, significant positive correlations were found 
between vaginal and rectal colonization, not only with respect to the presence of 
the same species rectally and vaginally, but also with respect to the bacterial load 
in both sites, i.e., there was a high degree of correspondence between vaginal 
bacterial load and rectal bacterial load for five of the six species: A. vaginae (r = 
0.60, p = 0.002), L. crispatus (r = 0.80, p < 0.0001), L. gasseri (r = 0.45, p = 0.005), 
L. iners (r = 0.51, p = 0.003) and L. jensenii (r = 0.85, p < 0.0001). Only for G. 
vaginalis, we could not establish significant correlation between vaginal and 
rectal bacterial load (r = 0.23, p = 0.172). This correspondence between vaginal 
and rectal load for five of the six species tested is also apparent from Figures 2 
(panels A-D and F). 
Culture vs qPCR results 
Figures 2, panels A-F, demonstrates that culture positive women mostly 
corresponded to women for which a high bacterial load was established when 
using qPCR. Women positive by culture for a certain species only vaginally or 
only rectally were usually found to carry this species in high numbers and in 
both sites, according to qPCR. Correspondingly, when women were culture 
positive, irrespective of whether this was vaginally only, rectally only or 
vaginorectally, they in general had high qPCR bacterial loads both vaginally and 
rectally. In addition, few culture negative women had high bacterial loads 
according to qPCR. This is especially clear for L. crispatus and L. jensenii, for 
which most culture positive women were found. 
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It can be noted that, when using culture, all species were recovered mostly only 
vaginally, whereas when using qPCR, most species were recovered from both 
vagina and rectum, except for A. vaginae, which was recovered mostly from the 
rectum. 
Presence and load of different bacterial species according to category of 
vaginal microflora 
In this study, Gram-stained smears of 71 vaginal swabs from pregnant women 
were examined microscopically and categorized as described previously [25]. 
Nineteen women had a vaginal microflora categorized as grade Ia, 7 as grade Iab, 
22 as grade Ib, 5 as grade I-like, 12 as grade II and 6 as grade III. 
We found a significantly higher level of vaginal L. crispatus in grade Ia (median 
value = 7.03 log 10 cells/ml), compared to its presence in the non grade I 
categories, i.e., 0 in grade II (p < 0.0001), 3.1 in grade III (p = 0.0025). Also, there 
was a higher level of L. crispatus in grade Iab (median = 7.6 log10 cells/ml), 
compared to the non grade I categories, i.e., 0 in grade II (p = 0.0011), 3.1 in 
grade III (p = 0.035) and 0 in grade I-like (p = 0.0012). The L. crispatus load in 
grade Ib samples (median = 3.00 log10 cells/ml) was not significantly different 
from that of the non grade I categories, i.e., 0 in grade II (p = 0.26) and 3.1 in 
grade III (p = 0.44). Accordingly, L. crispatus was also present in significantly 
higher amounts vaginally (p < 0.0001) in grade Ia (median = 7.03 log 10 
cells/ml) and grade Iab (7.6) than in grade Ib (2.6).  
L. iners was found in all grades, but at significantly higher concentrations in 
grade Iab (median = 7.8 log10 cells/ml) and grade Ib (8.1), than in grade Ia (0), 
grade II (0) and grade III (5.0). The L. iners load in grade Ib was not significantly 
different from that of grade Iab. The load of G. vaginalis in grade I (median = 2.7 
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log10 cells/ml) was significantly lower than that in grade II (8.7, p < 0.05) and 
grade III (9.1, p < 0.0001), but did not differ significantly between grades II and 
III. The load of A. vaginae in grade I (median = 0 log10 cells/ml) was significantly 
lower than that in grade II (5.3, p = 0.004) and grade III (5.6, p < 0.05), but did 
not differ significantly between grades II and III. 
Correlation between the presence and load of different species 
Forty two vaginal samples (59%) were positive for G. vaginalis by qPCR and 18 
(43%) of these were also positive for A. vaginae. Seven samples were positive for 
A. vaginae but negative for G. vaginalis. All six grade III samples were positive for 
G. vaginalis and four of these were also positive for A. vaginae. G. vaginalis and A. 
vaginae were present respectively in 10 and 7 of the 12 grade II samples.   
Significant positive correlations were found between the vaginal bacterial load in 
the different grades for G. vaginalis and A. vaginae (r = 0.396, p = 0.0006), as 
determined by qPCR. The bacterial load of both species was low in normal 
vaginal microflora (grades Ia and Iab), and high in disturbed vaginal microflora 
(grades II and III). Negative correlations were found between L. crispatus and G. 
vaginalis (r = - 0.363, p = 0.001) and also between L. crispatus and A. vaginae (r = 
- 0.261, p < 0.05). 
Significant positive correlations were found between the rectal bacterial load in 
the different grades for G. vaginalis and A. vaginae (r = 0.40, p = 0.0001), as 
determined by qPCR.  
Discussion 
In this study we compared the sensitivity of culture versus qPCR to detect, from 
the vagina and the rectum of pregnant women, six bacterial species that have 
been shown to be important components of the vaginal microflora. 
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qPCR has been applied previously for the description of changes in the vaginal 
microflora. Bradshaw et al. [29] applied qPCR for A. vaginae for a follow-up study 
of recurrent BV before and after treatment with oral metronidazole. Ferris et al. 
[30] applied qPCR for A. vaginae to samples of six BV patients before and after 
treatment with a topical metronidazole gel. Fredricks et al. [31] described the 
changes in vaginal bacterial concentrations following metronidazole therapy for 
BV and indicated that the detection of particular vaginal bacteria or consortia by 
PCR may be useful for the diagnosis or monitoring of the response to antibiotic 
therapy.  
Our findings are in agreement with previous studies, which indicate that 
bacterial vaginosis is associated with a significant increase in G. vaginalis and A. 
vaginae and a drop in Lactobacillus species. Biagi et al. [32] showed that bacterial 
vaginosis is associated with a significant increase of Prevotella, Atopobium, 
Veillonella and G. vaginalis and a decrease in Lactobacillus species and with high 
variability over time and between individuals, whereas the vaginal microflora 
under normal conditions and that of patients developing candidiasis was 
homogeneous and stable over time. Zarrifard et al. [33] and Sha et al. [34, 35], 
who quantified lactobacilli in cervicovaginal lavage samples, using a qPCR 
format, which picked up only L. crispatus and L. jensenii, found a decline in the 
number of lactobacilli in BV. qPCR based quantification of G. vaginalis and M. 
hominis from CVL was reported to be significantly more sensitive than the Amsel 
criteria for diagnosing BV [34]. Menard et al. [36] reported that qPCR can be 
used to objectively diagnose BV, when using cutoff values for the concentrations 
of A. vaginae and G. vaginalis. Recently, De Backer et al. [28] performed a study 
on 71 vaginal samples with the same primer sets, used here. Major advantages of 
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qPCR over the two most commonly used methods for diagnosing BV, i.e. the 
Amsel criteria [37] and the Gram stain [38] are the high sensitivity of PCR, which 
can be optimized to pick up very low numbers of bacteria, and the fact that it can 
be applied for the detection of bacteria in a dormant state, as is the case in 
biofilms, which are present vaginally in cases of BV, as has been shown by means 
of FISH [39]. To our knowledge, qPCR has not yet been used to compare in a 
quantitative manner the rectal and vaginal microflora of women, and in 
comparison with culture, as done in this study. 
Culture versus qPCR 
We compared the performance of qPCR and culture for the detection of four 
vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae.  
A striking finding is that a high number of pregnant women are positive for most 
of the species studied, when using qPCR, compared to culture. Instead of due to 
the high sensitivity of PCR, this could also be due to low specificity of this 
approach. However, this latter explanation is contradicted by the finding that 
women that were culture positive, usually also had the highest bacterial loads 
according to qPCR. In addition, the finding that for five of the six species, except 
G. vaginalis, high vaginal load usually corresponded with high rectal load, 
according to qPCR, is also an argument to explain these findings as result of the 
high sensitivity of qPCR rather than to its possible low specificity. In summary, 
qPCR is much more sensitive than culture for determining vaginal and rectal 
presence of bacteria, and qPCR indicates a much higher correspondence between 
vaginal and rectal bacterial loads, than can be established by culture. It should be 
noted that we picked a total of 8 colonies for each woman, whereas in routine 
culture applications only one or few colonies are selected for further 
15 
 
characterization, i.e., the sensitivity of culture in routine laboratories can be 
considered as even lower. This is not unexpected, because e.g., A. vaginae, G. 
vaginalis and L. iners are fastidious species, which moreover may be easily 
overlooked or overgrown when dealing with complex intestinal microflora. 
The finding that vaginal and/or rectal samples, which are culture positive for a 
certain species contain high loads of that bacterial species, as quantified by qPCR, 
indicates that culture detects Lactobacillus species, G. vaginalis and A. vaginae 
mostly only when these species are present in higher concentrations. 
Bacterial load in vaginal microflora 
In our study, significant positive correlations were found between the bacterial 
loads of G. vaginalis and A. vaginae, as determined by qPCR. The bacterial load of 
both species was low in normal vaginal microflora (grades Ia and Iab), and high 
in disturbed vaginal microflora (grades II and III). This confirmed our previous 
finding, i.e., a high correlation between vaginal bacterial loads for A. vaginae and 
G. vaginalis [28].  
Negative correlations were found between L. crispatus and G. vaginalis and also 
between L. crispatus and A. vaginae. In this study, we established a mean vaginal 
bacterial load of 9.1 cells/ml for G. vaginalis in grade III, which corresponds well 
to the value of 9.2 cells/ml, which we reported previously [28] and also to the 
value of  9.6 cfu/g, reported by Zariffard et al. [33]. In this study, we confirmed 
the coexistence of A. vaginae and G. vaginalis, which was recently documented in 
78%–96% of vaginal samples from women with BV, whereas this association 
was only present in 5%–10% of samples from women with normal vaginal 
microflora [13, 25, 29]. In agreement with these findings, Menard et al. [36] 
(2008) reported that qPCR based quantification of A. vaginae (≥ 108 copies/mL) 
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and G. vaginalis (≥ 109 copies/mL) had the highest predictive value for the 
diagnosis of BV. 
The correspondence between vaginal and rectal bacterial load 
In this study, using qPCR, significant positive correlations were found between 
vaginal and rectal colonization, i.e., there was high degree of correspondence 
between vaginal bacterial load and rectal bacterial load for five of the six species, 
i.e., A. vaginae, L. crispatus, L. gasseri, L. iners and L. jensenii. Only for G. vaginalis, 
we could not establish significant correlation between vaginal and rectal 
bacterial load (r = 0.23, p = 0.172), although Figure 2e indicates that also for G. 
vaginalis for most women the vaginal loads correspond largely with rectal loads. 
This correspondence between vaginal and rectal load for the different species is 
also apparent from Figure 2. Several studies have indicated the rectum as the 
reservoir for the vaginal microflora. The rectum seems to be the primary habitat 
of Candida spp. in patients with candidal vulvovaginitis [40]. Meyen et al. [41] 
showed that rectal colonisation with GBS was the most significant predictor of 
vaginal colonization, suggesting that the vagina becomes colonized with GBS as a 
result of transfer of the organism from the rectum to the vagina. This is not in 
contradiction with our previous genotyping study, which showed a high 
correspondence of vaginal and rectal colonisation with GBS, also at the strain 
level [20] . Halen et al. [18]  reported the simultaneous occurrence of Mobiluncus 
spp. in the vagina and rectum. Holst et al. [19]  reported that the reservoirs of 
Mobilincus spp., G. vaginalis and Mycoplasma hominis are in the intestinal tract. 
We previously showed high correlation between vaginal and rectal microflora, 
not only with regard to species composition but also with regard to the presence 
of 
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genotypically identical strains [20, 21]. To our knowledge, this study is the first 
one that also indicates a clear quantitative correspondence between the bacterial 
loads present in vagina and rectum, for at least five of the six species studied. 
The prevalence and role of L. iners as part of the vaginal microflora remains 
intriguing. In this study, using qPCR, L.iners was detected vaginally and rectally 
in high numbers, when compared to culture, and when compared to other 
studies of the rectal microflora [6, 42]. In our study, the prevalence of L. iners in 
the rectum was 2.8% using culture versus 52.0%, using qPCR. In previous 
studies [17, 42], L. iners was not isolated from the rectum only but in our study, 
using qPCR, we could detect it from the rectum only in 9.8% and from both the 
vagina and the rectum in 42.2% of the subjects. 
Establishing the prevalence of L. iners has been cumbersome thus far, when 
relying on culture and Gram-stain, because L. iners cannot be propagated on 
conventional Lactobacillus-selective media such as Rogosa or MRS agar [7] and 
because the cell morphology of L. iners is Gram-negative coccobacillar rather 
than Gram positive bacillar, as for regular lactobacilli [28]. Since it is the 
predominant Lactobacillus species in BV microflora [28], even present in high 
numbers, this has led to the false assumption that the BV microflora is devoid of 
lactobacilli. Moreover, because also the Gram-positive G. vaginalis stains Gram-
negative, this has lead to the description of BV microflora as dominated by 
‘anaerobic Gram-negatives’. 
More recently, several findings indicate some role for L. iners in the equilibrium 
between balanced and imbalanced vaginal microflora. In a previous qPCR based 
study, we found an inverse relationship between L. iners and L. gasseri, with L. 
iners predominant in grade III microflora, whereas L. gasseri was predominant in 
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grade II microflora [28]. Jakobsson and Forssum [43] reported pyrosequencing 
results that indicated that L. iners is a dominant part of the vaginal microflora 
when the microflora is in a transitional phase between abnormal and normal, 
either because of treatment or because of physiological changes such as varying 
estrogen levels. Ferris et al. [30] found that L. iners was predominant in 5 
patients with BV after metronidazole treatment, whereas for the sixth patient, 
the only one with a complete treatment failure, L. iners was present but not 
predominant.  
Conclusions 
We established significant differences between detection of six bacterial species 
of the vaginal and rectal microflora using culture or qPCR. The carriage rate was 
3-fold (for L. crispatus) to 17-fold (for A. vaginae) higher according to qPCR than 
according to culture, despite the fact that for each subject 8 colonies were picked 
and identified. Women were positive for the six species in 4.0 to 32.3% of cases 
according to culture, compared to 68.5 to 91.5% of cases according to qPCR. In 
addition and most importantly, using qPCR, significant correlation between 
quantities of vaginal and rectal lactobacilli and of A. vaginae were established, 
indicating important correspondence of the vaginal and rectal microflora, not 
only with regard to the simultaneous occurrence of these species in both niches, 
but also with regard to cell densities per bacterial species, and confirming the 
possible role of the rectum as a reservoir for vaginal colonization. Using qPCR, 
we could detect L. iners in high numbers vaginally and rectally when compared 
to other studies of the rectal microflora [6, 42]. Several recent studies, reviewed 
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here, indicate that the role of this peculiar Lactobacillus species in the transition 
between balanced and imbalanced vaginal microflora needs further elucidation. 
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Figures 
 
Figure 1. Number among 71 women carrying four Lactobacillus species (A-D) or Gardnerella vaginalis (E) or Atopobium vaginae (F)  
A. Lactobacillus 
crispatus 
B. Lactobacillus 
jensenii 
C. Lactobacillus 
gasseri 
D. Lactobacillus 
iners 
E. Gardnerella 
vaginalis 
F. Atopobium 
vaginae 
 
 
 
 
  
                                                   
Legend 
Y axis: Number of pregnant women. X axis: culture ( ) and qPCR ( ) results for V) vaginal only, R) rectal only, RV) both vaginal and 
rectal and T) overall (total) presence determinations. 
V R RV T V R RV T V R RV T V R RV T V R RV T V R RV T 
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A. Lactobacillus crispatus B. Lactobacillus jensenii C. Lactobacillus gasseri 
   
 
Figure 2. qPCR results, expressed as log10 concentration of Lactobacillus species (A-D) or Gardnerella vaginalis (E) or Atopobium vaginae (F), in 
relation to culture results 
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D. Lactobacillus iners E. Gardnerella vaginalis F. Atopobium vaginae 
   
Legend:  
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X axis: Log 10 concentration of the bacteria in rectal samples as estimated by qPCR 
Y axis: Log 10 concentration of the bacteria in vaginal samples as estimated by qPCR 
Blue horizontal line: The lower limit of qPCR based detection of the bacteria in rectal samples 
Blue vertical line: The lower limit of qPCR based detection of the bacteria in vaginal samples 
 
 
R+ V+: Both rectally and vaginally culture positive;  
R- V+: Rectally culture negative and vaginally culture positive;  
R+ V-: Rectally culture positive and vaginally culture negative;  
R- V-: Both vaginally and rectally culture negative. 
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Table 1. Vaginal and rectal occurrence of six bacterial species, as estimated by culture and qPCR, expressed as percentage 
positive of 71 pregnant women 
 
  
Species 
     Vagina alla Vagina only Vagina & Rectum  Rectum only Rectum alla Overall 
Culture qPCR Culture qPCR Culture qPCR Culture qPCR Culture qPCR Culture qPCR 
L. crispatus 30.9b 64.7 21.1 4.2 9.8 60 1.4 26.7 11.2 87.3 32.3 91.5 
L. jensenii 30.9 57.7 21.1 7 9.8 50.7 1.4 19.7 11.2 70.4 32.3 77.4 
L. iners 9.8 57.7 9.8 15.4 0 42.2 2.8 9.8 2.8 52.0 12.6 68.5 
L. gasseri 28.1 87.3 19.7 36.6 8.4 50.7 0 4.2 8.4 54.9 28.1 91.5 
G. vaginalis 11.2 59.0 11.2 9.8 0 49.2 1.4 15.4 1.4 64.7 12.6 74.6 
A. vaginae 4.2 35.1 4.2 4.2 0 30.9 1.4 33.8 1.4 64.7 5.6 69.0 
 
a: ‘Vagina all’ presents the sum of both the subjects with the species in the vagina only and the subjects with the species in both vagina 
and rectum. The column entitled ‘Rectum all’ presents the sum of both the subjects with the species in the rectum only and the subjects 
with the species in both vagina and rectum. 
b: Although the numbers of women that are culture positive for L. crispatus are identical to those positive for L. jensenii, for all sites, this 
is coincidental, because different women are culture positive for both species.  
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Abstract
Background: Group B streptococci (GBS), or Streptococcus agalactiae, are the leading bacterial cause of
meningitis and bacterial sepsis in newborns. Here we compared different culture media for GBS detection and
we compared the occurrence of different genotypes and serotypes of GBS isolates from the vagina and rectum.
Methods: Streptococcus agalactiae was cultured separately from both rectum and vagina, for a total of 150
pregnant women, i) directly onto Columbia CNA agar, or indirectly onto ii) Granada agar resp. iii) Columbia CNA
agar, after overnight incubation in Lim broth.
Results: Thirty six women (24%) were colonized by GBS. Of these, 19 harbored GBS in both rectum and vagina,
9 only in the vagina and 8 exclusively in the rectum. The combination of Lim broth and subculture on Granada
agar was the only culture method that detected all GBS positive women. Using RAPD-analysis, a total of 66
genotypes could be established among the 118 isolates from 32 women for which fingerprinting was carried out.
Up to 4 different genotypes in total (rectal + vaginal) were found for 4 women, one woman carried 3 different
genotypes vaginally and 14 women carried two 2 different genotypes vaginally. Only two subjects were found to
carry strains with the same genotype, although the serotype of both of these strains was different.
Eighteen of the 19 subjects with GBS at both sites had at least one vaginal and one rectal isolate with the same
genotype.
We report the presence of two to four different genotypes in 22 (61%) of the 36 GBS positive women and the
presence of identical genotypes in both sites for all women but one.
Conclusion: The combination of Lim broth and subculture on Granada medium provide high sensitivity for GBS
detection from vaginal and rectal swabs from pregnant women. We established a higher genotypic diversity per
individual than other studies, with up to four different genotypes among a maximum of 6 isolates per individual
picked. Still, 18 of the 19 women with GBS from both rectum and vagina had at least one isolate from each
sampling site with the same genotype.
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Streptococcus agalactiae, group B Streptococcus (GBS), is a
leading cause of neonatal morbidity and mortality in the
US, Western Europe and Australia. Maternal carriage has
been recognized as the most important risk factor for GBS
neonatal infection [1,2] and indeed vertical transmission
before or during delivery has been shown [3,4]. Mother-
to-child transmission may lead to neonatal infection in 1
to 2 infants per 1,000 live births [5] with mortality rates
ranging from 10 to 20% [6]. Among pregnant women, the
prevalence of colonization with GBS ranges from 3.2 to
36% [7-9]. Screening consists of obtaining vaginal and
rectal specimens for culture at 35 to 37 weeks of gestation.
Recently, several molecular techniques have been applied
to study the genetic diversity of GBS, such as restriction
fragment length polymorphism analysis (RFLP) [10],
ribotyping [10,11], pulsed-field gel electrophoresis
(PFGE) [3,12-17] multilocus enzyme electrophoresis
(MLEE) [18] randomly amplification of polymorphic
DNA-analysis (RAPD) [9,19,20], amplified cps restriction
polymorphism analysis [21] and multilocus sequence
typing (MLST) [13,22-25].
To our knowledge, only one study [12], addressed the
genotypic and serological diversity of GBS within individ-
ual women. Therefore, the aim of this study was to com-
pare the genotypes of the GBS isolates from separate
vaginal and rectal swabs using a simple genotypic
approach (RAPD analysis with primer OPM1, followed by
capillary electrophoresis) and also to study the correlation
between serotype and genotype of the GBS isolates.
Methods
Study design
The study was approved by the research ethics committee
(IRB protocol nr 2007/096) of Ghent University Hospital,
Flanders, North region of Belgium, and all the women
gave written informed consent. Between April and
December 2007, 150 paired vaginal and rectal swabs were
collected from pregnant women at 35 - 37 weeks of gesta-
tion.
Collection and culture of specimens
All specimens were collected using nylon flocked swabs
that were submerged into 1 ml of liquid Amies transport
medium (eSwab, Copan Diagnostics, Brescia, It.). For rec-
tal specimens, a swab was carefully inserted approxi-
mately 1.5 - 2 cm beyond the anal sphincter and then
gently rotated to touch anal crypts.
Vaginal samples were collected by inserting a swab into
the vagina. The swab was rolled round through 360
degrees against the vaginal wall at the midportion of the
vault. At Ghent University Hospital, the routine GBS-
screening of pregnant women is always performed during
the prenatal consultation at 35-37 weeks' gestation. All
study samples were collected by midwives and trans-
ported to the Laboratory of Bacteriology Research within
4 hours.
A total of 70 μl from the Amies liquid transport medium
of each of the vaginal and rectal swabs was seeded on
Columbia CNA agar with 5% sheep blood (Columbia
CNA agar, Becton Dickinson, Erembodegem, Belgium)
and 200 μl was inoculated into 5 ml of Lim Broth (Todd-
Hewitt broth, 1% yeast extract, 15 μg nalidixic acid/ml
and 10 μg colistin/ml) (Lim Broth, Becton Dickinson)
[26]. Both media are selective for Gram positive bacteria.
The Columbia CNA agar plates were incubated at 37°C in
5% CO2 for 24-48 h.
The Lim Broth was incubated aerobically at 37°C for 18-
24 hours and then subcultured onto Granada agar (Bec-
ton Dickinson) [27] and onto Columbia CNA agar. Gra-
nada agar was incubated at 37°C in an anaerobic chamber
(BugBox, LedTechno, Heusden-Zolder, B.) for 24-48 h
and Columbia CNA agar was incubated at 37°C in 5%
CO2 for 24-48 h.
Granada agar was examined for yellow-orange pigment
colonies that confirm the presence of GBS, whereas β-
haemolytic and non-haemolytic colonies were picked
from Columbia CNA agar for further identification as S.
agalactiae by the CAMP test.
Identification of the isolates as Streptococcus agalactiae
The isolates were identified as S. agalactiae by the follow-
ing criteria: growth and orange pigment formation on
Granada agar, positive for the CAMP test on blood agar
and molecular identification by tDNA-PCR [28].
Antibiotic susceptibility testing
Fourty isolates of group B streptococci of 8 pregnant
women were tested by disk diffusion for susceptibility to
clindamycin and erythromycin Colonies taken from Tryp-
ticase Soy Agar (TSA) + 5% sheep blood (Becton Dickin-
son) were suspended in 5 ml of saline and the inoculum
was adjusted to the turbidity of a 0.5 McFarland standard.
This suspension was streaked onto TSA + 5% sheep blood
to obtain confluent growth, disks were added and the
plates were incubated overnight at 37°C with 5% CO2.
Strains were considered resistant to clindamycin and
erythromycin when the inhibition zones were less than 15
mm.
DNA-extraction from isolates
DNA was extracted from cultured isolates by alkaline lysis
as follows: One bacterial colony was suspended in 20 μl
of lysis buffer (0.25% sodium dodecyl sulfate, 0.05 NPage 2 of 11
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diluted by adding 180 μl of distilled water. The cell debris
was spun down by centrifugation at 16,000 g for 5 min.
Supernatants were used for PCR or frozen at -20°C until
further use.
Genotyping of isolates
The cultured vaginal and rectal GBS isolates were geno-
typed using RAPD-analysis with the RAPD Ready-to-Go
beads (GE Healthcare. Buckinghamshire, UK) as
described previously [29] with primer OPM1 (5' GTT GGT
GGC T) at a final concentration of 2 μM, including 0.2 μM
of fluorescent TET-labeled OPM1 primer. After 5 min at
94°C, 5 min at 35°C and 5 min at 72°C, reaction mix-
tures were cycled 30 times in a Veriti™ Thermal Cycler
(Applied Biosystems, Foster City, Ca.), with the following
conditions: 30 s at 94°C, 1 min at 35°C, and 1 min at
72°C, with a final extension period of 5 min at 72°C.
Reaction vials were then cooled to 10°C and kept on ice
until electrophoresis.
Capillary electrophoresis
A volume of 11.9 μl of deionized formamide (ACE forma-
mide, Lucron, De Pinte) was mixed with 0.6 μl of an inter-
nal size standard mixture containing 0.3 μl of the ROX-
400 high-density size standard (Applied Biosystems, Fos-
ter City, Ca.) and 0.3 μl of Map marker 1000 size standard
(BioVentures, Murfreesboro, Tn.). One microliter of
OPM1-PCR product was added. The mixtures were dena-
tured by heating at 95°C for 3 min and placed directly on
ice for at least 10 min. Capillary electrophoresis was car-
ried out using an ABI-Prism 310 genetic analyzer (Applied
Biosystems) at 60°C, at a constant voltage of 1.5 kV, and
at a more or less constant current of approximately 10 mA.
Capillaries with a length of 47 cm and diameter of 50 μm
were filled with performance-optimized polymer 4. Elec-
tropherograms were normalized using Genescan Analysis
software, version 2.1 (Applied Biosystems).
Data analysis
OPM1-PCR fingerprints were obtained as table files from
the Gene Scan Analysis software and used in a software
program developed at our laboratory [30]. Using these
sample files composed of numbers, representing the
length of the amplification fragments in base pairs, a dis-
tance matrix was calculated with the in-house software
using the differential basepairs (dbp) and the Dice algo-
rithm [30]. Clustering analysis was done with the Phylip
software http://evolution.genetics.washington.edu/
phylip.html, using the Neighbor Joining algorithm.
Serotyping
A total of 122 GBS isolates from 36 pregnant women were
serotyped, using the latex co-agglutination kit of Essum
AB (Umea, Sweden), according to the manufacturer's
instructions. This kit enables to differentiate between
serotypes Ia, Ib, II, III, IV and V.
Statistical methods
The McNemar test for correlated percentages was used to
compare the sensitivity of the culture media.
Results
For a total of 150 women, culture was carried out sepa-
rately for both rectal and vaginal sites, using three culture
methods, i.e. directly onto Columbia CNA agar, or indi-
rectly, by subculturing onto Columbia CNA agar resp.
Granada agar, following overnight incubation in LIM
broth.
Comparison of culture techniques
A total of 36 out of 150 pregnant women studied (24%)
were colonized by GBS. Of 55 samples from which GBS
was isolated, 22 were positive by direct inoculation on
Columbia CNA agar, 55 by Lim broth enrichment with
subculture on Granada agar and 45 by Lim broth with
subculture on Columbia CNA agar, resulting in sensitivi-
ties of 40, 100 and 81% respectively (Table 1).
Culture of vaginal specimens by direct plating on Colum-
bia CNA agar was significantly less sensitive than culture
in Lim broth with subculture on Granada agar or subcul-
ture on Columbia CNA agar (McNemar test, p < 0.0001).
In addition, the culture of rectal specimens, direct plating
onto Columbia CNA agar was significantly less sensitive
than culture in Lim broth with subculture on Granada
agar (p < 0.0001), which was more sensitive than culture
on Lim broth with subculture on Columbia CNA agar (p
= 0.0313).
Table 1: Number of GBS-positive cultures detected by different culture media in separate vaginal and rectal specimens obtained from 
150 pregnant women
Specimen No. of positive GBS cultures detected by
Columbia CNA agar Lim broth + Granada agar Lim broth + Columbia CNA agar Total no. of women colonized
Vaginal 11 28 24 28
Rectal 11 27 11 27
Total 22 55 45 36Page 3 of 11
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For the 36 women that were found positive, 9 (25%) car-
ried GBS only in the vagina, 8 (22%) only in the rectum
and 19 (53%) in both sampling sites (Table 1). Using
three culture methods for two sampling sites, a maximum
of 6 colonies per woman was picked, one from each of the
positive culture plates. A total of 122 isolates were
obtained (Table 2) of which 118 were genotyped using
RAPD with primer OPM1 and analysis by capillary elec-
trophoresis. The single isolates from four women were not
fingerprinted, because there were no other isolates from
the same subject to compare with. A tree was constructed
after distance matrix calculation, and this revealed the
presence of a total of 66 genotypes among the 118 isolates
from 32 women for which fingerprinting was carried out.
Only two subjects (RVS033 and RVS062) were found to
carry strains of which the RAPD genotype was indistin-
guishable (Figure 1).
For 5 out of the 19 women from which both vaginal and
rectal isolates were obtained, all the rectal and vaginal iso-
lates were identical. For another 13 of these 19, at least
one of the vaginal isolates had a similar genotype as one
of the rectal isolates. Four women had two genotypes,
seven had three genotypes and three had four genotypes.
One of the five women with only rectal isolates had one
genotype, whereas the other four had two genotypes. For
the eight women with only vaginal isolates, four of them
Table 2: Overview of genotyping and serotyping results for 36 women positive for GBS.
Number Number V DC V LG V LC R DC R LG R LC
1 RVS143 - +a/Vb - - - -
2 RVS038 - A/III A/V - - -
3 RVS071 - A/IV A/IV - - -
4 RVS073 - A/III A/V - - -
5 RVS109 - A/V A/V - - -
6 RVS034 A/III B/Ib - - - -
7 RVS035 B/III A/II A/II - - -
8 RVS076 A/Ib B/Ib B/Ib - - -
9 RVS148 - A/III B/III - - -
10 RVS004 - - - - +/Ia -
11 RVS051 - - - - +/V -
12 RVS080 - - - - +/IV -
13 RVS084 - - - - A/NT A/NT
14 RVS021 - - - B/Ia A/Ib A/Ib
15 RVS061 - - - B/V A/NT A/NT
16 RVS120 - - - - A/Ia B/Ia
17 RVS145 - - - - A/Ia B/V
18 RVS017 - A/IV A/IV - A/IV -
19 RVS047 - A/IV A/IV A/IV A/IV A/IV
20 RVS106 A/II A/II - A/II A/II -
21 RVS127 A/IV A/IV A/IV - A/IV A/IV
22 RVS069 - A/NT - - A/NT -
23 RVS039 - A/Ia A/Ia - B/Ia A/Ia
24 RVS083 - A/III B/Ib A/III A/III A/III
25 RVS114 - B/V A/V - A/V A/V
26 RVS123 - A/NT A/NT - A/NT B/NT
27 RVS027 A/V A/V C/V A/V A/V B/V
28 RVS033 A/III C/III A/III A/III B/III A/III
29 RVS064 A/III B/III A/III A/III C/III A/III
30 RVS075 - B/II A/II - C/II A/II
31 RVS110 A/V A/V A/V C/V B/V A/V
32 RVS126 A/NT C/IV A/NT - B/IV A/NT
33 RVS136 - A/NT B/III - A/NT C/NT
34 RVS031 - D/III A/III B/NT A/III C/II
35 RVS062 - D/II A/II - B/II C/II
36 RVS074 B/Ib A/Ib D/Ib B/Ib A/Ib C/Ib
Column headings: V DC: Vaginal sample, cultured directly on Columbia Agar, V LG: after Lim broth enrichment culture, plated onto Granada agar, 
V LC: after Lim broth enrichment culture, plated onto Columbia agar; R DC: Rectal sample, idem as for vaginal samples.
-: No GBS isolated.
a: Genotype: +: strain present, but not genotyped, A, B, C, D: genotypes numbered per individual.
b: Serotype: serotype number as determined by the Essum AB kit (Umea, Sweden). The following serotypes can be detected by this kit: Ia, Ib, II, III, 
IV and V. NT: nontypeable.Page 4 of 11
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types.
Serotyping
In addition, all isolates were serotyped (Table 2). Seven-
teen isolates, from 7 subjects, were nontypeable. Further-
more, a rather equal distribution of the serotypes was
found among the strains (Table 2). Eight women were
found to carry isolates of the same genotype and serotype.
An example is shown in Figure 2. In 11 subjects, only one
serotype was present, although 2 to 4 genotypes could be
found per subject. Nine subjects were found to carry iso-
lates with different genotype and different serotype (Fig-
ure 3). The two isolates with the same genotype from the
two different subjects belonged to different serotypes.
The frequency of different serotypes was as follows Ia:
10.4%, Ib: 10.4%, II: 10.4%, III: 20.8%, IV: 12.5, V: 20.8
and nontypeable: 14.5%. Overall serotype distribution
among vaginal vs rectal isolates was comparable, with a
rectal predominance of Ia, i.e. 1 vaginal isolate vs 5 rectal
isolates and a vaginal predominance of III, i.e. 10 vaginal
isolates vs 4 rectal isolates. The presence of L. crispatus,
generally accepted to confer vaginal colonisation resist-
ance to pathogenic organisms [31,32], did not seem to
protect against vaginal S. agalactiae colonization, since a
comparable number of women colonized only vaginally
by S. agalactiae resp. only rectal by S. agalactiae were colo-
nized vaginally by L. crispatus, i.e. 3/9 resp. 2/8. Six of the
19 women colonized by S. agalactiae both rectally and
vaginally carried L. crispatus vaginally.
Fingerprints of two isolates from two different subjects (RVS033 and RVS062) showing the same genotype and different sero-typesigu e 1
Fingerprints of two isolates from two different subjects (RVS033 and RVS062) showing the same genotype and 
different serotypes. x-axis: length of amplified DNA fragments expressed in bps. y-axis: peak height (intensity of DNA-frag-
ment).Page 5 of 11
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GBS is considered homogenously susceptible to penicil-
line and amoxicillin. In case of allergy, second choice anti-
biotics are clindamycin or erythromycin. According to
CLSI erythromycine can be tested with a simple disk test,
although this is not done in our routine laboratory. Here
we checked 40 isolates from 8 patients and found 26 iso-
lates to be susceptible to both clindamycine and erythro-
mycine, 3 to be clindamycine resistant and 11 to be
resistant to both antibiotics. The susceptibility pattern of
all strains was homogeneous for six subjects, despite gen-
otypic differences among the isolates, whereas two sub-
jects carried clindamycin resistant strains besides isolates
susceptible to both antibiotics.
Discussion
Sensitivity and specificity of different culture techniques 
for the detection of GBS
In our study, only the combination of Lim broth and sub-
culture on Granada agar enabled detection of all carriers,
whereas direct inoculation onto Columbia CNA agar
achieved a sensitivity of 40% and subculture of the Lim
broth onto Columbia CNA agar detected 81% of the car-
riers.
Gil et al. [33] showed that in different studies the sensitiv-
ity of Granada agar ranged from 88.5 to 91.1%, that of
Columbia CNA agar from 83.9 to 94.3% and that of Lim
broth (to which 5% horse serum was added) was 63.5%
when subcultured on Granada agar and 75% when sub-
cultured on Columbia CNA agar. Bosch-Mestres et al. [34]
showed that the use of direct inoculation onto Granada
Fingerprints of different isolates of subject RVS047 with the same genotype and the same serotypeigu e 2
Fingerprints of different isolates of subject RVS047 with the same genotype and the same serotype. x-axis: 
length of amplified DNA fragments expressed in bps. y-axis: peak height (intensity of DNA-fragment).
          	
          	
          	

         
          	
          
          
          
          
      
   Page 6 of 11
(page number not for citation purposes)
BMC Infectious Diseases 2009, 9:153 http://www.biomedcentral.com/1471-2334/9/153agar allowed fast detection for about 87% of carriers,
where as the combination of Todd-Hewitt broth and sub-
culture on Granada agar or Columbia CNA agar allowed
detection of more than 99% of GBS carriers. Elsayed et al.
[35] reported 79% sensitivity for direct inoculation onto
Columbia CNA agar and incubation during 48 hours
compared to 100% sensitivity for Lim broth with subcul-
ture on blood agar. It can be concluded from this study
and others that the combination of broth enrichment
(Todd-Hewitt or LIM broth) with subculture on solid
medium, yields higher sensitivity than direct inoculation
onto solid media.
Although no definite conclusions can be drawn with
regard to the sensitivity of the different solid media, Gra-
nada agar has the advantage that it makes possible to pro-
vide overnight results by visual inspection of the presence
of red orange colonies, that are produced exclusively by
GBS. The red orange colonies are easily observed, even
when few colonies are present or when GBS is mixed with
other microorganisms, which are mainly other strepto-
cocci [33] . The colonies are so characteristic and unique
that identification by antigen detection or the CAMP test
is unnecessary. In this study, all red orange colonies were
CAMP positive (data not shown). Claeys et al. [36] missed
only two CAMP positive isolates on a total of 310 tested,
which were not red orange pigmented on Granada.
Blanckaert et al. [37] used a combination of Granada and
Columbia blood agar for GBS screening and demon-
strated that 6% of the samples positive for GBS on Colum-
bia blood agar lacked red orange colonies on Granada
agar. Notably, Granada agar does not detect non-pig-
mented isolates, and on blood-agar these non-hemolytic
isolates are difficult to detect as well. As a result of that,
Fingerprints of different isolates of subject RVS031 with different genotypes and different serotypesigu e 3
Fingerprints of different isolates of subject RVS031 with different genotypes and different serotypes. x-axis: 
length of amplified DNA fragments expressed in bps. y-axis: peak height (intensity of DNA-fragment).
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missed. In conclusion, in our hands, the use of combina-
tion of Lim broth and subculture on Granada agar pro-
vided high sensitivity and specificity for detecting GBS in
vaginal and rectal swabs from pregnant women.
Epidemiology
The high prevalence of S. agalactiae colonization, i.e. 24%,
as established in this study, is in accordance with results
from other European studies that report colonization
rates between 10% and 36% [38-43]. Thinkhamrop et al.
[44] reported a prevalence of 7.1% (Myanmar) to 19.1%
(Philadelphia), using Lim broth culture. Toresani et al. [9]
found a prevalence of only 3.2% among 531 Argentinan
pregnant women. Brimil et al. [38] showed equal carrier
rates of 16% for GBS among pregnant and nonpregnant
women and, based on the prevalence of GBS carriage,
these authors concluded that strict adherence to the guide-
lines for prevention of GBS neonatal infection results in
peripartal antibiotic prophylaxis in up to 20% of all deliv-
eries.
Our data, are also in correspondence with other results on
GBS prevalence in our country. Rectovaginal colonization
with group B streptococci in Belgium is 13-25%. These
data are based on different studies carried out by the Bel-
gian reference laboratory for GBS in collaboration with
the section of epidemiology of the Scientific Institute for
Public Health (ISP-WIV, Brussels) [45]. For example,
Blanckaert et al. [37] compared the results of GBS screen-
ing on Granada agar with those obtained using standard
Columbia blood agar at two participating centers in Bel-
gium. They reported GBS-positive culture results of 10-
30% of pregnant women. The Flemish Study Centre for
Perinatal Epidemiology evaluated GBS prevalence in Flan-
ders and found an average colonization rate of 16%
among Flemish pregnant women [46].
Manning et al. [41] found that the prevalence of GBS col-
onization was equally high among 241 women (34%)
and 211 men (20%) living in a college dormitory. Sexu-
ally experienced subjects had twice the colonization rates
of sexually inexperienced participants. Van der Mee-Mar-
quet et al. [47] reported that the prevalence of carriage was
27% in women and 32% in men. The major positive body
site was the genital tract (23% in women and 21% in
men) and skin, throats, and anal margins were also posi-
tive in 2%, 4%, and 14%, respectively.
Comparison between vaginal and rectal carriage
Brimil et al. [38] reported that for a total of 34 GBS posi-
tive pregnant women, 32% carried GBS only vaginal, 24%
only rectal and 44% both rectal and vaginal, which com-
pares well with our results, i.e. resp. 24%, 22% and 53%.
Serotypic and genotypic diversity among GBS isolates
We studied the rectal and vaginal colonization with GBS
of pregnant women attending the Ghent University hospi-
tal (Belgium) and the serotypic and genotypic diversity
among the GBS isolates. Strong genotypic and serotypic
heterogeneity was observed between women and for indi-
vidual women, e.g., we found a total of 66 genotypes
among 118 isolates (from 32 women), of which 4 women
had up to 4 different genotypes in total (rectal + vaginal)
and 14 women had up to 2 different genotypes vaginally.
Manning et al. [48] genotyped GBS isolates from vaginal-
rectal swabs of women at two visits and documented a
turnover in 8.3% of 126 women colonized both at 35-37
weeks of gestation and 6 weeks after delivery. Unfortu-
nately, only one isolate was genotyped per visit. Taking
into consideration the genotypic diversity per subject, as
observed in our study, a turnover of 8.3% might be an
overestimation. When the same subject, carrying e.g. gen-
otypes a, b and c, is sampled at two different moments,
and whereby on each occasion only one colony is picked,
the detection of a different genotype may be interpreted as
turn over, but it may be that a genotype a strain has picked
at the first visit but a genotype b or c strain at the second
visit.
Moreover, their conclusion that some clones are more
likely to be lost should be interpreted with care, since their
apparent disappearance might be explained by the pres-
ence of these clones in relatively lower numbers (com-
pared to other clones), which reduces their chance of
being picked at two separate occasions. To our knowledge,
only one group studied genotypic diversity within indi-
vidual women, by genotyping 15 randomly picked iso-
lates for each of 30 women, albeit from mixed vaginal-
rectal specimens [12]. In opposition to our results, these
authors found a high degree of genotypic and serotypic
homogeneity, i.e. for 29 of 30 women, all 15 isolates from
each woman had the same serotype, and for 27 of 30
women, all 15 isolates had the same chromosomal SmaI-
DNA restriction digest fingerprint. For the three women
with different PFGE types, one had three different geno-
types and two different serotypes. Another PFGE based
study reported high stability of the GBS type for each
woman, followed up to two years [40]. In accordance with
our results, these authors found 30 different GBS isolates
among 32 women, with only two women carrying isolates
with the same genotype.
The high level of heterogeneity established in our study,
compared to other studies, may be due to the different
culture media that were used and to the use of separate
swabs for sampling vagina and rectum for each individual
woman. We found that strains of the same serotype recov-
ered from different women were heterogeneous in DNAPage 8 of 11
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mosomal DNA and PFGE revealed high genotypic hetero-
geneity among both Zimbabwean serotype III and
serotype V isolates [16], another study also reported dif-
ferent SmaI restriction types within serotypes II and V
[12], and Fasola et al. [14] and Savoia et al. [49] showed
that several genotypic lineages are present within the dif-
ferent serotypes.
Serotype switching is believed to occur within genotypic
lineages [7,24,25], presumably by horizontal transfer of
genes of the cps locus, i.e. of genes encoding the GBS cap-
sular polysaccharide structure [50], and may be an expla-
nation for our observation of the presence of two isolates
in two different women with the same genotype, but with
a different serotype.
Although MLST has become the standard method to study
the population structure of GBS [22,24], more rapid and
less expensive and laborious methods remain useful for
carrying out single centre studies. We used RAPD-analysis
in combination with high resolution capillary electro-
phoresis, which also makes possible immediate digitiza-
tion of the fingerprints. Chatellier et al. [51] found that the
simplest typing scheme of S. agalactiae was obtained by
the combination of RAPD typing and serotyping (discrim-
inatory index 0.97). Zhang et al. [20] found congruence
between RAPD analysis and serotyping, on a limited
number of strains. The findings of Toresani et al. [9], who
found a total 16 RAPD profiles among 21 GBS isolates,
from 17 women, and of Chatellier et al. [51], who identi-
fied 71 RAPD types among 54 unrelated S. agalactiae
strains isolated from cerebrospinal fluid samples from
neonates, point to the same genotypic diversity as
observed in our study.
General serotype distribution
The capsule of S. agalactiae has long been recognized as
one of the most important virulence factors. Variations of
the capsular polysaccharide structure allow the antigenic
distinction of 13 different S. agalactiae serotypes, of which
9 are of clinical importance (Ia, Ib, II-VIII). Studies from
the US and Europe show that the serotypes Ia, II, III, and
V are found in 80-90% of all clinical isolates [4,48].
Serotype distribution among GBS isolates from pregnant
women in our study was compared with that reported by
others. Several studies indicate that serotype III is globally
the most prevalent serotype, e.g. 29.2% of Israelian iso-
lates [7], 28% of German isolates [38], 24.3% of Swedish
isolates [39] and 33.2% of Czech isolates [42]. In accord-
ance, we observed a frequency of 20.8% for serotype III
isolates in our study, as the most frequent serotype.
Antibiotic susceptibility
The finding that two out of 8 women carried isolates with
different susceptibility to clindamycin indicates that when
testing susceptibility for clindamycin several colonies
should be tested, since colonies with different susceptibil-
ity may be simultaneously present.
Conclusion
In summary, our study, including 150 pregnant women,
confirmed the European prevalence of around 20% of
GBS among pregnant women and the predominance of
serotypes III and V among these women, but we estab-
lished a higher genotypic diversity per individual than
other studies, with up to four different genotypes among
a maximum of 6 isolates per individual picked. Still, 18 of
the 19 women with GBS from both rectum and vagina
had at least one isolate from each sampling site with the
same genotype. In our hands, the combination of Lim
broth and subculture on Granada medium provided
higher sensitivity than direct culture on Columbia CNA or
Lim broth and subculture on Columbia CNA for GBS
detection from vaginal and rectal swabs from pregnant
women.
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Abstract
Background: Streptococcus agalactiae (group B streptococcus; GBS) is a significant cause of perinatal and neonatal
infections worldwide. To detect GBS colonization in pregnant women, the CDC recommends isolation of the
bacterium from vaginal and anorectal swab samples by growth in a selective enrichment medium, such as Lim
broth (Todd-Hewitt broth supplemented with selective antibiotics), followed by subculture on sheep blood agar.
However, this procedure may require 48 h to complete. We compared different sampling and culture techniques
for the detection of GBS.
Methods: A total of 300 swabs was taken from 100 pregnant women at 35-37 weeks of gestation. For each
subject, one rectovaginal, one vaginal and one rectal ESwab were collected. Plating onto Columbia CNA agar
(CNA), group B streptococcus differential agar (GBSDA) (Granada Medium) and chromID Strepto B agar (CA), with
and without Lim broth enrichment, were compared. The isolates were confirmed as S. agalactiae using the CAMP
test on blood agar and by molecular identification with tDNA-PCR or by 16S rRNA gene sequence determination.
Results: The overall GBS colonization rate was 22%. GBS positivity for rectovaginal sampling (100%) was
significantly higher than detection on the basis of vaginal sampling (50%), but not significantly higher than for
rectal sampling (82%). Direct plating of the rectovaginal swab on CNA, GBSDA and CA resulted in detection of 59,
91 and 95% of the carriers, respectively, whereas subculturing of Lim broth yielded 77, 95 and 100% positivity,
respectively. Lim broth enrichment enabled the detection of only one additional GBS positive subject. There was
no significant difference between GBSDA and CA, whereas both were more sensitive than CNA. Direct culture onto
GBSDA or CA (91 and 95%) detected more carriers than Lim broth enrichment and subculture onto CNA (77%).
One false negative isolate was observed on GBSDA, and three false positives on CA.
Conclusions: In conclusion, rectovaginal sampling increased the number GBS positive women detected, compared to
vaginal and/or rectal sampling. Direct plating on CA and/or GBSDA provided rapid detection of GBS that was at least as
sensitive and specific as the CDC recommended method of Lim broth subcultured onto non chromogenic agar.
Background
Streptococcus agalactiae (group B streptococcus, GBS) is
a significant cause of perinatal and neonatal infections
worldwide. Rectovaginal colonization occurs in 10 to
30% of pregnant women [1-3] and is responsible for 1.8
neonatal infections per 1,000 live births per year [4]. In
Belgium, 13 to 25% of pregnant women are colonized
with GBS. GBS is responsible for 38% of early neonatal
infections [5].
GBS can be acquired during labor or in utero
by transmission from maternal vaginal or anorectal-
colonized mucosa. Prematurity is also a risk factor for
GBS neonatal sepsis, and mortality due to GBS is higher
in preterm than in term newborns [6]. Because results
at 35-37 weeks correlate more closely with GBS coloni-
zation at term delivery, the Centers for Disease Control
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and Prevention (CDC) has recommended that all preg-
nant women be screened for carriage of GBS at between
35 and 37 weeks of gestation [7], so that GBS positive
women can receive antibacterial treatment (chemopro-
phylaxis) prior to delivery, to reduce mother-to-child
transmission.
To maximize GBS carriage detection rates, both the
anatomic site of sampling and the culture methods used
are important. Rectovaginal swabs have been reported to
provide high bacterial yields, as the gastrointestinal tract
is a natural reservoir for GBS and a potential source of
vaginal colonization [7-11]. In the present study, we
compared three sampling techniques, i.e. rectovaginal
swabbing, vaginal swabbing only and rectal swabbing
only, using the ESwab, a nylon flocked swab in liquid
Amies transport medium (Copan, Brescia, Italy), which,
according to the manufacturer, is a liquid-based multi-
purpose collection and transport system that maintains
viability of aerobic, anaerobic and fastidious bacteria for
up to 48 hours at room and refrigerator temperature,
and suitable for automation, gram stains, and traditional
culture, and which compares well to other swabs with
regard to species recovery [12,13].
With regard to bacterial culture, the CDC recom-
mends isolation of the bacterium from vaginal and rectal
swabs by growth in a selective enrichment medium,
such as Lim broth, i.e. Todd-Hewitt broth with colistin
and nalidixic acid, followed by subculture on sheep
blood agar. In the same guidelines, the CDC identified
various research priorities, including ‘the development
of media with a reliable color indicator to signal the
presence of GBS to improve accuracy of prenatal culture
results and facilitate prenatal culture processing at clini-
cal laboratories with limited technical capacity’ [14].
Therefore, in the present study, we also determined
the sensitivity and specificity of two types of color indi-
cator based media that are commercially available for
detecting GBS carriage in pregnant women, with that of
the CDC recommended method, i.e. Lim broth enrich-
ment with subculture onto sheep blood agar.
The first type, designated Granada Medium (GM)
[15], is an adaptation of Islam’s medium [16], and
exploits the ability of GBS to synthesize - under anaero-
bic conditions and on media containing starch and
serum - an orange pigment, recently identified as grana-
daene [17].
This method is very specific and simple, thereby
allowing identification of GBS in a single step within 24
h. Later, a modification of GM was described as new
GM [15]. In this study, we used group B streptococcus
differential agar (GBSDA, Becton Dickinson), which is
itself a modification of new GM and of which the manu-
facturer claims that it has improved selectivity and stabi-
lity compared to new GM, without further specification.
The second type of medium used in this study, recently
developed by bioMérieux as chromID™ Strepto B agar
(CA), is a selective chromogenic medium, of which the
constituents are not specified by the company, and which
enables the recognition of S. agalactiae as pink to red,
round and pearly colonies, without the need of anaerobic
incubation. Most other bacterial species are either inhib-
ited or the colonies produced have a different colour (e.g.
violet, blue, colourless) [18-20].
In summary, in addition to comparing three sampling
methods, we compared six different culture methods,
i.e. direct culture onto Columbia Colistine Nalidixic
Acid Agar (CNA), GBSDA and CA, and Lim broth
enrichment with subculture on these three agars.
Methods
Study design
The study was approved by the research ethics commit-
tee (IRB protocol nr 2007/096) of the Ghent University
Hospital, Flanders, Belgium, and all the women gave
written informed consent. Between June 2009 and Janu-
ary 2010, 100 vaginal samples, 100 rectal and 100 recto-
vaginal ESwab samples were collected from 100 pregnant
women at 35 - 37 weeks of gestation, i.e. three different
samples per subject.
Collection and culture of specimens
Rectovaginal, vaginal and rectal samples were collected
using nylon flocked swabs that were submerged into 1
ml of ESwab transport medium (ESwab, Copan Diagnos-
tics, Brescia, Italy).
Rectovaginal sampling was carried out by rotating an
ESwab against the vaginal wall at the midportion of the
vault. Subsequently, the swab was carefully withdrawn
to prevent contamination with microflora from the
vulva and introitus and the swab was inserted 1.5 to 2
cm beyond the anal sphincter and gently rotated to
touch the anal crypts. Next, vaginal sampling was car-
ried out by inserting the ESwab following the same pro-
cedure described above for swabbing the vaginal wall.
Finally, an ESwab was used for rectal sampling as
described above for the anal procedure of the rectovagi-
nal sampling.
All samples were collected by midwives and trans-
ported to the Laboratory of Bacteriology Research
within 4 hours. Direct plating was carried out only for
the rectovaginal ESwab, by inoculating 50 μl from the
ESwab transport medium onto Columbia agar with 5%
sheep blood and with 10 mg/ml colistin and 15 mg/ml
nalidixic acid (CNA, Becton Dickinson, Erembodegem,
Belgium), 50 μl onto group B streptococcus differential
agar (GBSDA, Becton Dickinson) and 50 μl onto chro-
mID™ Strepto B agar (CA, BioMérieux, Marcy l’Etoile,
France). The CNA plates were incubated at 37°C in 5%
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CO2 for 24-48 h, the GBSDA plates were incubated at
37°C in an anaerobic chamber (BugBox, LedTechno,
Heusden-Zolder, Belgium) for 24-48 h, and the CA
plates were incubated at 37°C for 18-24 hours in aerobic
conditions in the dark. Volumes of 200 μl from the
ESwab transport medium of the rectovaginal, vaginal
and rectal ESwabs were inoculated into separate tubes
with 5 ml of Todd-Hewitt broth with 1% yeast extract,
15 μg/ml nalidixic acid and 10 μg colistin/ml (Lim
broth, Becton Dickinson), which were incubated aerobi-
cally at 37°C and subcultured onto CNA, GBSDA and
CA after overnight incubation. GBSDA was examined
for yellow-orange pigment colonies indicative of the pre-
sence of GBS, whereas CA was examined for pale pink
to red, round and pearly colonies. b-haemolytic and
non-haemolytic colonies were picked from CNA for
further identification (Figure 1). The isolates were con-
firmed as S. agalactiae using the CAMP test on sheep
blood agar. GBS colonies with discrepant results (either
false positive on CA or false negative on GBSDA) were
identified using tDNA-PCR, as described previously
[21], and by 16S rRNA gene sequence determination.
Figure 1 Appearance after 24 h incubation of (A): Streptococcus agalactiae (Group B Streptococcus (GBS) and (B) Enterococcus faecalis
on GBSDA, (C) GBS and (D) Enterococcus faecalis on Strepto B ID® chromogenic agar and (E) GBS and (F) Enterococcus faecalis on CNA.
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Statistical methods
The McNemar test for correlated percentages was used
to compare the sensitivity of the culture methods. The
total number of positive subjects (22) was taken as
100%, to calculate sensitivities, specificities, positive and
negative predictive values of the different sampling and
culture methods.
Results
A total of 300 swabs was taken from 100 pregnant
women at 35-37 weeks of gestation, and 49 of these
swabs were positive for a total of 22 subjects. Data for
each subject, sampling site and method and culture
method are listed in additional file 1, Table 1. GBS
could be cultured from all 22 rectovaginal swabs,
although one was only positive after Lim broth enrich-
ment. Of the 22 GBS positive subjects, GBS could be
cultured for nine from both the rectal and vaginal
swabs, for two only from the vaginal swab, and for nine
exclusively from the rectal swabs. For another two
women, only the rectovaginal swab was positive.
The GBS detection rate on the basis of rectovaginal
samples (22 GBS positive women) were significantly
higher than the detection rate on the basis of vaginal
samples (11 positive) (P = 0.01), but not significantly
higher than that on the basis of rectal samples (18 posi-
tive) (P = 0.12).
Direct plating of the rectovaginal swabs on CNA,
GBSDA and CA resulted in detection of 59, 91 and 95%
respectively of the total number of carriers detected on
all samples and media, whereas Lim broth with subcul-
ture onto on CNA, GBSDA and CA resulted in positiv-
ities of 77, 95 and 100% respectively (Table 1). For all
sampling methods, and for the rectovaginal swab with
and without enrichment, GBSDA and CA detected more
positive women than CNA. In addition, detection of
GBS from rectovaginal specimens by direct plating onto
GBSDA or CA was equally sensitive as detection by Lim
broth enrichment with subculture on these agars (P = 1)
and only one pregnant woman (RVS001) was identified
as GBS-positive only after Lim broth enrichment. It
should be noted that the inoculum of GBS in this sub-
ject was low, as only a few colonies were observed on
the agars, even after the enrichment incubation. One
false-negative result on GBSDA, i.e. a colony without
orange pigmentation, corresponded to a non-haemolytic
and non-pigmented GBS strain that was correctly identi-
fied on CA. Three false positives for three different
women were observed on CA, because the red colonies
isolated from CA were all three identified as Streptococ-
cus anginosus, by means of 16S rRNA gene sequence
determination and/or tDNA-PCR [21].
Discussion
This study intended to compare the sensitivity of differ-
ent sampling and culture procedures to establish the
presence of GBS in pregnant women. We compared i)
rectovaginal, vaginal and rectal sampling, and ii) culture
on Columbia CNA agar (CNA), on group B streptococ-
cus differential agar (GBSDA) and on Chromogenic
Strepto B ID Agar (CA), iii) directly and after Lim broth
enrichment. Other groups studying chromogenic agar
did so only for vaginal samples [18-20,22], whereas we
also included the CDC recommended rectovaginal sam-
pling method, or they did not compare to Granada agar
and used miscellaneous samples [23].
A limitation of this study may be the limited sample
size of one hundred subjects, although it should be
noted that each subject was studied intensively, i.e. three
different sampling sites and six different culture meth-
ods were compared for each subject, in a strictly
designed study setup that enabled to compare the cul-
ture results for each subject in a direct and unambigu-
ous manner.
Comparison of rectovaginal, vaginal and rectal sampling
We found that rectovaginal swabbing was the best sam-
pling method to detect GBS colonization of pregnant
women, because all 22 GBS positive women in this
study were detected by means of rectovaginal sampling
and because two subjects were GBS positive only on the
basis of the rectovaginal swab. Our results correspond
with previous reports that GBS colonization of rectal
samples is 18% to 24% higher than that of vaginal sam-
ples [24,25] and with those of other studies that find
rectovaginal sampling more appropriate than vaginal
sampling only [7,26,27]. For example, in an analysis of
651 specimens, the combination of separate rectal and
Table 1 Number of GBS culture positive samples detected by different culture media in rectovaginal, vaginal and
rectal specimens obtained from 49 GBS positive samples from 22 GBS positive women
Specimen CNA GBSDA CA Lim-CNA Lim- GBSDA Lim- CA Estimated number of women colonized
Rectovaginal ESwab 13 20 21 17 21 22 22
Vaginal ESwab NT NT NT 9 11 11 11
Rectal Eswab NT NT NT 13 17 18 18
CA: Chrom ID Strepto B agar (BioMérieux), CNA: colistin nalidixic acid Columbia agar, GBSDA: GBS Differential Agar (Becton Dickinson), Lim: Lim broth.
NT: Not tested.
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vaginal sampling enabled detection of 97.8% of GBS car-
riers, compared to 31.8% of positives as established by
vaginal sampling only [28]. Although our results are in
correspondence with the CDC recommendations to
carry out rectovaginal sampling, it should be noticed
that Nomura et al. [29] found no significant difference
in detection rates between vaginal and rectal samples
and Gupta & Briski [30] reported a similar detection
rate of 23.8% of GBS when using rectovaginal and vagi-
nal sampling. Votava et al. [11] even found that the
GBS detection rate using rectovaginal samples was only
16.9%, whereas the use of separate vaginal and rectal
swabs yielded 22.7 and 24.1% GBS positive women,
respectively. Also, several obstetric departments still use
vaginal sampling only to assess GBS positivity.
It is worthwhile mentioning that we also compared
vaginal sampling using the recently marketed ESwab
with vaginal sampling using the classical cotton swab in
Amies gel transport medium (Nuova Aptaca, Canelli,
Italy) for the detection of GBS (data not presented to
increase readability of the manuscript). Both swabs were
introduced simultaneously into the vagina and culture
was carried out in an identical manner for both swabs.
The classical swab could detect two more GBS positive
subjects than the ESwab, raising the number of women
positive for GBS in the vagina from 11 to 13.
Different types of selective media formulations
Different selective media for the improved isolation of
GBS have been described. Islam et al. [16] showed that
adding horse serum and starch to agar based media
increased the orange/red pigment formation, that was
already present to some degree on Columbia agar and
that was typical for GBS, being absent for all other sero-
types. De la Rosa et al. [31] improved this medium add-
ing horse serum at 90 to 95°C instead of at 55°C,
making the agar opaque and increasing the natural pig-
mentation of the colonies, specific for S. agalactiae.
They showed that pigmentation depends strongly on the
use of the correct starch and of proteose peptone n°3
and that it was further increased by the addition of the
folate inhibitor trimethoprim (15 μg/ml), in combination
with anaerobic incubation. This medium was designated
Granada Medium (GM). The same authors later
improved GM, which they designated as New Granada
medium (NGM) [15], by replacing trimethoprim with 6
μg/ml methotrexoate, which is also a folate synthesis
inhibitor, but further increases orange to salmon pig-
mentation of the GBS colonies, and by adding 0.2 μg/ml
crystal violet, 5 μg/ml colistin sulphate and 10 μg/ml
metronidazole as selective agents. It should be noted
that horse serum was added again at 55°C. The com-
mercially available group B streptococcus differential
agar (GBSDA), that was used in this study, is a modifi-
cation of NGM with improved stability and selectivity,
not further specified by the company. Its usefulness has
been evaluated in several studies [9,32-34]. Bou et al.
[32] found that the intensity of colony pigmentation on
GBSDA is stronger than on GM and that the commen-
sal microflora is more suppressed.
Because different modifications have been used, some-
times also designated as GM, or because the media were
home made [35] or prepared by other companies than
the one that supplied the GBSDA in this study [30,36],
or because other selective media were used [8,37,38], it
is difficult to compare the outcome of several of the
previous studies with this study. Therefore, we largely
limit our comparison to studies that explicitly used CA
from BioMérieux and/or GBSDA from Becton
Dickinson.
Direct plating vs broth enrichment culture
Possibly, the use of different (commercial) preparations,
modifications and designations, as mentioned above,
may explain why some studies found comparable sensi-
tivity of direct plating on ‘Granada Medium’ compared
with Lim broth enrichment [11,15,39,40], whereas other
studies found direct plating on chromogenic and/or
selective media significantly less sensitive [30,36].
Blanckaert et al. [41] suggested to use a combination of
Granada and Columbia blood agar and an adequate
sample (rectovaginal swab in transport medium) for
optimal GBS screening.
In our study, the sensitivity of direct plating on CA
and GBSDA was comparable to that of plating on
CAand GBSDA after Lim broth enrichment, whereby
the latter enabled the detection of only one additional
sample, leading to 22 GBS (22%) positive women. Our
data suggest that CA and GBSDA are not only faster
and easier to use than the CDC recommended method,
but that they are also at least as sensitive for the detec-
tion of GBS, in agreement with several other recent stu-
dies. Also Tazi et al. [18] found that, compared to CA
and GBSDA, Lim broth enrichment enabled the detec-
tion of only two additional samples leading to 34 (17%)
GBS positive cultures. Also in the study of Bou et al.
[28], only one swab was only positive following subcul-
ture in Lim broth and was missed on direct GBSDA
[32]. Adler et al. [34] reported that GBSDA is not only
faster and easier to use than Lim broth combined with
antigen detection or with subculture on blood agar, but
is also at least as sensitive for the detection of GBS from
vaginal swabs. In addition, Dunne et al. [8] reported that
direct plating on neomycin nalidixic acid agar reduced
the potential of enterococci competitively overgrowing
and masking the presence of GBS in the Lim broth, and
this ultimately increased the sensitivity of the direct
assay by 14%.
In conclusion, although we missed one out of 22 car-
riers by direct plating on CA and GBSDA, in our hands
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direct plating on CA and GBSDA provided high sensi-
tivity for GBS detection among pregnant women.
CA and GBSDA vs colistin nalidixic acid selective agar (CNA)
We found that CA and GBSDA had comparable sensitivity
and provided superior recovery of GBS when compared
with CNA. This difference was even more apparent for
direct plating. Also, the single subject (RVS072) positive
only for the rectovaginal swab was so only on CA and
GBSDA, but not on CNA. This is in agreement with
another study [30] that showed that selective media pro-
ducing pigmented colonies are more sensitive in GBS
detection than enriched media like blood agar or selective
media like CNA.
Direct plating on CA and GBSDA offers the advantage
of reducing workload and providing an identification of
GBS 24 h sooner than the Lim broth enrichment
method. In this study, all GBS isolated from CA and
GBSDA were identified within 1-2 days of specimen
receipt, whereas all Lim broth enrichment cultures
required a minimum of 2-3 days for the identification of
specimens positive for GBS. In addition, CA offers an
additional advantage with respect to GBSDA, because
culture on CA can be carried out aerobically, not requir-
ing special equipment and extra costs and workload
associated with anaerobic culture needed for GBSDA.
Sensitivity, specificity, positive and negative predictive
value of GBS detection with CA versus GBSDA
The sensitivity and positive predictive value of direct
plating of CA for GBS detection were 100 and 87,
respectively (Table 2), whereas these values for direct
plating on GBSDA were 95 and 100, respectively. In this
study, one false negative isolate, lacking the orange pig-
ment, was found on GBSDA, for subject RVS041. This
isolate was not missed on CA and was confirmed as
GBS by means of the CAMP test. Also Tazi et al. [18]
found two false negative isolates on Granada medium.
Non-haemolytic and non-pigmented GBS have been
reported to occur in 1 to 4% among pregnant women
[11,30,36,39,40]. Pigment is produced by 93 to 98.5% of
GBS clinical isolates. There is a high correlation
between the capacity to produce pigment and the
capacity to release hemolysin [42,43], since the genes
that determine these properties are in contiguous loci
on the chromosome [40].
In our study, we found three false positive results with
CA after 24 hrs of incubation, whereby all three isolates
were identified as Streptococcus anginosus. Tazi et al.
[18] found two false positive results on Chromagar and
showed that these corresponded either to Streptococcus
pyogenes or S. porcinus. These observations indicate that
colonies that grow on CA and are suspected to be GBS
must be confirmed by additional tests such as CAMP,
latex agglutination or molecular techniques, or by posi-
tivity on GBSDA. It may be suggested that the combina-
tion of direct plating onto CA with aerobic incubation
(95% sensitivity), with confirmation of CA positive iso-
lates by means of the CAMP test (100% specificity), may
be a highly sensitive, specific and cost effective manner
to detect GBS from pregnant women.
Conclusions
In conclusion, to detect GBS carriage among pregnant
women, our results indicate i) that rectovaginal sampling
is the preferred sampling method, ii) that the ESwab is
not superior to the classical cotton swab for sampling,
iii) that the inoculation of rectovaginal specimens
directly onto CA (21 positives/22) and/or GBSDA (20
positives) has comparable sensitivity as enrichment by
Lim broth (22 and 21 positives after subculture onto CA
and GBSDA, respectively), and iv) that direct inoculation
onto CA or GBSDA is at least as sensitive as the recom-
mended CDC method, i.e. overnight Lim broth enrich-
ment followed by plating onto sheep blood agar (which
in this study was replaced by CNA: 17 positives).
Direct inoculation offers several advantages such as
decreased workload, because no subculture is needed,
and decreased time to detection, i.e. at least 24 hours
faster than the standard method. Reagent costs of using
CA or GBSDA may be comparable to Lim broth enrich-
ment and subculture on blood agar, also because addi-
tional testing is rarely needed for the former approach.
Plating on CA in addition does not require anaerobic
incubation as is the case for GBSDA. The specificity
Table 2 Sensitivities, specificities, positive and negative predictive values for the six different culture methods, based
on all 300 samples, and calculated for a number of 22 positive subjects on a total number of 100 subjects included
Culture Medium % Sensitivity % Specificity % Positive predictive value % Negative Predictive value
CNAa 56 84 52 86
GBSDA 95 100 100 99
CA 100 96 87 100
Lim broth + CNA 78 84 60 93
Lim broth + GBSDA 96 100 100 99
Lim broth + CA 100 96 88 100
a: False positive on CNA: beta-hemolytic colonies which were CAMP negative.
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problems associated with the use of CA can be resolved
by confirmation of CA positive isolates with the CAMP
test.
Additional material
Additional file 1: Table 1: Detection of GBS by means of culture on
different media for vaginal, rectal and rectovaginal samples from
22 GBS positive pregnant women. Three samples were collected from
pregnant women (vaginal, rectal and rectovaginal). The rectovaginal
samples were cultured directly and after Lim broth enrichment on the
following media (CNA, GBSDA and CA) whereas vaginal and rectal
samples were cultured only after Lim broth enrichment on the same
three media.
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Abstract  
Objectives: Comparison of culture with two different qPCR assays for detection of 
Group B streptococci in pregnant women. 
Methods 
For a total of 100 pregnant women at 35-37 weeks of gestation, one rectovaginal ESwab 
was collected. Eswab was inoculated into Lim broth, incubated for 24 hours and plated 
onto chromID™ Strepto B agar (ChromAgar). DNA was extracted with the bioMérieux 
easyMAG platform, either directly from the rectovaginal ESwab or from the Lim broth 
enrichment culture. Two different qPCR formats were compared, i.e. the hydrolysis 
probe format (Taqman, Roche), targeting the sip gene and the hybridization probe 
format (Hybprobe, Roche), targeting the cfb gene. 
Results 
Both qPCR techniques identified 33% of the women as GBS positive. Only one culture-
positive sample was qPCR-negative. qPCR, directly on the sample, already significantly 
increased the number of women found to be GBS positive (27%), compared to culture  
(22%). Moreover, the sensitivity of qPCR after Lim broth enrichment (33%) was again 
significantly higher than qPCR after DNA extraction directly from the rectovaginal 
swabs (27%). 
Conclusions 
When detecting GBS from rectovaginal swabs, the application of qPCR, irrespective of 
the target (sip or cfb) has increased the number of GBS positive women in comparison 
with culture. 
Key words: 
Group B streptococci, qPCR, Lim broth, Chromagar, pregnant women 
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Introduction 
      Group B streptococci (GBS), i.e. Streptococcus agalactiae, have remained the 
leading cause of bacterial sepsis and meningitis in neonates for the last two 
decades, despite a broadly implemented screen-and-treat policy. In Belgium, 13-
25% of pregnant women are colonized with GBS and GBS is responsible for 38% of 
the early neonatal infections [1]. The incidence of invasive neonatal GBS infection is 
currently reported to amount from 0.5 to 3.0 per 1000 live births, with a 4% to 
10% mortality, associated with early-onset infections within the first week of life 
[2, 3]. GBS disease has two clinical presentations, both of which can cause 
significant morbidity and mortality: 1) early-onset disease, which is defined by 
onset within the first 6 days of life, accounting for 85% of neonatal GBS infections, 
and 2) late-onset disease, which occurs after the 6th day of life with most of the 
infections occurring before 3 months of age [4]. Early-onset neonatal infection 
usually results from vertical transmission during delivery, or acquisition in utero 
just before labour, whereas late-onset disease is regarded as being caused 
predominantly by horizontal transmission. Of the colonized neonates, 1-3% 
develop disease, almost always in the form of early-onset infection within 24 h of 
birth [5]. Administration of intravenous intrapartum antibiotic prophylaxis is 
effective in reducing the incidence of early-onset neonatal GBS infections [6]. 
Guidelines from the Centers for Disease Control and Prevention (CDC) recommend 
that all women should be screened at 35–37 weeks of gestation and that those 
women found to be colonized with group B streptococci should receive 
intrapartum antibiotic prophylaxis either with penicillin G or ampicillin [2]. The 
standard method for the diagnosis of group B streptococcal colonization comprises 
culture of combined vaginal and rectal samples in a selective broth medium that 
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inhibits the growth of other microorganisms, with subculture onto solid media. 
Although this method has been shown to be sensitive and specific, it is time 
consuming, requiring 48-72 h [7]. 
Recently, alternative methods have become commercially available for the 
detection of GBS colonization. These include a novel chromogenic agar, i.e. chromID 
Strepto B (formerly Strepto B ID) agar or ChromAgar, which highlights GBS as red 
colonies, after aerobic incubation [8-10], which distinguishes it from other media, 
such as Granada agar, which rely on pigment production that is only revealed 
under anaerobic conditions [11]. Also qPCR assays have been described and 
commercialized. Ke et al. [12] developed a qPCR method, based on amplification of 
a cfb gene fragment that is present in virtually every strain of GBS and Bergh et al. 
[13] established a qPCR targeting the sip gene, present across all serotypes of GBS. 
In this study, we compared the sensitivity of both qPCR formats, directly from 
samples and after Lim broth enrichment, with that of an optimized culture method, 
as published previously [14]. 
Materials and methods 
Study design 
The study was approved by the research ethics committee (IRB protocol nr 
2007/096) of the Ghent University Hospital, Flanders, Belgium, and all women 
gave written informed consent. Between June 2009 and January 2010, a 
rectovaginal ESwab was collected from each of 100 pregnant women at 35 – 37 
weeks of gestation.  
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Collection and culture of specimens 
Rectovaginal samples were collected using nylon flocked swabs that were 
submerged into 1 ml of ESwab transport medium (ESwab, Copan Diagnostics, 
Brescia, Italy).  
Rectovaginal sampling was carried out by rotating an ESwab against the vaginal 
wall at the midportion of the vault. Subsequently, the swab was carefully 
withdrawn to prevent contamination with microflora from the vulva and introitus 
and the swab was inserted 1.5 to 2 cm beyond the anal sphincter and gently rotated 
to touch the anal crypts. All samples were collected by midwives and transported 
to the Laboratory of Bacteriology Research within 4 hours.  
Direct plating was carried out by inoculating 50 µl from the ESwab transport 
medium onto ChromAgar, i.e. chromID™ Strepto B agar (BioMérieux, Marcy l’Etoile, 
France). The ChromAgar plates were incubated at 37 °C for 18-24 hours in aerobic 
conditions in the dark. Another 200 µl was inoculated into tubes with 5 ml of Todd-
Hewitt broth with 1% yeast extract, 15 µg/ml nalidixic acid and 10 µg colistin/ml 
(Lim Broth, Becton Dickinson), which were incubated aerobically at 37 °C and 
subcultured onto ChromAgar after overnight incubation. ChromAgar was examined 
for pale pink to red, round and pearly colonies.  
DNA extraction  
For DNA extraction, volumes of 200 µl were taken i) from the ESwab transport 
medium of the rectovaginal sample and ii) from the incubated Lim broth tubes. 
DNA extractions from the sample and from the Lim broth were performed using 
the NucliSENS easyMAG platform (BioMérieux, Marcy l’Etoile, France) according to 
the manufacturer’s instructions. Briefly, 200 μl of the ESwab transport medium, a 
modified Amies transport medium, from the rectovaginal ESwab or 200 µl from the 
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incubated Lim broth was added to 1800 µl easyMAG lysis buffer and incubated for 
10 min at room temperature and stored at -80 °C until extraction. Total nucleic acid 
extraction was carried out by the off-board protocol and nucleic acids were eluted 
in 100 μL of elution buffer.  
qPCR assays 
GBS nucleic acid detection was based on two different qPCR assays, one targeting 
the cfb gene, which encodes the CAMP factor [12], and the other targeting the sip 
gene, which encodes the surface immunogenic protein Sip [13]. Primers and probes 
for the sip and cfb genes were as described previously [12, 13]. For detection of the 
sip gene, one hydrolysis probe (TaqMan Probe) was used for the qPCR assay [13]. 
The qPCR was performed in a 20 µL reaction volume on the LightCycler® 1.2 
instrument using the LightCycler® Taqman Master kit (Roche Diagnostics, 
Mannheim, Germany). Each reaction contained reagents to final concentrations of 
0.5 μM of each primer and 0.2 μM of the hydrolysis probe, and contained 5 µl of 
DNA extract. Thermal cycling parameters consisted of 95°C denaturation for 10 
min for polymerase activation, followed by 50 amplification cycles of denaturation 
at 96 °C for 5 sec, annealing at 58 °C for 10 sec and extension at 72 °C for 1 sec. 
Detection of the cfb gene was done with a pair of fluorescently labeled adjacent 
hybridization probes, i.e. STB-F and STB-C [12]. The qPCR was performed in a 20 
µL reaction volume on the LightCycler® v1.2 instrument using the LightCycler® 
FastStart DNA Master HybProbe kit (Roche Diagnostics). Each reaction contained 
reagents to final concentrations of 0.4 μM of each primer and 0.2 μM of each 
hybridization probe and 5 µl of DNA-extract. Thermal cycling parameters consisted 
of 95 °C denaturation for 10 min, followed by 45 amplification cycles of 
denaturation at 95 °C for 10 sec, annealing at 55 °C for 10 sec and extension at 72 
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°C for 5 sec. The melting curve programme consisted of 45 °C for 30 sec and 
continuous acquisition of fluorescence data during temperature transition to 80 °C 
at 0.1 °C /sec.  
Using qPCR, the concentration of GBS can be determined as the cycle number 
whereby the fluorescence signal intensity crosses the detection threshold. This 
value is expressed as the quantification cycle (Cq). Running along a standard 
dilution series of GBS DNA (see below) makes it possible to determine the 
approximate number of bacterial cells initially present. Serial dilutions of a DNA 
extract of the type strain LMG 14694T were ran along to produce a standard curve 
and to establish the lower limit of detection (LOD) of the assays, which was 
established at 100 copies of GBS genomic DNA per PCR reaction. 
Positive controls (highly purified DNA from 5 x 108 GBS cells) and negative controls 
(HPLC purified water) were included in each run. Samples with discordant results 
(positive by qPCR and negative by standard culture) were investigated further by 
DNA sequence analysis of the amplification product. 
Statistical methods. The sensitivities of qPCR assays and the culture methods 
were compared by McNemar’s test and the Mann-Whitney U test, with p values of < 
0.05 considered as significant. 
Results  
We compared the sensitivity and specificity of culture on ChromAgar after Lim 
broth enrichment, with that of two qPCR formats, both with and without Lim broth 
enrichment, for their ability to detect GBS from rectovaginal swabs from pregnant 
women at 35-37 weeks of gestation. 
Lim broth with subculture on ChromAgar, which we previously showed to be more 
sensitive than Lim broth and colistin nalidixic agar or Lim broth and Granada agar 
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[14] was used as gold standard to evaluate the sensitivity of the qPCR formats. In 
total, 100 pregnant women were tested, of which 66 were negative by both culture 
and qPCR, 22 were positive by Lim broth enrichment and subculture on 
ChromAgar, 27 by direct qPCR and 33 by qPCR after Lim broth enrichment. The 
one sample that was positive by culture and negative by qPCR, was culture positive 
only after enrichment (Table 1, row: this study).  
In summary, the qPCR approach after Lim broth enrichment generated significantly 
(p < 0.001; McNemar’s test) more positive results (33%) than did the culture 
method (22%). qPCR after Lim broth enrichment also detected GBS in six 
additional women, compared to qPCR directly from the rectovaginal swab (27%) (p 
< 0.05 ; McNemar’s test). No difference was found between both types of qPCR, i.e. 
hybridization probe technology targeting the cfb gene and hydrolysis probe 
technology targeting the sip gene. For the 21 samples that were positive for both 
culture and qPCR, both the DNA directly from the sample and the DNA extracted 
after Lim broth enrichment were qPCR positive.  
Discussion 
Hybridization probes versus hydrolysis probe-based qPCR 
To our knowledge, this is the first study that compared two different real-time PCR 
(qPCR) detection chemistries, thereby targeting two different genes for detection of 
group B streptococci (GBS). We found complete agreement between both PCR 
assays, i.e. hybridization probe-based qPCR targeting the cfb gene and hydrolysis 
probe-based qPCR targeting the sip gene. Both techniques indicated 33% of the 
women as GBS positive. The identical results with both assays can be taken as 
indicative for the robustness of the qPCR approach in general. 
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Lim broth enhanced qPCR versus Lim broth subculture 
To prevent GBS disease in neonates, the current recommendation is to screen 
pregnant women by culture of combined vaginal and rectal mucosae at 35 to 37 
weeks’ gestation and to treat those with positive cultures. Molecular non-
amplification-based methods for identifying GBS have been described almost two 
decades ago [15]. The Accuprobe system (Gen-Probe, San Diego, Ca.) was shown to 
be suitable for the identification of GBS from cultures but to be insufficiently 
sensitive for direct detection from clinical specimens [15]. During the last decade, 
several studies have demonstrated the utility of real-time PCR (qPCR) for rapidly 
and reliably detecting GBS colonization in (pregnant) women, as summarized in 
Table 1. 
Prevalence established by culture and by qPCR 
Although the prevalence of colonization in our study on the basis of Lim broth 
enrichment and subculture onto ChromAgar was 22%, which is in agreement with 
that reported in the literature, on the basis of culture-based prevalence studies [16-
18], we found a significantly higher number of women positive, when direct qPCR 
was applied (27%). This is in agreement with other studies that reported increases 
of 12% to 21% GBS positives using direct qPCR [19-21]. In our study, the one 
sample positive by culture and negative by qPCR, was culture positive only after 
enrichment, as has also been observed previously [13]. The lower sensitivity of 
culture can be possibly explained by the presence of antagonistic microorganisms, 
such as enterococci, which inhibit the growth of GBS or overgrow the GBS [8]. Also 
antibiotics and feminine hygiene products have been shown to inhibit the growth 
of GBS [22]. Furthermore, inappropriate storage, collection and transport 
conditions of the samples from obstetrical clinics to the laboratory could also result 
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in false negative culture results, especially in cases of light colonization [23]. 
Besides higher sensitivity and less-demanding sample storage and transport, as 
offered by PCR, qPCR brings the additional advantage of quantification. It is indeed 
important to quantify the bacterial load because heavy colonization with GBS has 
been shown to correlate with a higher risk of neonatal sepsis [24]. In our study, we 
found that the Cq-values were indicative for the bacterial load, because the samples 
with the highest Cq-values, which can be assumed to be the samples with the 
lowest bacterial load, were also the ones that were culture negative, which is also 
indicative of a lower bacterial load, i.e. the mean Cq value for the 21 culture/ PCR 
positive samples was 21.5 (CI: 18.7-24.3), whereas that for the 12 culture negative, 
PCR positive samples it was 26.5 (CI: 22.3-30.8), strongly indicative for a lower 
bacterial load in the latter (p < 0.05). For the 12 samples that were positive only by 
qPCR, the mean Cq value for the six samples, that were positive also when the DNA 
was extracted directly from the samples, was 22.6 (CI: 15.4-29.8), whereas the 
other six samples, that were only positive when DNA was extracted from the Lim 
broth after enrichment, the Cq-value was 30.3 (CI: 27.7-32.9), strongly indicative 
for a lower bacterial load in the latter (p < 0.05). Fig. 1 presents the Cq-values 
observed for these three categories of samples. 
Direct qPCR vs Lim broth-enhanced qPCR 
Quantitative PCR may also offer the advantage of reduced time-to-result, making it 
even useful to be used as an intrapartum screening method [19, 25, 26]. However, 
our results indicate that combining qPCR with prior Lim broth enrichment 
significantly increases the sensitivity, compared to qPCR directly on the sample. 
GBS colonization was determined to be 33% on the basis of qPCR of DNA extracted 
from Lim broth after enrichment incubation, which is significantly higher than the 
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colonization rate established by Lim broth with subculture. The increased 
sensitivity of qPCR after Lim broth enrichment compared to subculture after Lim 
broth enrichment is in correspondence with most other studies. Goodrich et al. [27] 
established GBS colonization on the basis of rectovaginal swabs for at total of 200 
women, after enrichment during 4 h in Lim broth followed by culture, Strep B 
Analyte Specific Reagent (LightCycler qPCR) and BD-StrepB test, and found 
colonization rates of respectively 26.5, 29.5 and 30.0%. Correspondingly, Rallu et 
al. (30) reported that Lim broth-enhanced scpB PCR identified 37% of a total 605 
rectovaginal specimens as GBS positive, whereas subculture identified only 16% as 
positive. Also, Block et al. [28] reported that the rate of S. agalactiae detection by 
carrot broth-enhanced qPCR (33.0%) trended higher than the rates generated by 
carrot broth culture and subculture (29.6%). However, Scicchitano et al. [29] found 
that both culture and the BD GeneOhm StrepB assay, both after Lim broth 
enrichment, detected 95.3% of the total number of GBS positives. 
Also our finding that qPCR after Lim broth enrichment is more sensitive than qPCR 
directly on the swabs, is in agreement with other studies. Maloney et al. [30] 
reported that BD GeneOhm StrepB detected more GBS positive women after Lim 
broth enrichment (no detailed data available). Block et al. [28] also concluded that 
broth-enhanced qPCR was more sensitive than direct swab PCR, although precise 
data were not provided. Hutchens and Schreckenberger [31] reported that the 
IDIStrepB Cepheid Strep B SmartCycler assay had a sensitivity of 85.7% when it 
was performed directly on swab specimens compared to the sensitivity after 
enrichment culture. 
          In conclusion, when detecting GBS directly from rectovaginal swabs, the 
application of qPCR, irrespective of the qPCR assay (hybridization probes qPCR 
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targeting the sip gene or hydrolysis probe qPCR targeting the cfb gene), increased 
the number of GBS positive women compared to culture, and sensitivity was 
further increase by combining Lim broth enrichment with qPCR.  
Because the introduction of overnight incubated Lim broth enrichment prior to 
qPCR, in order to optimize the sensitivity of GBS detection, reduces the speed – as 
achieved when direct qPCR is carried out – again, future studies should indicate 
which of both, i.e. intrapartum screening with a rapid technique or antepartum 
screening with the currently most sensitive approach, is clinically most relevant. 
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Table 1. Results of different studies on qPCR tests for detetion of GBS from vaginal, rectal and rectovaginal samples  
R e f e re nc e P o p ula t io n S amp le s C ult ure  t e c hniq ue q P C R  t e c hniq ue To t a l  numb e r C  + /  P + C  + /  P - C  -  /  P + C  -  /  P - S e ns it iv it y S p e c if ic it y P P + P P -
Bergh et  al. 2004  consecutive V Direct  & selective culture s ip , LC, Taqman p robe 100 24 1 8 67 96 89 75 98 .5
Davies  et  al. 2004 Intrapartum Calgary VR selective culture           IDI-Strep  B 427 76 1 12 338 99 97 86 .4 99 .7
Intrapartum Houston 75 17 2 4 52 89 93 81 96 .3
Intrapartum Milwaukee 48 11 2 0 35 85 100 100 94 .6
Intrapartum Montreal 166 14 1 11 139 93 93 56 99 .3
IntrapartumPittsburgh 87 22 3 0 62 88 100 100 95.4
Intrapartum To tal 803 140 9 27 626 94 95.9 83 .8 98 .6
Convert  et  al. 2005 Antepartum(33-37 w) V selective culture cfb , LC, HybProbe 400 75 0 47 278 100 85 61 100
Rég lier-Poupet  et  al. 2005       Antepartum (35-37 w) V Direct  culture cfb , LC, HybProbe 269 44 1 8 216 97 96 84 .6 99
Bergeron et  al. 2006    Antepartum (35-37 w) R, V, VR   select ive culture cfb , LC, HybProbe 112 32 1 0 79 97.0 100 100 98 .8
Bergseng  et  al. 2007 Intrapartum R + V Direct  & selective culture s ip , LC, Taqman p robe 251 84 2 3 87 97.6 97 96 .5 89 .5
Gavino  et  al. 2007 Intrapartum VR GenXpert  (Cepheid ) 55 23 1 11 20 95.8 64 .5 67.6 95.2
Goodrich et  al. 2007 Antepartum (35-37 w) VR  select ive culture LC Strep  B ASR(p ts I, LC, HybProbe) 200 53 0 6 141 100 95.9 89 100
BD-StrepB tes t 49 4 11 136 92 .5 92 .5 81 97
Chan et  al. 2008 Intrapartum LV selective culture cfb , LC, HybProbe 143 9 11 1 122 45 99 90 91.7
Edwards  et  al. 2008 Antepartum-36  w (366) VR selective culture XPert  GBS 784 173 17 24 570 91.1 96 .0 87.8 97.1
& intrapartum (418) IDI-Strep  B
Money et  al. 2008 Intrapartum VR selective culture IDI-Strep  B 190 49 5 3 121 90 ,7 93 ,2 94 ,2 96
& Bourbeau 2009  Antepartum (35-37 w) V,VR  Direct  & selective culture BD GeneOhm StrepB assay 498 136 5 5 349 96 ,6 99 ,1 96 ,4 98 ,5
(p revious ly IDI-Strep  B)
Wernecke et  al. 2009 Antepartum (35-37 w) V selective culture (RiboSEQ, LC, HybProbe) 159 107 4 2 46 96 .4 95.8 98 .2 92
BD GeneOhm™ StrepB Assay 105 6 5 43 94 .6 89 .6 95.5 87.8
El Helani et  al. 2009 Intrapartum V Direct  & selective culture Xpert  GBS; Cepheid 968 135 3 2 723 98 .5 99 .6 97.8 99 .7
Wilson et  al. 2010 Antepartum (35-37 w) G, V, VR   select ive culture Smart  GBS assay 206 64 0 0 142 100 100 100 100
This  s tudy Antepartum (35-37 w) VR Direct  & selective culture cfb , LC, HybProbe
s ip , LC, Taqman p robe
Direct  DNA 100 21 1 6 72 95.4 92 .3 77 98 .6
Lim b ro th DNA 100 21 1 12 66 95.4 84 .6 63 ,6 98 .5
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FIG 1. Cq values of the GBS-qPCR positive rectovaginal samples using the hybridization probe assay (cfb gene). 
 
 
Legend: x-axis: C+: culture positive, D+: qPCR positive, directly from sample, Lim+:qPCR positive only after Lim broth enrichment.  
y-axis: Cq-value of qPCR.  
C+/D+/Lim+ C-/D+/Lim+ C-/D-/Lim+ 
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Chapter III: General discussion and future perspectives 
 
III.1. Characterization of vaginal microflora of pregnant women 
Characterisation of the normal vaginal microflora (VMF) may provide a better 
understanding of the mechanisms involved in the stability of the lactobacilli-dominated 
VMF, or conversely, with their failure to maintain homeostasis of the vaginal ecosystem. 
The bacteria normally present in the human vagina play a key role in preventing 
successful colonization by ‘undesirable’ organisms, including those responsible for 
bacterial vaginosis, yeast infections, sexually transmitted diseases and urinary tract 
infections (89, 152, 343, 373). Four Lactobacillus species are now generally agreed to 
dominate the VMF, in particular L. crispatus, L. jensenii, L. gasseri and L. iners (128, 377, 
380). Verstraelen et al. (382) reported that the presence of different Lactobacillus 
species in the normal VMF is a major determinant to the stability of the VMF in 
pregnancy. L. crispatus is associated with a particularly stable vaginal ecosystem. 
Conversely, microflora comprising L. jensenii elicits intermediate stability, while VMF 
comprising L. gasseri/L. iners is the least stable. A fifth species, L. vaginalis, may be 
present more frequently than is now assumed, but may be missed when using anaerobic 
culture in jars for culture (see below). 
Microscopy, culture and different molecular techniques have been used to study the 
composition of the VMF. The most widely performed method is microscopy in 
combination with the Gram-stain based scoring system of vaginal smears, developed by 
Nugent et al., with high intracenter and intercenter, as well as intraobserver and 
interobserver reproducibility (266). Verhelst et al. (380) showed that it is possible to 
differentiate to some degree between L. crispatus (short plump rods), L. gasseri (long 
tender rods) and L. jensenii (very long bacilli) on the basis of Gram smear. De Backer et 
al. (75) found that L. iners cells surprisingly present as Gram-negative small coccobacilli, 
instead of as Gram-positive bacilli, which, together with the inability to grow on MRS 
medium and its formation of small colonies on other media, is probably the reason why 
this species has been long overlooked and has been confused with Gardnerella vaginalis. 
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Both culture and molecular techniques have their advantages and limitations when 
studying the composition of the complex VMF. The human vagina harbors a complex 
microflora, including many fastidious bacteria. Hence, culture-dependent analysis is 
likely to overestimate the role of cultivable bacteria while uncultivable species are 
overlooked (295). During this doctoral research, it was possible to identify the vaginal 
Lactobacillus species rapidly and with high discriminatory power by means of tDNA-PCR 
(10, 375, 393), whereas lactobacilli remain difficult to identify with biochemical means. 
Other molecular techniques than tDNA-PCR remain laborious. Using tDNA-PCR, we 
found that a total of 121 (91.6%) of 132 vaginal samples and 51 (38.6%) of 132 rectal 
samples were positive for lactobacilli (100). L. crispatus was the most frequently isolated 
Lactobacillus species from the vagina (40% of the subjects were positive), followed by L. 
jensenii (32%), L. gasseri (30%) and L. iners (11%). L. gasseri was the most frequently 
isolated Lactobacillus species from the rectum (15%), followed by L. jensenii (12%), L. 
crispatus (11%) and L. iners (2%) (100). We also observed that incubation in anaerobic 
gas containers (GasPak, Becton Dickinson, Erembodegem, Belgium) yields much lower 
numbers of L. vaginalis, compared to culture in an anaerobic cabinet (BugBoxPlus, LED 
Techno, Heusden-Zolder, Belgium), as was used for our studies. L. vaginalis was not 
found by Marrazzo et al. (238) and virtually absent in the study of Antonio et al. (6) and 
Verhelst et al. (379), all using jars, whereas we found a vaginal carriage rate of 
approximately 10%. 
In our study, a total of 46 (35%) of 132 pregnant women carried two or more 
Lactobacillus species vaginally and/or rectally. Marrazzo et al. (238) reported 72% of 
237 participants to be colonized overall by lactobacilli and 24% to be colonized with 
more than one Lactobacillus species. Antonio et al. (5) reported that 8% carried more 
than one Lactobacillus species in the vagina, with 3.5% colonized by both L. crispatus 
and L. jensenii.  
A total of 18 women (12%) in our study were colonized by both L. crispatus and L. 
jensenii (17 vaginally and one rectally). Vaginal colonization of women with L. crispatus 
and L. jensenii has been suggested to be advantageous in the maintenance of a normal 
microflora and the prevention of sexually transmitted diseases (5, 6). 
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II.2. Vaginal/rectal colonization 
Several bacterial species are known to colonize both the gastrointestinal and the 
reproductive tract, and it is largely agreed that the rectum plays an important role as a 
source or reservoir for organisms that colonize the vagina. For example, group B 
Streptococcus (GBS) colonizes both the vagina and the rectum of many women of 
reproductive age (256), as was shown in this doctoral study as well (99). Also, 
Escherichia coli, known as an intestinal commensal, is the most important cause of 
urinary tract infection in women. Colonization of the vagina by intestinal microflora is 
also clear from studies with orally administered probiotic lactobacilli that were able to 
colonize the vagina (293). Of 100 pregnant women in our study, 17 harbored E. coli in 
both rectum and vagina, 7 only in the vagina and 76 exclusively in the rectum. Also for 
Candida albicans, there is a close correlation between the vagina and rectum, which has 
been considered as the reservoir whence vaginal reinfection occurs (225). We found 12 
women harboring Candida albicans in both rectum and vagina, five only in the vagina 
and two exclusively in the rectum.  
Also organisms associated with bacterial vaginosis, i.e. Mobiluncus spp. Mycoplasma 
hominis and G. vaginalis, have been claimed not to be transmitted sexually but to 
colonize the vagina from an endogenous intestinal tract site (155, 178).  
Recently, Song et al. (345) and Antonio et al. (6) studied lactobacilli from rectal and 
vaginal origin by DNA-based identification of cultured isolates. Antonio et al. (6) found 
that co-colonization of the vagina and rectum by H2O2-producing lactobacilli was 
associated with the lowest prevalence of bacterial vaginosis (5%), whereas females 
colonized only vaginally, only rectally, or at neither site had an increased risk of 
bacterial vaginosis. Because of the close proximity of the rectum to the vagina, the 
isolation of H2O2-producing vaginal Lactobacillus species from the rectum suggests that 
it may play a role as a reservoir for these microorganisms and that the presence of the 
right Lactobacillus species in the rectum may contribute to the maintenance of 
undisturbed VMF (6). 
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In this doctoral study, we not only compared the prevalence of the same species in both 
vagina and rectum, but also genotyped the obtained isolates, to assess whether not only 
the species but also the genotypes of the isolates were identical. To our knowledge, this 
is the first study comparing vaginal and rectal isolates at the strain level. RAPD-analysis 
was used in our study to assess genotypic similarity of vaginal and rectal isolates of the 
same bacterial species, for those species that were found to be present simultaneously at 
both sites (100). Several of the total of 63 species identified, were found only vaginally 
(9, i.e. 14.3%) or only rectally (26, i.e. 41.3%), but 29 species (44.4%) were isolated from 
both sites, indicating that many species can colonize the vagina from the rectum or 
migrate to the rectum from the vagina. For the 8 species for which isolates were present 
simultaneously in the same subject in vagina and rectum, we found that the genotype of 
the vaginal isolate was identical to that of the rectal isolate for 70% of the 50 
vaginal/rectal species pairs that had been obtained. These data show that the 
simultaneous presence of the same species in rectum and vagina is not a random event, 
but that indeed it is the same strain, which has colonized both sites (100).  
In addition, we found genotypic similarity between the vagina and rectum when 
studying group B streptococci (GBS). For five out of the 19 women from which both 
vaginal and rectal GBS isolates were obtained, all the rectal and vaginal isolates that 
were genotyped were identical. For another 13 of these 19, at least one of the vaginal 
isolates had a similar genotype as one of the rectal isolates (99). Strong genotypic and 
serotypic heterogeneity was observed between women and for individual women, e.g., 
we found a total of 66 genotypes among 118 isolates (from 32 women), of which 4 
women had up to 4 different genotypes in total (rectal + vaginal) and 14 women had up 
to 2 different genotypes vaginally (99). The high level of heterogeneity established in 
our study, compared to other studies, may be due to the different culture media that 
were used and to the use of separate swabs for sampling vagina and rectum for each 
individual woman. The high overall genotypic intraspecific diversity indicates that our 
findings of genotypic identity between rectal and vaginal isolates of the same subject is 
genuine and not due to a bias as might be caused e.g. by low discriminatory power of the 
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genotyping method used, or overall low genotypic diversity within the species S. 
agalactiae. 
Using qPCR, it was also possible to assess whether the vaginal and rectal bacterial loads 
corresponded (96). We found indeed significant positive correlations between vaginal 
and rectal colonization, i.e. there was high degree of correspondence between vaginal 
bacterial load and rectal bacterial load for five of the six species, i.e. A. vaginae, L. 
crispatus, L. gasseri, L. iners and L. jensenii, indicating that not only the same species and 
strains can be present simultaneously in both niches, but also that cell densities per 
bacterial species do correlate between both niches, confirming that both niches are in 
close correspondence.  
This study (96) also confirmed previous findings of our group (75), as we found positive 
correlation between the bacterial load for G. vaginalis and A. vaginae, i.e. the bacterial 
load of both species was low in normal VMF (grades Ia and Iab), and high in disturbed 
VMF (grades II and III). Negative correlations were found between L. crispatus and G. 
vaginalis and also between L. crispatus and A. vaginae. In our study, A. vaginae was found 
less frequently than G. vaginalis in non-grade III samples, but was present in high 
concentrations in 10 of the 12 grade III samples, confirming that the presence of A. 
vaginae seems to be a diagnostically more valuable marker for BV than the presence of 
G. vaginalis, as suggested by Verhelst et al. (379) and confirmed by several other studies 
(38, 44, 75, 117). 
In accordance, Swidsinski et al. (358) concluded that bacterial vaginosis does not occur 
as a result of simple growth per continuum of perianal bacterial biofilm migrating to the 
vagina, but that some species originating from the intestinal tract, e.g. G. vaginalis, do 
display pronounced vaginotropism, whereas many other species do not.  
 
III.3. Comparison of culture and qPCR to characterize the vaginal 
and rectal microflora 
Both culture and molecular methods have their advantages and drawbacks. Cultivation 
of bacteria enables to obtain critical insights about the microbial phenotypic 
 156 
 
characteristics, that are difficult to  derive from molecular studies. Furthermore, 
cultivated microbes allow for the experimental manipulation of these organisms in the 
laboratory and the testing of hypotheses about pathogenesis and virulence factors. 
Accordingly, cultivation studies remain an important area of investigation in vaginal 
microbiology research (85).  
Besides for basic research, the VMF is also studied for diagnostic reasons. Because the 
microflora of the human vagina can affect the health of women, their fetuses, and 
newborns and because conventional cultivation methods fail to detect some fastidious 
vaginal bacteria, leading to an incomplete census, the development of highly sensitive 
molecular methods for detection of (pathogenic) bacteria has been a central topic of 
research in gynaecological and obstetric microbiology during the last decades.  
The major limitation of culture-based methods has been described as ‘the great plate 
count anomaly’, because only a small fraction of microorganisms that are present in a 
population can be cultured (170). Cultivation-based characterization of the VMF is 
further biased by the type of culture medium and microbial density present in the 
sample. For example, L. jensenii forms larger colonies on Schaedler than on Columbia 
agar, which results in an easier isolation of L. jensenii from the former medium, but on 
the other hand this renders it more difficult to isolate other species on Schaedler agar 
from a sample mainly colonized with L. jensenii. L. iners does not grow on MRS agar, 
routinely used for detection of lactobacilli in vaginal samples, and has therefore been 
overlooked in many studies. 
Recent advances in molecular biology have facilitated the detection and identification of 
bacteria without cultivation. The most commonly employed target for molecular 
identification of bacteria is the small ribosomal subunit or 16S rRNA gene. The 16S rRNA 
gene is useful, because it is present in all bacteria and has regions of sequence 
conservation that can be targeted with broad range PCR primers and areas of sequence 
heterogeneity that can be used to identify bacteria or infer phylogenetic relationships 
(15, 317, 394). Molecular studies of the VMF help to augment, but do not replace, the 
census data generated using cultivation-based approaches. They have made it possible 
to discover many non-cultivable or fastidious bacterial species, such as A. vaginae (379), 
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BV-associated bacteria (BVAB) - belonging to the Clostridiales, and bacteria related to 
Megasphaera, Leptotrichia and Dialister (349).  
We established significant differences between the detection of six bacterial species of 
the vaginal and rectal microflora using culture and qPCR. The carriage rate was 3-fold 
(for L. crispatus) to 17-fold (for A. vaginae) higher according to qPCR than according to 
culture. Women were positive for the six species in 4.0 to 32.3% of cases according to 
culture, compared to 68.5 to 91.5% of cases according to qPCR. Using qPCR, we could 
also detect L. iners in high numbers vaginally and rectally when compared to other 
studies of the rectal microflora (5, 238), which may be of additional importance because 
several recent molecular studies (119, 186) indicate that the possible role of this 
peculiar lactobacillar species in the transition between balanced and imbalanced VMF 
needs further elucidation.  
Using two different qPCR assays in GBS detection from pregnant women(97), we found 
that  qPCR approach after Lim broth enrichment generated significantly (p < 0.001; 
McNemar’s test) more positive results (33%) than did the culture method (22%). qPCR 
after Lim broth enrichment also detected GBS in six additional women, compared to 
qPCR directly from the rectovaginal swab (27%) (p < 0.05 ; McNemar’s test). No 
difference was found between both types of qPCR, i.e. hybridization probe technology 
targeting the cfb gene and hydrolysis probe technology targeting the sip gene. 
While molecular methods have many advantages over cultivation approaches for 
characterizing microbial diversity, there are also limitations (18, 123). Use of universal 
primers targeting conserved regions of the 16S rRNA gene may not detect all bacteria 
present in a sample due to the presence of polymorphic nucleotides at conserved 
positions. This was pointed out by Verhelst et al. (379), who found that the ‘universal’ 
16S rRNA gene primers, used by many research groups, failed to amplify this gene from 
G. vaginalis, because of the presence of 3 mismatches in the forward primer. 
Another problem is primer specificity, e.g., when using the primers of L. jensenii for 
qPCR, we recently discovered (personal communication Piet Cools) an aspecific – false 
positive - reaction in some (African) vaginal samples. We could show that this was due 
to the amplification of an undefined fragment present in the L. iners genome and thus 
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occurred only for samples where L. iners was present. The use of a hydrolysis probe, so 
that only specific amplification is reported, could solve this problem.  
Heterogeneity of the 16S rRNA gene can also hamper  analysis (313), because the 
conserved primer regions may contain some mismatches for some species anyway. 
Lowering the annealing temperature during PCR to enable amplification of those species 
with some primer mismatches, may also allow nonspecific amplification of DNA from 
human tissues (349). 
The DNA extraction step is also vital to obtain a representative pool of DNA, which will 
then be used for PCR amplification. Species bias for different extraction methods has 
been described (240, 351), and can originate from differences in the kits used for DNA 
extraction, or from the fact that the DNA of Gram negative bacteria is much easier to 
isolate than that of Gram positives (131), due to the thick peptidoglycan layer of the 
latter. 
Presence of inhibitors in the clinical samples from blood, mucus, or vaginal products can 
lead to failed or reduced amplification. Amplification controls are useful in tracking DNA 
quality whereby the efficiency of amplification of human target genes such as beta-
globin (130) or the 18S rRNA gene (199) can be assessed. Use of internal amplification 
controls by adding an exogenous template at known concentrations to the clinical 
samples can help in detection of PCR inhibitors (239), particularly when performing 
quantitative PCR analysis.  
The opposite problem is formed by false positives, which can occur especially when 
broad range bacterial primers are used. Low levels of bacterial DNA may be present in 
the laboratory (carry over of previously amplified DNA), in DNA extraction kits or in PCR 
reagents, such as recombinant Taq polymerase (32, 318). A way to monitor this problem 
is to include negative (no template) controls in every run of PCR, which allow for 
detection of this type of contaminants.  
The PCR amplification step itself can introduce biases such as skewed representation of 
a sample based on the different guanosine plus cytosine (G+C) contents of the bacterial 
species (93), because bacteria with a higher G+C content of the target may be more 
difficult to amplify when compared with bacteria with lower G+C.  
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III.4. Prenatal screening of group B streptococci  
In 2002, the Center for Disease Control and Prevention (CDC) published revised 
guidelines for the prevention of perinatal GBS disease, and recommended routine 
culture for all pregnant women between 35 and 37 weeks of gestation (320). These 
recommendations were prompted by the recognition that a culture-based screening 
strategy is at least 50% more effective in preventing neonatal infection than the 
previously recommended risk-based screening (322).  
Different culture-based approaches have been developed. Because GBS are components 
of the complex normal microflora in the human vagina and rectum, GBS-selective broth 
media supplemented with antibiotics that inhibit growth of non-GBS organisms have 
been developed to improve GBS recovery from clinical samples (190).  
In 2010, the Center for Disease Control and Prevention (CDC) published new guidelines 
for the prevention of perinatal GBS disease (58), and recommended the use of  selective 
broth that incorporates chromogenic pigments for GBS detection and as optionally, 
direct broth testing using DNA probe, latex agglutination or nucleic acid amplification 
techniques. 
In our first study (99), which included 150 pregnant women, we compared the number 
of GBS positive women when assessed Granada agar, only after Lim broth enrichment, 
and Columbia CNA agar, with or without enrichment. Lim broth combined with Granada 
agar enabled detection of all the women that were found GBS positive in this study (n = 
36), whereas direct inoculation onto Columbia CNA agar achieved a sensitivity of 40% 
and subculture of the Lim broth onto Columbia CNA agar detected 81% of the carriers 
(99).  
In our second study (98), which included an additional 100 pregnant women, we 
compared Granada agar and Chromagar, with and without prior Lim broth enrichment, 
and found the same sensitivity for both media. In addition, we found that Lim broth 
enabled the detection of only one additional sample, leading to 22 GBS (22%) positive 
cultures. This is in agreement with some studies that found comparable sensitivity 
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between Granada agar plating directly from the sample and after Lim Broth enrichment 
(78, 140, 386), whereas other studies found direct plating significantly less sensitive 
(151, 270). Although the published materials and methods do not enable to fully support 
the following statement, this difference might possibly be explained by different brands 
of the plates used. 
Our data suggest that Granada agar and Chromagar are not only faster and easier to use 
than the CDC recommended method, but is also at least as sensitive for the detection of 
GBS. This is in agreement with other studies (277, 282, 362). The cost of using direct 
Granada agar or Chromagar may be comparable to Lim Broth enrichment and 
subculture on blood agar. Finally, direct plating onto Chromagar, besides being equally 
sensitive and rapid as direct plating onto Granada agar, in addition did not require 
anaerobic incubation as is the case for Granada agar. The specificity problems associated 
with the use of Chromagar, i.e. three false positive colonies, which were shown to be 
Streptococcus anginosus, can be resolved by confirmation of Chromagar positive isolates 
with the CAMP test.  
The only other research groups studying chromogenic agars so far did so only for 
vaginal samples (277, 362), whereas we also included the CDC recommended 
vaginorectal sampling method. We concluded that vaginorectal swabs were the best 
samples to detect colonization by S. agalactiae in pregnant women, in correspondence 
with previous reports (2, 57, 83).  
Rapid detection methods for GBS may be advantageous for women who present in labor 
without any information on their GBS colonization status. Ke et al. (196) developed a 
qPCR method based on amplification of a cfb gene fragment that is present in virtually 
every strain of GBS. Also Bergh et al. (22) established a qPCR targeting the sip gene 
universally present across all serotypes of GBS. We compared both approaches and 
found both of them had the same sensitivity and specificity (97). qPCR methods that 
offer the ability to detect GBS colonization within 1 h of sample receipt, have also been 
developed (72). The BD GeneOhm StrepB test (BD GeneOhm Sciences, San Diego, CA; 
formerly IDI-StrepB), the Cepheid GeneXpert GBS and Smart GBS (Cepheid, Sunnyvale, 
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CA) offer detection of GBS directly from vaginorectal swabs for antepartum or 
intrapartum detection of GBS colonization. 
We also compared the sensitivity of the most sensitive culture method, i.e. Lim broth 
enrichment combined with Chromagar (97), with the two qPCR methods (22, 196). Our 
study found that 33% of pregnant women were colonized with GBS according to the 
qPCR assays, whereas only 22 women were found positive using Lim broth and 
subculture on Chromagar. This was in agreement with other studies that report 
increases of GBS positive women of 12% to 21% using PCR (68, 72, 288).  
Interestingly, in our study, GBS was detected with qPCR from six additional women, only 
from DNA extracted from the Lim broth and not from the DNA extracted directly from 
the sample: In total, 33 GBS positive women were detected by Lim broth enrichment, 
followed by qPCR, whereas only 27 were detected by direct qPCR. Few other studies 
compared direct molecular methods with molecular methods after broth enrichment. In 
a conference abstract, Maloney et al. (236) reported that the sensitivity of the BD 
GeneOhm StrepB was higher for specimens pre-incubated in Lim broth than for the 
same specimens with direct testing, but no data were provided. Also in correspondence 
to our findings, Rallu et al. (30) reported that, out of a total of 605 vaginorectal 
specimens, Lim broth-enhanced scpB PCR identified 226 samples (37%) as GBS positive, 
whereas culture identified only 96 samples (16%) as positive.  
It may be of importance to note that the prevalence of GBS positive women, which was 
established as 33% according to our findings on the basis of qPCR, exceeds largely the 
estimated prevalence of 13-25%, as estimated by the Belgian reference laboratories in 
collaboration with the section of epidemiology of the Scientific Institute for Public 
Health (ISP-WIV, Brussels) (150). The data of this National Institute are of course based 
on culture, and our culture based prevalence estimation (22%) indeed corresponds with 
these data.  
The advantages of molecular applications, increased sensitivity and decreased time of 
result relative to culture, are clear, also from our study. One disadvantage of the 
molecular detection of GBS, directly from the samples, is that there is no isolate readily 
available for susceptibility testing as needed for penicillin-allergic patients, but our most 
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sensitive method, Lim broth enrichment combined with qPCR, circumvents this 
problem, at the expense of increased time-to-result.  
In conclusion, the combined data from our studies and from most other studies indicate 
that direct culture on selective media like Granada agar and Chromagar is equally 
sensitive as Lim broth enriched culture. Because we found Chromagar slightly more 
sensitive and especially because it can be incubated aerobically, the latter may be the 
preferable method. Furthermore, when comparing two different qPCR formats targeting 
different genes, we found both approaches to be equally sensitive, but more importantly, 
to be more sensitive and rapid than culture. The most sensitive approach turned out to 
be Lim broth enrichment followed by qPCR (recommended as an option by the most 
recent CDC guidelines of 2010 (58), which reduces speed again and therefore 
intrapartum applicability.  
 
III.5. Further perspectives 
In our study we reported high species- and strain similarity between vaginal and rectal 
microflora (96, 99, 100), strongly suggestive for the important role of the rectum as a 
source of vaginal colonization not only at the level of the normal VMF but also of species 
like G. vaginalis and A. vaginae, typical for disturbed microflora. Although  it is difficult to 
establish studies which clearly indicate that it is the rectum that serves as a source for 
vaginal colonization and not vice versa, the former is more likely, also because studies 
with orally administered probiotic lactobacilli showed that these were able to colonize 
the vagina (293). Studies whereby the dynamics of the vaginal and rectal microflora are 
detailed, by collecting consecutive samples from the same subject during e.g. two 
menstrual cycles (ongoing PhD Research Guido Lopes dos Santos Santiago, LBR), might 
shed more light on the primary source of the vaginal microflora. In addition, 
metagenomic studies, as possible by next generation sequencing (229, 286), may 
enhance largely our capacities to document the microbial overlapping and exchange 
between both niches, although it should be kept in mind that the biases, introduced by 
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nucleic acid extraction and amplification, as discussed above, should be taken into 
account.  
Furthermore, because of the likeliness that the rectum serves as the source for vaginal 
(re-)colonisation, the capacity of vaginally introduced lactobacilli to colonize the rectum 
may also be an important criterion that should be considered in the choice of a probiotic 
strain for the reconstitution of vaginal lactobacilli and the normal vaginal microflora.  
Given the epidemiological differences between L. crispatus, L. jensenii, L. gasseri and L. 
iners (380, 381), confirmed by one of our studies (96), detailed characterization of 
metabolic pathways and adherence properties of these species through pan-genomic 
studies (see I.5.2) might pinpoint why L. crispatus apparently confers colonization 
resistance while the other Lactobacillus species do not or to a lesser extent. The question 
is which characteristics of L. crispatus inhibit growth of other bacteria and why the 
presence of L. crispatus in pregnant women decreases the likelihood of other vaginal  
bacteria  are found later in pregnancy (382). For A. vaginae and G. vaginalis, two species 
predominantly present in disturbed VMF, pan-genomic studies can help to determine 
whether the presence of these species is merely a sign of disturbance rather than that 
they possess special enzymatic activity which confers to the disturbance of the normal 
VMF. 
Regarding our studies on Streptococcus agalactiae or group B streptococci (GBS), it is 
clear that also here technological advances will further improve infection prevention 
and treatment efforts. Our work, although on a limited series of women (97, 99), 
convincingly showed the value of the selective solid media, such as Granada agar (79, 
304) and Chromagar (277, 362), obviating the need for broth enrichment and speeding 
up the culture-based procedure. Probably, this is the best culture-based solution at the 
moment and little further improvement on the basis of culture seems possible, except 
maybe in reducing the already limited number of false positive (Chromagar) and false 
negative (Granada agar) colonies. 
Our study, comparing culture and qPCR (97) showed, that - although culture has been 
optimized as much as possible (see above) - the estimation by qPCR of the number of 
women  positive for GBS, largely exceeds that of the culture-based estimation. Future 
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research might consist of renewed screening on a national basis to establish the 
prevalence of GBS positive women in Belgium, as assessed by molecular techniques.  
Advantages of rapid and reliable intrapartum screening, that can be performed in the 
labor and delivery area,  could lead to an  additional decrease in the incidence of early-
onset neonatal GBS infections and in morbidity and mortality associated with those 
infections. The availability of such screening methods offers the potential for GBS 
detection among women without prenatal care, or in women who are admitted in 
preterm labour. The qPCR technology which makes intrapartum screening possible, is 
relatively new, and thus far its use does not appear to be widespread among hospitals. 
At present, only biochemistry and haematology laboratories can deliver  results within 1 
h. As qPCR tests become more widely available, the possibility of precise microbial 
identification for selected pathogens in 30–45 min instead of 2–3 days may be 
generalized, increasing the appropriateness of clinical management of pregnant women 
at delivery.  
The cost of in house qPCR and culture (chromogenic agars and enrichment broths) may 
be comparable. Commercial qPCR (e.g., 40 Euro for one GeneExpert Assay on the 
Cepheid Smart Cycler) is at present much more expensive than culture. 
Future research should document how relevant the diagnostic value of intrapartum 
screening really is, compared to prepartum screening. It should be noted that our 
quantitative molecular data, as possible by means of qPCR, indicate that women who are 
positive only after Lim broth enriched qPCR are colonized by lower numbers of GBS. 
Future studies should clarify whether it is of clinical importance to detect also pregnant 
women colonized by low numbers of GBS. If it turns out that it is clinically important to 
detect every GBS positive woman, including those with a low colonisation load, there 
will be a continued need to combine molecular methods with culture-based enrichment 
to obtain maximum sensitivity. As a consequence, intrapartum screening, although 
possible because of the extremely rapid and technically non-demanding approaches, 
such as GeneXpert GBS assay, whereby DNA-extraction, qPCR and interpretation are 
reduced to a minimum of handling (101, 136), obviating the need of culture, may need to 
be reconsidered. It will have to be decided whether the advantages of culture-free and 
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thus rapid intrapartum screening outweigh the fact that a category of the carriers, i.e. 
the low load GBS carriers, is missed. 
As mentioned in the CDC recommendation, chemoprophylaxis for prevention of GBS 
disease has some limitations, including the emergence of antibiotic-resistant bacteria 
and the occurrence of side effects associated with the administered antibiotics (59). 
Possibly, the continued development of strategies aiming at active maternal 
immunisation might offer a better solution for prevention of GBS disease. Vaccination of 
women could be a future alternative in preventing both early-onset and late-onset 
neonatal GBS infection by transplacental transfer of protective IgG antibodies (19, 141). 
This strategy might be effective in reducing neonatal infection and may as well have an 
impact on perinatal and maternal infectious morbidity (335).  
Trials of protein conjugate vaccines have been performed, as reviewed by Pettersson et 
al. (278). These trials have demonstrated that these vaccines are safe, well tolerated and 
immunogenic, producing an increase in antibody levels known to prevent disease in 
90% of the subjects. Moreover, in these trials the antibody response was observed to 
persist for more than a year in the mother while the passive protection in the neonate 
persisted for at least 3 months. The authors concluded that a large randomized trial is 
needed, confirming the high efficacy in reducing neonatal infection, before a vaccination 
strategy can be considered as an alternative in preventing GBS infection in newborns.  
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